
<html lang="en"     class="pb-page"  data-request-id="76ba8b56-f197-4d3c-a5b6-28f77e0a3dd9"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/jm400731m;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2013.56.issue-20"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Benzazepinones and Benzoxazepinones as Antagonists of Inhibitor of Apoptosis Proteins (IAPs) Selective for the Second Baculovirus IAP Repeat (BIR2) Domain" /></meta><meta name="dc.Creator" content="Andrew F.  Donnell" /></meta><meta name="dc.Creator" content="Christophe  Michoud" /></meta><meta name="dc.Creator" content="Kenneth C.  Rupert" /></meta><meta name="dc.Creator" content="Xiaochun  Han" /></meta><meta name="dc.Creator" content="Douglas  Aguilar" /></meta><meta name="dc.Creator" content="Karl B.  Frank" /></meta><meta name="dc.Creator" content="Adrian J.  Fretland" /></meta><meta name="dc.Creator" content="Lin  Gao" /></meta><meta name="dc.Creator" content="Barry  Goggin" /></meta><meta name="dc.Creator" content="J. Heather  Hogg" /></meta><meta name="dc.Creator" content="Kyoungja  Hong" /></meta><meta name="dc.Creator" content="Cheryl A.  Janson" /></meta><meta name="dc.Creator" content="Robert F.  Kester" /></meta><meta name="dc.Creator" content="Norman  Kong" /></meta><meta name="dc.Creator" content="Kang  Le" /></meta><meta name="dc.Creator" content="Shirley  Li" /></meta><meta name="dc.Creator" content="Weiling  Liang" /></meta><meta name="dc.Creator" content="Louis J.  Lombardo" /></meta><meta name="dc.Creator" content="Yan  Lou" /></meta><meta name="dc.Creator" content="Christine M.  Lukacs" /></meta><meta name="dc.Creator" content="Steven  Mischke" /></meta><meta name="dc.Creator" content="John A.  Moliterni" /></meta><meta name="dc.Creator" content="Ann  Polonskaia" /></meta><meta name="dc.Creator" content="Andrew D.  Schutt" /></meta><meta name="dc.Creator" content="Dave S.  Solis" /></meta><meta name="dc.Creator" content="Anthony  Specian" /></meta><meta name="dc.Creator" content="Robert T.  Taylor" /></meta><meta name="dc.Creator" content="Martin  Weisel" /></meta><meta name="dc.Creator" content="Stacy W.  Remiszewski" /></meta><meta name="dc.Description" content="XIAP is a key regulator of apoptosis, and its overexpression in cancer cells may contribute to their survival. The antiapoptotic function of XIAP derives from its BIR domains, which bind to and inh..." /></meta><meta name="Description" content="XIAP is a key regulator of apoptosis, and its overexpression in cancer cells may contribute to their survival. The antiapoptotic function of XIAP derives from its BIR domains, which bind to and inh..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 1, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400731m" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400731m" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400731m" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400731m" /></link>
        
    
    

<title>Benzazepinones and Benzoxazepinones as Antagonists of Inhibitor of Apoptosis Proteins (IAPs) Selective for the Second Baculovirus IAP Repeat (BIR2) Domain | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400731m" /></meta><meta property="og:title" content="Benzazepinones and Benzoxazepinones as Antagonists of Inhibitor of Apoptosis Proteins (IAPs) Selective for the Second Baculovirus IAP Repeat (BIR2) Domain" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0022.jpeg" /></meta><meta property="og:description" content="XIAP is a key regulator of apoptosis, and its overexpression in cancer cells may contribute to their survival. The antiapoptotic function of XIAP derives from its BIR domains, which bind to and inhibit pro-apoptotic caspases. Most known IAP inhibitors are selective for the BIR3 domain and bind to cIAP1 and cIAP2 as well as XIAP. Pathways activated upon cIAP binding contribute to the function of these compounds. Inhibitors selective for XIAP should exert pro-apoptotic effects through competition with the terminal caspases. This paper details our synthetic explorations of a novel XIAP BIR2-selective benzazepinone screening hit with a focus on increasing BIR2 potency and overcoming high in vivo clearance. These efforts led to the discovery of benzoxazepinone 40, a potent BIR2-selective inhibitor with good in vivo pharmacokinetic properties which potentiates apoptotic signaling in a manner mechanistically distinct from that of known pan-IAP inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400731m"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400731m">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400731m&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400731m&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400731m&amp;href=/doi/10.1021/jm400731m" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 7772-7787</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm400325j" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm400732v" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Benzazepinones and Benzoxazepinones as Antagonists of Inhibitor of Apoptosis Proteins (IAPs) Selective for the Second Baculovirus IAP Repeat (BIR2) Domain</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+F.++Donnell">Andrew F. Donnell</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christophe++Michoud">Christophe Michoud</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth+C.++Rupert">Kenneth C. Rupert</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaochun++Han">Xiaochun Han</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Douglas++Aguilar">Douglas Aguilar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karl+B.++Frank">Karl B. Frank</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adrian+J.++Fretland">Adrian J. Fretland</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lin++Gao">Lin Gao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barry++Goggin">Barry Goggin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J.+Heather++Hogg">J. Heather Hogg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kyoungja++Hong">Kyoungja Hong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cheryl+A.++Janson">Cheryl A. Janson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+F.++Kester">Robert F. Kester</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Norman++Kong">Norman Kong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kang++Le">Kang Le</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shirley++Li">Shirley Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Weiling++Liang">Weiling Liang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Louis+J.++Lombardo">Louis J. Lombardo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yan++Lou">Yan Lou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine+M.++Lukacs">Christine M. Lukacs</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Mischke">Steven Mischke</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+A.++Moliterni">John A. Moliterni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ann++Polonskaia">Ann Polonskaia</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+D.++Schutt">Andrew D. Schutt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dave+S.++Solis">Dave S. Solis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anthony++Specian">Anthony Specian</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+T.++Taylor">Robert T. Taylor</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Weisel">Martin Weisel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stacy+W.++Remiszewski">Stacy W. Remiszewski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>â </sup>Departments of Discovery Chemistry, <sup>â¡</sup>Discovery Technologies, <sup>Â§</sup>Non-clinical Safety, Early ADME, and <sup>â¥</sup>Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#61000f051304164f074f050e0f0f040d0d21060c00080d4f020e0c"><span class="__cf_email__" data-cfemail="cbaaa5afb9aebce5ade5afa4a5a5aea7a78baca6aaa2a7e5a8a4a6">[emailÂ protected]</span></a>. Phone: (609) 785-1304.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400731m&amp;href=/doi/10.1021%2Fjm400731m" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 7772â7787</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 1, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 May 2013</li><li><span class="item_label"><b>Published</b> online</span>1 October 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 October 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400731m" title="DOI URL">https://doi.org/10.1021/jm400731m</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7772%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAndrew%2BF.%2BDonnell%252C%2BChristophe%2BMichoud%252C%2BKenneth%2BC.%2BRupert%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D20%26contentID%3Djm400731m%26title%3DBenzazepinones%2Band%2BBenzoxazepinones%2Bas%2BAntagonists%2Bof%2BInhibitor%2Bof%2BApoptosis%2BProteins%2B%2528IAPs%2529%2BSelective%2Bfor%2Bthe%2BSecond%2BBaculovirus%2BIAP%2BRepeat%2B%2528BIR2%2529%2BDomain%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7787%26publicationDate%3DOctober%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400731m"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2124</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">22</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400731m" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Benzazepinones and Benzoxazepinones as Antagonists of Inhibitor of Apoptosis Proteins (IAPs) Selective for the Second Baculovirus IAP Repeat (BIR2) Domain&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;F. Donnell&quot;},{&quot;first_name&quot;:&quot;Christophe&quot;,&quot;last_name&quot;:&quot;Michoud&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;C. Rupert&quot;},{&quot;first_name&quot;:&quot;Xiaochun&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;Aguilar&quot;},{&quot;first_name&quot;:&quot;Karl&quot;,&quot;last_name&quot;:&quot;B. Frank&quot;},{&quot;first_name&quot;:&quot;Adrian&quot;,&quot;last_name&quot;:&quot;J. Fretland&quot;},{&quot;first_name&quot;:&quot;Lin&quot;,&quot;last_name&quot;:&quot;Gao&quot;},{&quot;first_name&quot;:&quot;Barry&quot;,&quot;last_name&quot;:&quot;Goggin&quot;},{&quot;first_name&quot;:&quot;J.&quot;,&quot;last_name&quot;:&quot;Heather Hogg&quot;},{&quot;first_name&quot;:&quot;Kyoungja&quot;,&quot;last_name&quot;:&quot;Hong&quot;},{&quot;first_name&quot;:&quot;Cheryl&quot;,&quot;last_name&quot;:&quot;A. Janson&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;F. Kester&quot;},{&quot;first_name&quot;:&quot;Norman&quot;,&quot;last_name&quot;:&quot;Kong&quot;},{&quot;first_name&quot;:&quot;Kang&quot;,&quot;last_name&quot;:&quot;Le&quot;},{&quot;first_name&quot;:&quot;Shirley&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Weiling&quot;,&quot;last_name&quot;:&quot;Liang&quot;},{&quot;first_name&quot;:&quot;Louis&quot;,&quot;last_name&quot;:&quot;J. Lombardo&quot;},{&quot;first_name&quot;:&quot;Yan&quot;,&quot;last_name&quot;:&quot;Lou&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;M. Lukacs&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Mischke&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;A. Moliterni&quot;},{&quot;first_name&quot;:&quot;Ann&quot;,&quot;last_name&quot;:&quot;Polonskaia&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;D. Schutt&quot;},{&quot;first_name&quot;:&quot;Dave&quot;,&quot;last_name&quot;:&quot;S. Solis&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;Specian&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;T. Taylor&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Weisel&quot;},{&quot;first_name&quot;:&quot;Stacy&quot;,&quot;last_name&quot;:&quot;W. Remiszewski&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;01&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;7772-7787&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400731m&quot;},&quot;abstract&quot;:&quot;XIAP is a key regulator of apoptosis, and its overexpression in cancer cells may contribute to their survival. The antiapoptotic function of XIAP derives from its BIR domains, which bind to and inhibit pro-apoptotic caspases. Most known IAP inhibitors are selective for the BIR3 domain and bind to cIAP1 and cIAP2 as well as XIAP. Pathways activated upon cIAP binding contribute to the function of these compounds. Inhibitors selective for XIAP should exert pro-apoptotic effects through competition with the terminal caspases. This paper details our synthetic explorations of a novel XIAP BIR2-selective benzazepinone screening hit with a focus on increasing BIR2 potency and overcoming high in vivo clearance. These efforts led to the discovery of benzoxazepinone 40, a potent BIR2-selective inhibitor with good in vivo pharmacokinetic properties which potentiates apoptotic signaling in a manner mechanistically distinct from that of known pan-IAP inhibitors.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400731m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400731m" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400731m&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400731m" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400731m&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400731m" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400731m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400731m&amp;href=/doi/10.1021/jm400731m" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400731m" /></input><a href="/doi/pdf/10.1021/jm400731m" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400731m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400731m%26sid%3Dliteratum%253Aachs%26pmid%3D24083782%26genre%3Darticle%26aulast%3DDonnell%26date%3D2013%26atitle%3DBenzazepinones%2Band%2BBenzoxazepinones%2Bas%2BAntagonists%2Bof%2BInhibitor%2Bof%2BApoptosis%2BProteins%2B%2528IAPs%2529%2BSelective%2Bfor%2Bthe%2BSecond%2BBaculovirus%2BIAP%2BRepeat%2B%2528BIR2%2529%2BDomain%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D20%26spage%3D7772%26epage%3D7787%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jmcmar.2013.56.issue-20/production/jmcmar.2013.56.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">XIAP is a key regulator of apoptosis, and its overexpression in cancer cells may contribute to their survival. The antiapoptotic function of XIAP derives from its BIR domains, which bind to and inhibit pro-apoptotic caspases. Most known IAP inhibitors are selective for the BIR3 domain and bind to cIAP1 and cIAP2 as well as XIAP. Pathways activated upon cIAP binding contribute to the function of these compounds. Inhibitors selective for XIAP should exert pro-apoptotic effects through competition with the terminal caspases. This paper details our synthetic explorations of a novel XIAP BIR2-selective benzazepinone screening hit with a focus on increasing BIR2 potency and overcoming high in vivo clearance. These efforts led to the discovery of benzoxazepinone <b>40</b>, a potent BIR2-selective inhibitor with good in vivo pharmacokinetic properties which potentiates apoptotic signaling in a manner mechanistically distinct from that of known pan-IAP inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84431" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84431" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Apoptosis is a cell death program that is essential for normal physiological function, and the ability to avoid apoptosis is one of the characteristics of cancer cells.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The inhibitor of apoptosis proteins (IAPs) are key regulators of the apoptosis pathways and are often overexpressed in cancer cells, rendering them potential targets for cancer therapy.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5">(2-5)</a> Members of the IAP family include X-linked IAP (XIAP), cellular IAP 1 (cIAP1), cellular IAP 2 (cIAP2), and others.</div><div class="NLM_p">There are two major pathways for apoptotic signal transduction. The intrinsic pathway is activated by intracellular stress, such as that caused by chemotherapy and radiation, and leads to the activation of caspase 9. The extrinsic pathway is activated in response to extracellular signals mediated through the death receptors and leads to the activation of caspase 8. Both pathways converge by causing the activation of the effector caspases 3 and 7. XIAP regulates both pathways by directly binding to and inhibiting caspases 3, 7, and 9 via two of its three baculovirus IAP repeat (BIR) domains.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The BIR3 domain of XIAP binds to and inhibits caspase 9,<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> and the BIR2 domain is involved with caspase 3 and 7 binding.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a></div><div class="NLM_p">Second mitochondria-derived activator of caspases (Smac, also known as direct IAP-binding protein with a low p<i>I</i>, DIABLO) is an endogenous mitochondrial protein that binds with high affinity to the BIR3 domain of XIAP and the cIAPs and with lower affinity to the BIR2 domain via its N-terminal AVPI peptide sequence.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15">(12-15)</a> This four-peptide motif has inspired substantial interest in compounds that target the IAPs,<a onclick="showRef(event, 'ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19">(16-19)</a> which has resulted in the discovery of several compounds that have entered clinical trials, those illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, SM-406 (<b>1</b>),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> GDC-0152 (<b>2</b>),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and LCL161 (<b>3</b>),<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> as well as one additional monovalent inhibitor and two bivalent inhibitors.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> These compounds are pan-IAP inhibitors that bind to XIAP, cIAP1, and cIAP2. They bind with high affinity to the BIR3 domain of these proteins and, in some cases, are selective for BIR3 over BIR2. In other cases, the BIR2 affinity has not been disclosed. It has been shown that they cause degradation of the cIAPs, leading to production of the cytokine TNFÎ± via NF-ÎºB pathways, and it has been suggested that their activity depends primarily on this process.<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25-27)</a> We expected that competition with the terminal caspases by selective inhibitors of XIAP would present a distinct and attractive mechanism of action, and this could potentially be achieved by selectively targeting the BIR2 domain of XIAP. One recent paper describes a series of Smac-mimetic compounds with up to 7-fold selectivity for XIAP BIR2 versus XIAP BIR3.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Herein, we report the discovery of a novel class of inhibitors that are highly selective for the BIR2 domain of XIAP over the BIR3 domain, and we describe the iterative synthetic explorations and structure-based design efforts leading to a highly potent and selective analogue that has good oral bioavailability. We show that this compound is 78-fold selective for the BIR2 versus the BIR3 domain of XIAP and it is 7-fold selective for XIAP versus cIAP1. We also demonstrate that it affects apoptotic signaling without promoting cIAP-related NF-ÎºB activation, supporting the utility of selective XIAP inhibition via the BIR2 domain as a potential approach for cancer therapy.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. IAP inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A high-throughput screen of our corporate compound library led to the identification of benzazepinone <b>4</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) as a BIR2-selective XIAP inhibitor. The relatively small size (MW 261) and low lipophilicity (cLogP 0.62) of <b>4</b> made it an appealing starting point for a medicinal chemistry campaign. Preliminary exploration of the SAR around this scaffold led to compounds such as <b>5</b>, where benzazepinones and benzoxazepinones had comparable BIR2 potency, <i>N</i>-methylation of the <span class="smallcaps smallerCapital">l</span>-alanine moiety was preferred, and there was room for expansion around the azepinone N-substituent. In particular, substituents containing aromatic groups were preferred in this position.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. HTS hit and initial lead evolution.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23161" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23161" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our studies of the benzazepinone scaffold included the exploration of a range of N-substituents of the azepinone amide. We also explored some modifications to the alanine group. The chemistry to prepare these analogues is outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Starting with the amino benzazepinone <b>6</b>, amide coupling with either BOC-<i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine or the amino acid of interest gave <b>7</b>â<b>11</b>. These compounds were then alkylated with the appropriate alkyl halide or mesylate in the presence of cesium carbonate. Under these conditions, we observed exclusive alkylation of the aniline amide. The BOC group was then removed to provide the final compounds <b>12</b>â<b>23</b>. The compounds were typically isolated and tested as either the HCl or TFA salts.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Benzazepinones <b>12</b>â<b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sup>1</sup>CO<sub>2</sub>H, HBTU, HOBt, Et<sub>3</sub>N, DMF, rt, 47%âquant; (b) R<sup>2</sup>CH<sub>2</sub>X, Cs<sub>2</sub>CO<sub>3</sub>, NaI, DMF, 60 Â°C; (c) HCl, MeOH, Et<sub>2</sub>O, rt or TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 24â60% (2 steps).</p></p></figure><div class="NLM_p">Construction of the benzoxazepinone scaffold commenced with the S<sub>N</sub>Ar reaction of (<i>S</i>)-2-(<i>tert</i>-butoxycarbonylamino)-3-hydroxypropanoic acid (<b>24</b>) and 1-fluoro-2-nitrobenzene to yield ether <b>25</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Reduction of the nitro group, cyclization under amide-coupling conditions, and acidic removal of the BOC group provided the amino benzoxazepinone core <b>26</b>, which was subjected to chemistry similar to that described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> above to prepare compound <b>27</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0013.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Benzoxazepinone <b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, 1-fluoro-2-nitrobenzene, DMF, 0 Â°C, 97%; (b) H<sub>2</sub>, 10% Pd/C, EtOH, rt, 95%; (c) EDCI, DMF, rt, 62%; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C, quant; (e) BOC-<i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine, HBTU, HOBt, Et<sub>3</sub>N, DMF, rt, 95%; (f) 6-bromo-1-(chloromethyl)-2-methoxynaphthalene, Cs<sub>2</sub>CO<sub>3</sub>, NaI, DMF, 60 Â°C, 54%; (g) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C, 56%.</p></p></figure><div class="NLM_p">We also prepared benzoxazepinones with a spirocyclic tetrahydropyran substituent (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). The synthesis of these analogues began with the aldol condensation of dibenzylglycine ethyl ester (<b>28</b>) and dihydro-2<i>H</i>-pyran-4(3<i>H</i>)-one, which was followed by hydrolysis of the ester to provide acid <b>29</b>. The ether linkage of <b>30</b> was formed by the reaction with 1-fluoro-2-nitrobenzene. Chemoselective reduction of the nitro group, cyclization, and removal of the benzyl protecting groups gave the amino benzoxazepinone scaffold <b>31</b>. The amino acid moiety was installed and the diastereomers were separated using SFC to provide <b>32</b>, and then the targeted analogues <b>33</b>â<b>40</b> were made via the same alkylationâdeprotection sequence described above. This proved to be a versatile method for preparing spirocyclic benzoxazepinones, and we synthesized several novel analogues starting from a variety of cyclic ketones (not shown). Analogue <b>36</b>, which has a carboxylic acid at the 6-position of the naphthalene, was prepared from the corresponding aryl bromide by palladium-catalyzed carbonylation and hydrolysis of the resulting methyl ester.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0014.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Spirocyclic Benzoxazepinone Analogues <b>33</b>â<b>40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LDA, THF; dihydro-2<i>H</i>-pyran-4(3<i>H</i>)-one, â78 Â°C to rt, 50%; (b) KOH, H<sub>2</sub>O, MeOH, 60 Â°C, 92%; (c) 1-fluoro-2-nitrobenzene, KHMDS, THF, rt, 92%; (d) Zn, NH<sub>4</sub>Cl, MeOH, 65 Â°C, quant; (e) EDCI, HOBt, DMF, rt, 74%; (f) H<sub>2</sub>, Pd(OH)<sub>2</sub>/C, MeOH, rt, quant; (g) BOC-<i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine, HBTU, HOBt, Et<sub>3</sub>N, DMF, rt, separated diastereomers, 37%; (h) RCH<sub>2</sub>X, Cs<sub>2</sub>CO<sub>3</sub>, NaI, DMF, rtâ70 Â°C; (i) for <b>33</b>â<b>35</b>, <b>37</b>, <b>38</b>, HCl, MeOH, Et<sub>2</sub>O, rt; for <b>39</b>, <b>40</b>, TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C, 44â93% (2 steps); (j) 6-bromo-1-(chloromethyl)-2-methoxynaphthalene, Cs<sub>2</sub>CO<sub>3</sub>, NaI, DMF, 60 Â°C, 54%; (k) CO, MeOH, Pd(OAc)<sub>2</sub>, Xantphos, Et<sub>3</sub>N, 70 Â°C, 67%; (l) LiOHÂ·H<sub>2</sub>O, THFâH<sub>2</sub>O, rt, 88%; (m) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 83%.</p></p></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21600" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21600" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our efforts commenced with a survey of azepinone N-substituents with the aim of improving the XIAP BIR2 potency while retaining selectivity over XIAP BIR3. Results are displayed in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. The starting point was benzyl analogue <b>12</b>. Extended linkers, such as that of <b>13</b>, were disfavored. Naphthyl <b>14</b> was approximately equipotent with <b>12</b>, while the analogue <b>15</b> that was attached at the 1-position of the naphthyl was more potent. We explored a range of substitutions on the naphthyl ring, and analogues such as <b>16</b> provided a modest 2-fold improvement in potency compared with <b>15</b>. Substitution at the 2-position of the naphthyl was preferred, and the 2-methylnaphthyl analogue <b>17</b> had an IC<sub>50</sub> of 0.489 Î¼M. Further improvements were realized by replacing the methyl with a methoxy group (<b>18</b>), and the most promising analogue was 6-bromo-2-methoxynaphthyl <b>19</b>. None of these compounds had any significant activity at XIAP BIR3 at up to 54 Î¼M.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. XIAP Activity for N-Substituted Benzazepinone Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0015.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0016.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">All compounds were HCl salts.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Values are reported as: mean Â± SD (number of determinations).</p></div></div><div></div></div><div class="NLM_p">The 6-bromo-2-methoxynaphthyl analogue <b>19</b> displayed moderate clearance in our in vitro rat liver microsome and hepatocyte assays (17 and 38 mL/min/kg, respectively), however, when we advanced it into rat PK studies (single-compound dosing, 2 mg/kg iv), we observed a very high in vivo clearance rate of 116 mL/min/kg, approximately two times hepatic blood flow. To help determine which structural features contributed to this clearance rate, we conducted an in vivo metabolite identification study in rats by administering a 4 mg/kg iv dose of <b>19</b> and analyzing urine and plasma samples, where we observed significant quantities of the material derived from hydrolysis of the alanine amide.</div><div class="NLM_p">Initially, we sought to stabilize the amide against hydrolysis by modulating the steric properties of the amino acid substituent (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). To efficiently profile the effect of these changes on the clearance values, we employed cassette dosing in our PK studies using groups of 3â4 compounds per study. Selected compounds were tested in both cassette and single-compound PK studies, confirming that each method provided comparable values.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The <span class="smallcaps smallerCapital">d</span>-alanine analogue <b>20</b> was 10-fold less potent than the natural isomer. Some larger substituents were tolerated, such as those of the Î±-aminobutyric acid analogue <b>21</b> and the threonine analogue <b>22</b>, although these groups did not improve the clearance, and in the case of the <b>22</b> it was considerably worse. Larger substituents were significantly less active at BIR2, as were analogues with a quaternary Î±-carbon (data not shown). Some modifications at the N-terminus were tolerated. For example, the methyl group could be replaced by ethyl (<b>23</b>), but this did not affect the clearance rate.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. XIAP Activity for Benzazepinone Amino Acid Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0017.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0018.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">All compounds were HCl salts except <b>21</b> which was a TFA salt.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Values that are the result of multiple determinations are reported as: mean Â± SD (number of determinations).</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Cassette dosing, 0.5 mg/kg iv.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Not tested, the compound was not evaluated in this assay.</p></div></div><div></div></div><div class="NLM_p">These efforts were complicated by a continued lack of correlation between the clearance in rat liver microsomes or hepatocytes and that observed in vivo. Despite conducting the PK studies using cassette dosing, we still lacked sufficient throughput to rapidly build up the structureâproperty relationships necessary to address the clearance issue, so we aimed to develop an alternate in vitro screening protocol. We profiled selected compounds in several systems, including rat liver and kidney S9 fractions, plasma, and whole blood, and we observed a correlation between in vivo clearance and stability in rat whole blood. Compounds were incubated in rat blood for 4 h, and the percent of the compound remaining was quantitated. All compounds with <50% remaining displayed unacceptably high in vivo clearance. For compounds with >50% remaining, we observed a range of in vivo clearance values, suggesting that we were addressing one of multiple potential clearance pathways. Nevertheless, the blood stability assay proved to be a valuable filter to ease our reliance on resource-intensive PK studies. As we continued to modify the scaffold, only those analogues that passed the 50% blood-stability cutoff were profiled in vivo.</div><div class="NLM_p">Another approach we explored for blocking hydrolysis of the amide involved the introduction of substituents onto the azepinone ring. The benzazepinone and benzoxazepinone templates typically provided equivalent activity and carried similar metabolic liabilities (compare <b>19</b> and <b>27</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), so most of these changes were evaluated using the more synthetically tractable benzoxazepinone template. Many of the substitution patterns we examined brought improvements to blood stability, and the spiro-tetrahydropyran <b>33</b> was the most promising (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). It had high blood stability, and when we profiled <b>33</b> in PK studies it had a substantially lower clearance than <b>27</b>, although at 60 mL/min/kg its rate was still close to rat liver blood flow.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Comparison of in Vitro CL and Blood Stability with in Vivo CL across Scaffolds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0019.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center"><b>19</b></th><th class="colsep0 rowsep0" align="center"><b>27</b></th><th class="colsep0 rowsep0" align="center"><b>33</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">XIAP BIR2 IC<sub>50</sub> (Î¼M)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">0.194Â Â±Â 0.124Â (6)</td><td class="colsep0 rowsep0" align="left">0.101Â Â±Â 0.011Â (2)</td><td class="colsep0 rowsep0" align="left">0.065Â Â±Â 0.042Â (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">XIAP BIR3 IC<sub>50</sub> (Î¼M)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">>54Â (6)</td><td class="colsep0 rowsep0" align="left">>54Â (2)</td><td class="colsep0 rowsep0" align="left">23.5Â Â±Â 10.3Â (4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat liver microsomes CL (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat liver hepatocytes CL (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">38</td><td class="colsep0 rowsep0" align="left">n.t.<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat blood stability (% remaining at 4Â h)</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">88</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat iv PK, CL (mL/min/kg)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">155</td><td class="colsep0 rowsep0" align="left">521</td><td class="colsep0 rowsep0" align="left">60</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Values are reported as: mean Â± SD (number of determinations).</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Not tested, the compound was not evaluated in this assay.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Cassette dosing, 0.5 mg/kg iv.</p></div></div></div><div class="NLM_p">While the spiro-tetrahydropyran may have effectively blocked the extrahepatic amide hydrolysis, other degradation pathways would also need to be addressed to bring the clearance of <b>33</b> to an acceptable range for in vivo applications. To determine potential sites of CYP-mediated oxidative metabolism, we incubated <b>33</b> with both rat and human hepatocytes and analyzed the metabolites formed. We detected two major metabolites: one derived from demethylation of the <i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine moiety and the other from demethylation of the methoxy group of the naphthalene. To address the latter issue, we reexamined the naphthyl moiety (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Replacing the methoxy group with methyl caused a 10-fold loss of potency (compound <b>34</b>). Attempts to stabilize the methoxy group with analogues such as the difluoromethoxy <b>35</b> likewise resulted in an unacceptable loss of potency. We did not evaluate the PK properties of these less potent analogues. In a different approach, we looked at other changes such as replacing the bromine with a carboxylic acid (<b>36</b>). The BIR2 potency of this compound was improved, but its clearance was worse. We prepared several heterocyclic analogues to modulate the electronic properties of the ring system. Quinoline <b>37</b> had an acceptable level of BIR2 activity, but its clearance was about 3-fold higher than that of <b>33</b>. Benzisoxazole <b>38</b> was significantly less active. To aid in our design of new analogues, we obtained a cocrystal structure of the carboxylic acid analogue <b>36</b> bound to the XIAP BIR2 domain (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). This also revealed some of the features that may contribute to the selectivity for BIR2 versus BIR3.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> For example, the fused benzene ring of the benzoxazepinone scaffold is situated in close proximity to His223. This is a larger tryptophan residue in BIR3 that would clash with the benzene ring. The naphthyl ring system extends into a hydrophobic pocket between the side chains of Lys206 and Lys208. This pocket is absent in BIR3, which has glycine and threonine at these positions. Additionally, the methoxy group of the naphthyl is in the cleft between His223 and Phe224; this cleft is much more restricted in BIR3 where these residues are tryptophan and tyrosine. The structural data indicated that relatively bulky groups could be added to the solvent-exposed edge of the naphthyl moiety, and we hypothesized that a 2-cyanophenyl group extending from the bicyclic system could accept a hydrogen bond from the backbone NH of Lys206. After modeling several possible arrangements, we expected a 5,6-bicycle such as indazole to optimally position this group (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). To test this, we prepared <b>39</b> and found that it did improve BIR2 potency compared to <b>38</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Notably, this change also brought an improvement to the clearance. Because 2-position substituents on the naphthyl ring generally enhanced the BIR2 affinity, we prepared the analogous indole system of <b>40</b> with a nitrile in that position. This compound exhibited excellent BIR2 potency while maintaining an acceptable clearance rate. Interestingly, this compound also showed a greater level of XIAP BIR3 inhibition than the other analogues, but it was still 78-fold selective for BIR2. The PK properties of this compound were comparable in both rat and mouse and it had good oral exposure (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). We felt that the potency and selectivity of this compound, coupled with its favorable PK profile, would allow us to more fully evaluate the biological properties of this class of XIAP BIR2 inhibitors.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. XIAP Activity of N-Substituted Derivatives of Spirocyclic Benzoxazepinone Core</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0020.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0021.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">All compounds were HCl salts except <b>36</b>, which was a TFA salt and <b>39</b> and <b>40</b> which were free bases.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Values that are the result of multiple determinations are reported as mean Â± SD (number of determinations).</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">Cassette dosing, 0.5 mg/kg iv.</p></div><div class="footnote" id="t4fn4"><sup>Table d</sup><p class="last">Not tested, the compound was not evaluated in this assay.</p></div></div><div></div></div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray cocrystal structure of <b>36</b> bound to the peptide-binding groove of the BIR2 domain of XIAP, represented with an electrostatic surface. Hydrogen-bonding interactions between the ligand and the protein are indicated by dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. The energy-minimized structure of <b>39</b> (green) overlaid with the crystal structure of <b>36</b> (yellow) bound to XIAP BIR2. The energy minimization of <b>39</b> was performed with MOE (Chemical Computing Group Inc., version 2011.10) using the MMFF94x forcefield.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. PK Properties of Compound <b>40</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">property</th><th class="colsep0 rowsep0" align="center">rat, iv<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">mouse, iv<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">mouse, po<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC (ngÂ·h/mL)</td><td class="colsep0 rowsep0" align="left">196</td><td class="colsep0 rowsep0" align="left">543</td><td class="colsep0 rowsep0" align="left">2858</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="left">190</td><td class="colsep0 rowsep0" align="left">495</td><td class="colsep0 rowsep0" align="left">647</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">6.9</td><td class="colsep0 rowsep0" align="left">5.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">4.1</td><td class="colsep0 rowsep0" align="left">8.6</td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">53</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Cassette dosing, 0.5 mg/kg iv.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Single-compound dosing, 1 mg/kg iv.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Single-compound dosing, 10 mg/kg po.</p></div></div></div><div class="NLM_p">To further understand the selectivity profile of <b>40</b>, we measured its activity against the BIR2 and BIR3 domains of cIAP1 (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). This compound did not have any significant activity at the cIAP1 BIR3 domain, but it did have a submicromolar IC<sub>50</sub> for cIAP1 BIR2 inhibition. Still, it was 7-fold selective for XIAP BIR2. Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> also shows the IC<sub>50</sub> values for the known BIR3-selective pan-IAP inhibitor <b>3</b> for comparison.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Biochemical Properties of <b>40</b> Compared to <b>3</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">property</th><th class="colsep0 rowsep0" align="center">value for <b>40</b><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">value for <b>3</b><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left"><b>XIAP activity</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BIR2 IC<sub>50</sub> (Î¼M)</td><td class="colsep0 rowsep0" align="left">0.039Â Â±Â 0.010Â (2)</td><td class="colsep0 rowsep0" align="left">1.05Â Â±Â 0.31Â (2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BIR3 IC<sub>50</sub> (Î¼M)</td><td class="colsep0 rowsep0" align="left">3.06Â Â±Â 0.28Â (2)</td><td class="colsep0 rowsep0" align="left">0.030Â Â±Â 0.009Â (2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left"><b>cIAP1 activity</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BIR2 IC<sub>50</sub> (Î¼M)</td><td class="colsep0 rowsep0" align="left">0.271Â Â±Â 0.115Â (2)</td><td class="colsep0 rowsep0" align="left">2.72Â Â±Â 0.81Â (2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BIR3 IC<sub>50</sub> (Î¼M)</td><td class="colsep0 rowsep0" align="left">>55Â (2)</td><td class="colsep0 rowsep0" align="left">0.058Â Â±Â 0.004Â (2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left"><b>XIAP-caspase reactivation</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EC<sub>50</sub> (Î¼M)</td><td class="colsep0 rowsep0" align="left">0.140</td><td class="colsep0 rowsep0" align="left">0.283</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Values that are the result of multiple determinations are reported as mean Â± SD (number of determinations).</p></div></div></div><div class="NLM_p">To assess the functional competence of BIR2-selective compounds, we profiled <b>40</b> in an in vitro caspase reactivation assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Cellular lysates were treated with cytochrome c and ATP, resulting in activation of caspases. The caspase activity was monitored by the cleavage of the fluorogenic substrate Ac-DEVD-AFC, which is specific for caspase 3/7. Addition of full-length XIAP inhibited the caspase activity and addition of <b>40</b> restored it with an EC<sub>50</sub> of 0.140 Î¼M. This was similar behavior to that observed for <b>3</b>.</div><div class="NLM_p">Compound <b>40</b> was screened for cell-based activity against several cancer cell lines. No single-agent activity was observed, but a significant effect on cell viability was observed in combination with the DR5 antibody conatumumab,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> which provides apoptotic pressure mediated through the extrinsic pathway. In that regard, its activity was compared to that of <b>3</b>. Parts A and B of Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> show the doseâresponse curves for conatumumab in a 5 day MTS assay in SW620 cells in combination with two concentrations of test compound. In the absence of test compound, conatumumab had little effect on cell viability at any of the tested concentrations. Modest sensitization was observed in the presence of 1.1 Î¼M of test compound (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A) and greater sensitization was observed at 3.3 Î¼M (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B). At the latter concentration, <b>40</b> was more effective than <b>3</b>. Similar levels of activity were observed in other cancer cell lines (data is summarized in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>; see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Figure S1">Supporting Information Figure S1</a> for tabulated EC<sub>50</sub> values).</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A,B) Comparison of the activity of <b>3</b> and <b>40</b> in combination with the DR5 antibody conatumumab in SW620 cells in a 5 day MTS cell proliferation assay. Each graph shows doseâresponse curves for conatumumab in the presence of the indicated concentration of test compound. Values are the mean of four determinations Â± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cell line sensitivity to <b>40</b> and <b>3</b> in combination with DR5 agonistic antibody conatumumab. Each bar represents the EC<sub>50</sub> of conatumumab, either alone (blue bars) or in the presence of <b>3</b> (3.3 Î¼M) (red bars) or <b>40</b> (3.3 Î¼M) (green bars) in a 5 day MTS assay measuring viability of the indicated cell line (for LOX cells, the assay was performed in a 3 day format).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To confirm that this antiproliferative activity correlated with increased apoptotic signaling, we measured the caspase 3/7 activity in SW620 cells after treatment with conatumumab in combination with either <b>3</b> or <b>40</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). Slightly elevated caspase 3/7 levels were observed upon treatment with conatumumab alone, and this was potentiated in a dose-dependent manner by both <b>3</b> and <b>40</b>. Again, <b>40</b> promoted greater levels of activity than <b>3</b>.</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Caspase 3/7 activity in SW620 cells 4 h after treatment with the test compounds. Cells were incubated with conatumumab, <b>3</b>, and/or <b>40</b> at the indicated concentrations (combinations used 0.5 Î¼g/mL conatumumab with the indicated concentrations of <b>3</b> or <b>40</b>) for 4 h, and then they were lysed and the caspase 3/7 activity was measured by the cleavage of DEVD-AMC. Values are the mean of two determinations Â± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The BIR3-selective compound <b>3</b> exerts single agent activity in MDA-MB-231 cells that is dependent on cIAP binding and degradation, which leads to increased TNFÎ± levels.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Because <b>40</b> has some affinity for the BIR2 domain of cIAP1, we examined whether it would display a similar activity profile in this system. We treated MDA-MB-231 cells with either <b>3</b> or <b>40</b> and measured TNFÎ± levels after 19 h (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). TNFÎ± levels were significantly elevated in cells treated with <b>3</b>, while cells treated with <b>40</b> were not substantially different from vehicle at up to 10 Î¼M, confirming that <b>40</b> does not induce TNFÎ± in this system.</div><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0009.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Presence of TNFÎ± in the supernate from MDA-MB-231 cells 19 h after treatment with the indicated concentration of BIR3-selective compound <b>3</b> or BIR2-selective compound <b>40</b> in comparison with TNFÎ± standards. Values are the mean of two determinations Â± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further understand the activity of our inhibitor, we conducted an in vivo study using LOX xenograft-bearing nude mice. The mice were treated with a single dose of conatumumab (1 mg/kg ip), <b>3</b> (100 mg/kg po), or <b>40</b> (200 mg/kg po), or a combination of conatumumab with <b>3</b> or <b>4</b>. After 8 h, the tumors were removed, and caspase 3/7 activity was determined using a fluorescence assay based on cleavage of DEVD-AMC (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>). Additionally, the effect on protein levels was examined by Western blot analysis (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>). The caspase activity of conatumumab, <b>3</b>, or <b>40</b> alone was not significantly different from vehicle, whereas in combination with the DR5 antibody, both <b>3</b> and <b>40</b> promoted substantial increases in caspase 3/7 activity. Western blot analysis showed cleavage of PARP and caspase 3 upon treatment with conatumumab in combination with either <b>3</b> or <b>40</b>, consistent with the induction of apoptosis. Compound <b>3</b> promoted substantial levels of cIAP1 degradation, while this was not observed for <b>40</b>. XIAP levels were not significantly impacted by either compound.</div><figure id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0010.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Caspase 3/7 activity in LOX melanoma xenografts. Tumor-bearing nude mice were treated with a single dose of conatumumab (1 mg/kg ip), <b>40</b> (100 mg/kg po), <b>3</b> (200 mg/kg po), or a combination. After 8 h, xenografts were removed and caspase 3/7 activity was determined with a fluorescence assay measuring cleavage of DEVD-AMC. Mean Â± SD is indicated for each group (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0011.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Western blot analysis of LOX melanoma xenograft homogenates after 8 h treatment with a single dose of the DR5 antibody conatumumab (1 mg/kg ip) or a combination of conatumumab (1 mg/kg ip) with <b>3</b> (100 mg/kg po) or <b>40</b> (200 mg/kg po). Each lane is the result of a single xenograft.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Further profiling of <b>40</b> revealed significant in vitro safety liabilities. This compound was both a potent inhibitor and time-dependent inhibitor of CYP3A4, and it also exhibited significant CYP3A4 induction. These liabilities limited the clinical utility of <b>40</b>, however, we felt that we could apply some of the SAR lessons from this investigation to overcome these liabilities using a related benzodiazepinone scaffold. Those optimization efforts are the subject of a <a href="https://doi.org/10.1021/jm400732v">subsequent report</a>.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Despite its liabilities, <b>40</b> is a potent and selective XIAP BIR2 inhibitor with a PK profile suitable for in vivo studies, and it proved to be a valuable tool for investigating the biology of BIR2-selective XIAP inhibitors. In a separate report, we will describe additional studies of the biological utility of <b>40</b>, including a demonstration of in vivo efficacy in a tumor xenograft study.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> These studies support the usefulness of targeting the BIR2-domain to achieve selectivity for XIAP and impact apoptotic pathways in a manner mechanistically differentiated from BIR3-selective pan-IAP inhibitors.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17406" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17406" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Chemistry</h3><div id="sec3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> General</h4><div class="NLM_p last">All commercially available reactants, reagents, and solvents were used as received. Reactions using air- or moisture-sensitive reagents were performed under an atmosphere of Ar or N<sub>2</sub>. Reactions were monitored by LC-MS or TLC. Flash chromatography was performed with Isco CombiFlash Companion or AnaLogix IntelliFlash chromatography systems using prepacked silica gel columns (40â60 Î¼m particle size RediSep or 20â40 Î¼m spherical silica gel RediSep Gold columns purchased from Teledyne Isco or comparable products from other vendors). Preparative HPLC was performed using a Waters HPLC system consisting of a 2767 sample manager, 2525 binary gradient module, and 2996 photodiode array detector with a SunFire Prep C18 OBD column (5 Î¼m, 30 mm Ã 100 mm) eluted with a 10â100% MeCNâH<sub>2</sub>O linear gradient with 0.1% v/v TFA at a flow rate of 30 mL/min or using similar methods on a comparable system. NMR spectra were measured on Bruker 300 or 400 MHz spectrometers. Chemical shifts are reported in ppm downfield from TMS using residual nondeuterated solvent as an internal standard (CHCl<sub>3</sub>, 7.26 ppm; DMSO, 2.50 ppm; MeOH, 3.31 ppm). Data are reported in the form: chemical shift (multiplicity, coupling constants, integration). Multiplicities are recorded by the following abbreviations: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad. HRMS data were recorded on a ThermoFisher OrbiTrap FTMS system using flow injection with electrospray ionization in positive mode. Analytical HPLC and LC-MS analyses were performed using either Waters or Agilent LC-MS systems. The Waters system was comprised of a ZQ mass spectrometer using multimode (ES/APCI) ionization with alternating Â± switching and an ES Industries Chromegabond WR C18 column (3 Î¼m, 120 Ã, 30 mm Ã 3.2 mm) eluted with a 10â90% MeCNâH<sub>2</sub>O linear gradient with 0.1% v/v HCO<sub>2</sub>H. The Agilent system was comprised of a 6140 mass spectrometer using multimode (ES/APCI) ionization with alternating Â± switching and an Agilent Zorbax SB C-18 column (3.5 Î¼m, 30 mm Ã 2.1 mm) eluted with a 10â90% MeCNâH<sub>2</sub>O linear gradient with 0.1% v/v HCO<sub>2</sub>H. All tested compounds were evaluated on one of these analytical HPLC systems and determined to be â¥95% pure.</div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> General Procedure A: Amino Acid Coupling</h4><div class="NLM_p last">To a rt solution of <b>6</b>, <b>25</b>, or <b>30</b> (1 equiv) in DMF (0.1â0.2 M) was added the appropriate amino acid (1.0â1.2 equiv), followed by Et<sub>3</sub>N (3 equiv), HBTU (1.2 equiv), and HOBt (1.2 equiv). The reaction was stirred at rt until complete, then it was diluted with H<sub>2</sub>O and extracted with EtOAc. The combined organic layers were washed with 1:1 satd aq NaHCO<sub>3</sub>âsatd aq NaCl and then satd aq NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude material was purified by flash chromatography to provide product.</div></div><div id="sec3_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> General Procedure B: Alkylation of Core</h4><div class="NLM_p last">To a rt solution of above material in DMF was added the appropriate alkyl halide or mesylate (1.4 equiv), Cs<sub>2</sub>CO<sub>3</sub> (1.5 equiv), and NaI (1.5 equiv). The reaction was stirred at 60 Â°C overnight, then cooled to rt, diluted with H<sub>2</sub>O, and extracted with EtOAc. The combined organic layers were washed with satd aq NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude material was purified by flash chromatography to provide product.</div></div><div id="sec3_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> General Procedure C: Deprotection</h4><div class="NLM_p last">To a rt solution of above material in MeOH was added 2.0 M HCl in Et<sub>2</sub>O. The reaction was stirred at rt until complete, then concentrated in vacuo and lyophilized from MeCNâH<sub>2</sub>O to provide product.</div></div><div id="sec3_1_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>tert</i>-Butyl Methyl((<i>S</i>)-1-oxo-1-((<i>S</i>)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>]azepin-3-ylamino)propan-2-yl)carbamate (<b>7</b>)</h4><div class="NLM_p last">According to general procedure A, <b>6</b> (0.419 g, 2.38 mmol) and BOC-<i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine (579 mg, 2.85 mmol) were converted to <b>7</b> (0.808 g, 94%) as a white foam. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.82 (s, 1H), 7.87 (d, <i>J</i> = 7.9 Hz, 1H), 7.22â7.31 (m, 2H), 7.09â7.16 (m, 1H), 7.00 (d, <i>J</i> = 7.5 Hz, 1H), 4.29â4.62 (m, 1H), 4.10â4.24 (m, 1H), 2.69 (s, 3H), 2.66â2.75 (m, 2H), 2.19â2.36 (m, 1H), 2.00â2.14 (m, 1H), 1.36 (s, 9H), 1.22 (d, <i>J</i> = 7.2 Hz, 3H). MS <i>m</i>/<i>z</i> 362 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>tert</i>-Butyl Methyl((<i>R</i>)-1-oxo-1-((<i>S</i>)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>]azepin-3-ylamino)propan-2-yl)carbamate (<b>8</b>)</h4><div class="NLM_p last">According to general procedure A, racemic <b>6</b> (0.50 g, 2.8 mmol) and BOC-<i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-alanine (692 mg, 3.4 mmol) were converted to <b>8</b> (0.409 g, 40%) as a white solid (the diastereomers were separated during flash chromatography). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.86 (s, 1H), 7.88 (d, <i>J</i> = 7.86 Hz, 1H), 7.23â7.31 (m, 2H), 7.10â7.15 (m, 1H), 7.00 (d, <i>J</i> = 7.7 Hz, 1H), 4.32â4.68 (m, 1H), 4.15â4.24 (m, 1H), 2.70 (s, 3H), 2.63â2.77 (m, 2H), 2.20â2.33 (m, 1H), 2.02â2.14 (m, 1H), 1.39 (s, 9H), 1.13â1.21 (m, 3H).</div></div><div id="sec3_1_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>tert</i>-Butyl Methyl((<i>S</i>)-1-oxo-1-((<i>S</i>)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>]azepin-3-ylamino)butan-2-yl)carbamate (<b>9</b>)</h4><div class="NLM_p last">According to general procedure A, <b>6</b> (81.1 mg, 0.460 mmol) and (<i>S</i>)-2-(<i>tert</i>-butoxycarbonyl(methyl)amino)butanoic acid (100 mg, 0.460 mmol) were converted to <b>9</b> (121 mg, 70%) as a white foam. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.81 (s, 1H), 7.93 (d, <i>J</i> = 7.4 Hz, 1H), 7.23â7.32 (m, 2H), 7.09â7.16 (m, 1H), 7.00 (d, <i>J</i> = 7.4 Hz, 1H), 4.10â4.48 (m, 2H), 2.68 (s, 3H), 2.64â2.75 (m, 2H), 2.20â2.33 (m, 1H), 2.02â2.13 (m, 1H), 1.73â1.87 (m, 1H), 1.46â1.61 (m, 2H), 1.38 (s, 9H), 0.76â0.88 (m, 3H). MS <i>m</i>/<i>z</i> 376 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <i>tert</i>-Butyl (2<i>S</i>,3<i>S</i>)-3-Hydroxy-1-oxo-1-((<i>S</i>)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>]azepin-3-ylamino)butan-2-ylcarbamate (<b>10</b>)</h4><div class="NLM_p last">According to general procedure A, except 6 equiv Et<sub>3</sub>N were used, <b>6</b> (123 mg, 0.698 mmol) and BOC-<span class="smallcaps smallerCapital">l</span>-<i>allo</i>-threonine dicyclohexylamine (336 mg, 0.838 mmol) were converted to <b>10</b> (263 mg, quant) as a white foam. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.97 (s, 1H), 8.02 (d, <i>J</i> = 7.5 Hz, 1H), 7.23â7.33 (m, 2H), 7.11â7.18 (m, 1H), 7.01 (d, <i>J</i> = 7.7 Hz, 1H), 6.72 (d, <i>J</i> = 8.7 Hz, 1H), 4.88 (d, <i>J</i> = 4.0 Hz, 1H), 4.11â4.21 (m, 1H), 3.68â3.92 (m, 2H), 2.63â2.79 (m, 2H), 2.26â2.39 (m, 1H), 1.99â2.09 (m, 1H), 1.30â1.40 (m, 9H), 1.03 (d, <i>J</i> = 6.0 Hz, 3H). MS <i>m</i>/<i>z</i> 378 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>tert</i>-Butyl Ethyl((<i>S</i>)-1-oxo-1-((<i>S</i>)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>]azepin-3-ylamino)propan-2-yl)carbamate (<b>11</b>)</h4><div class="NLM_p last">According to general procedure A, <b>6</b> (203 mg, 1.15 mmol) and (<i>S</i>)-2-(<i>tert</i>-butoxycarbonyl(ethyl)amino)propanoic acid (0.25 g, 1.2 mmol) were converted to <b>11</b> (0.205 mg, 47%) as a white foam. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.86 (s, 1H), 7.65â7.79 (m, 1H), 7.22â7.32 (m, 2H), 7.09â7.17 (m, 1H), 7.00 (d, <i>J</i> = 7.7 Hz, 1H), 4.08â4.58 (m, 2H), 3.01â3.27 (m, 2H), 2.60â2.80 (m, 2H), 2.23â2.39 (m, 1H), 1.94â2.12 (m, 1H), 1.37 (s, 9H), 1.24 (d, <i>J</i> = 7.0 Hz, 3H), 1.02 (t, <i>J</i> = 6.9 Hz, 3H). MS <i>m</i>/<i>z</i> 398 [M + Na]<sup>+</sup>.</div></div><div id="sec3_1_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>S</i>)-<i>N</i>-((<i>S</i>)-1-Benzyl-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>]azepin-3-yl)-2-(methylamino)propanamide Hydrochloride (<b>12</b>)</h4><div class="NLM_p last">According to general procedures B and C, <b>7</b> (0.10 g, 0.279 mmol) and benzyl bromide (0.071 g, 0.415 mmol) were converted to <b>12</b> (46.6 mg, 48% 2 steps) as a white solid. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) Î´ 8.71 (d, <i>J</i> = 6.9 Hz, 1H), 7.30â7.40 (m, 2H), 7.16â7.27 (m, 7H), 5.29 (dd, <i>J</i> = 14.8, 2.4 Hz, 1H), 4.81â4.86 (m, 1H), 4.32â4.45 (m, 1H), 3.78â3.90 (m, 1H), 2.62 (d, <i>J</i> = 2.1 Hz, 3H), 2.54 (d, <i>J</i> = 5.4 Hz, 2H), 2.36 (d, <i>J</i> = 9.7 Hz, 1H), 2.01â2.20 (m, 1H), 1.49â1.63 (m, 3H). HRMS <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>26</sub>O<sub>2</sub>N<sub>3</sub> [M + H]<sup>+</sup> 352.20195, found 352.20105.</div></div><div id="sec3_1_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>S</i>)-2-(Methylamino)-<i>N</i>-((<i>S</i>)-2-oxo-1-phenethyl-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>]azepin-3-yl)propanamide Hydrochloride (<b>13</b>)</h4><div class="NLM_p last">According to general procedure B, except the sodium iodide was omitted, and general procedure C, <b>7</b> (0.13 g, 0.36 mmol) and (2-bromoethyl)benzene (0.10 g, 0.54 mmol) were converted to <b>13</b> (52.4 mg, 36% 2 steps) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.09â9.33 (m, 1H), 8.81â8.95 (m, 1H), 8.65â8.79 (m, 1H), 7.33â7.41 (m, 2H), 7.08â7.32 (m, 7H), 4.30â4.50 (m, 1H), 4.05â4.23 (m, 1H), 3.71â3.89 (m, 2H), 2.63â2.91 (m, 2H), 2.35â2.59 (m, 5H), 2.09â2.25 (m, 1H), 1.87â2.03 (m, 1H), 1.27â1.41 (m, 3H). HRMS <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>28</sub>O<sub>2</sub>N<sub>3</sub> [M + H]<sup>+</sup> 366.21760, found 366.21683.</div></div><div id="sec3_1_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (<i>S</i>)-2-(Methylamino)-<i>N</i>-((<i>S</i>)-1-(naphthalen-2-ylmethyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>]azepin-3-yl)propanamide Hydrochloride (<b>14</b>)</h4><div class="NLM_p last">According to general procedure B, except the sodium iodide was omitted, and general procedure C, <b>7</b> (0.10 g, 0.279 mmol) and 2-(bromomethyl)naphthalene (0.092 g, 0.415 mmol) were converted to <b>14</b> (72.6 mg, 60% 2 steps) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.34 (br s, 1H), 8.97 (d, <i>J</i> = 7.6 Hz, 1H), 8.84 (br s, 1H), 7.76â7.89 (m, 3H), 7.70 (s, 1H), 7.43â7.51 (m, 3H), 7.30â7.38 (m, 2H), 7.14â7.25 (m, 2H), 5.44 (d, <i>J</i> = 15.1 Hz, 1H), 5.00 (d, <i>J</i> = 15.1 Hz, 1H), 4.22â4.37 (m, 1H), 3.75â3.86 (m, 1H), 3.45â3.63 (m, 1H), 2.47â2.60 (m, 1H), 2.42â2.46 (m, 3H), 2.03â2.33 (m, 2H), 1.41 (d, <i>J</i> = 7.0 Hz, 3H). MS <i>m</i>/<i>z</i> 402 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>S</i>)-2-(Methylamino)-<i>N</i>-((<i>S</i>)-1-(naphthalen-1-ylmethyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>]azepin-3-yl)propanamide Hydrochloride (<b>15</b>)</h4><div class="NLM_p last">According to general procedures B and C, <b>7</b> (0.10 g, 0.279 mmol) and 1-(chloromethyl)naphthalene (0.073 g, 0.415 mmol) were converted to <b>15</b> (40.9 mg, 33% 2 steps) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.28 (br s, 1H), 9.00 (d, <i>J</i> = 7.6 Hz, 1H), 8.82 (br s, 1H), 8.21 (dd, <i>J</i> = 6.2, 3.5 Hz, 1H), 7.91 (dd, <i>J</i> = 6.2, 3.2 Hz, 1H), 7.78 (d, <i>J</i> = 7.6 Hz, 1H), 7.59 (d, <i>J</i> = 8.2 Hz, 1H), 7.49â7.55 (m, 2H), 7.28â7.38 (m, 3H), 7.09â7.15 (m, 2H), 5.94 (d, <i>J</i> = 15.1 Hz, 1H), 5.21 (d, <i>J</i> = 15.4 Hz, 1H), 4.24â4.36 (m, 1H), 3.75â3.86 (m, 1H), 3.35â3.48 (m, 1H), 2.41â2.47 (m, 3H), 1.97â2.38 (m, 3H), 1.42 (d, <i>J</i> = 6.6 Hz, 3H). HRMS <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>28</sub>O<sub>2</sub>N<sub>3</sub> [M + H]<sup>+</sup> 402.21760, found 402.21646.</div></div><div id="sec3_1_4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>S</i>)-2-(Methylamino)-<i>N</i>-((<i>S</i>)-1-((4-methylnaphthalen-1-yl)methyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>]azepin-3-yl)propanamide Hydrochloride (<b>16</b>)</h4><div class="NLM_p last">According to general procedures B and C, <b>7</b> (0.10 g, 0.277 mmol) and 1-(chloromethyl)-4-methylnaphthalene (0.079 g, 0.415 mmol) were converted to <b>16</b> (30.5 mg, 24% 2 steps) as a white solid. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) Î´ 8.22 (d, <i>J</i> = 7.9 Hz, 1H), 8.02 (d, <i>J</i> = 8.2 Hz, 1H), 7.44â7.57 (m, 3H), 7.28â7.36 (m, 1H), 7.23â7.27 (m, 1H), 7.06â7.19 (m, 3H), 5.97 (d, <i>J</i> = 15.1 Hz, 1H), 5.17 (d, <i>J</i> = 15.1 Hz, 1H), 4.36â4.47 (m, 1H), 3.86 (q, <i>J</i> = 6.7 Hz, 1H), 2.63 (s, 3H), 2.60 (s, 3H), 2.21â2.43 (m, 3H), 2.01â2.15 (m, 1H), 1.59 (d, <i>J</i> = 6.9 Hz, 3H). HRMS <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>30</sub>O<sub>2</sub>N<sub>3</sub> [M + H]<sup>+</sup> 416.23325, found 416.23218.</div></div><div id="sec3_1_4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>S</i>)-2-(Methylamino)-<i>N</i>-((<i>S</i>)-1-((2-methylnaphthalen-1-yl)methyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>]azepin-3-yl)propanamide Hydrochloride (<b>17</b>)</h4><div class="NLM_p last">According to general procedures B and C, <b>7</b> (0.10 g, 0.277 mmol) and 1-(chloromethyl)-2-methylnaphthalene (0.079 g, 0.415 mmol) were converted to <b>17</b> (63.7 mg, 51% 2 steps) as a white solid. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) Î´ 8.15â8.25 (m, 1H), 7.73â7.81 (m, 1H), 7.63 (d, <i>J</i> = 8.5 Hz, 1H), 7.37â7.46 (m, 2H), 7.07â7.20 (m, 4H), 7.01â7.06 (m, 1H), 5.91 (d, <i>J</i> = 14.8 Hz, 1H), 5.42 (d, <i>J</i> = 14.8 Hz, 1H), 4.24â4.34 (m, 1H), 3.86 (q, <i>J</i> = 6.9 Hz, 1H), 2.62 (s, 3H), 2.41 (s, 3H), 2.35â2.50 (m, 1H), 2.12â2.31 (m, 2H), 1.95â2.09 (m, 1H), 1.61 (d, <i>J</i> = 6.9 Hz, 3H). HRMS <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>30</sub>O<sub>2</sub>N<sub>3</sub> [M + H]<sup>+</sup> 416.23325, found 416.23212.</div></div><div id="sec3_1_4_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>S</i>)-<i>N</i>-((<i>S</i>)-1-((2-Methoxynaphthalen-1-yl)methyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>]azepin-3-yl)-2-(methylamino)propanamide Hydrochloride (<b>18</b>)</h4><div class="NLM_p last">According to general procedures B and C, <b>7</b> (0.10 g, 0.277 mmol) and 1-(chloromethyl)-2-methoxynaphthalene (0.086 g, 0.415 mmol) were converted to <b>18</b> (55.0 mg, 42% 2 steps) as a light-yellow solid. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) Î´ 8.24 (d, <i>J</i> = 8.5 Hz, 1H), 7.68â7.76 (m, 2H), 7.42â7.55 (m, 2H), 7.28â7.36 (m, 1H), 7.23 (t, <i>J</i> = 7.7 Hz, 1H), 7.15 (d, <i>J</i> = 9.1 Hz, 1H), 7.04 (t, <i>J</i> = 7.4 Hz, 1H), 6.90â6.95 (m, 1H), 6.04 (d, <i>J</i> = 14.5 Hz, 1H), 5.38 (d, <i>J</i> = 14.5 Hz, 1H), 4.25â4.38 (m, 1H), 3.88 (q, <i>J</i> = 6.9 Hz, 1H), 3.77 (s, 3H), 2.62 (s, 3H), 1.96â2.42 (m, 4H), 1.62 (d, <i>J</i> = 6.9 Hz, 3H). HRMS <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>30</sub>O<sub>3</sub>N<sub>3</sub> [M + H]<sup>+</sup> 432.22817, found 432.22678.</div></div><div id="sec3_1_4_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>S</i>)-<i>N</i>-((<i>S</i>)-1-((6-Bromo-2-methoxynaphthalen-1-yl)methyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>]azepin-3-yl)-2-(methylamino)propanamide Hydrochloride (<b>19</b>)</h4><div class="NLM_p last">According to general procedures B and C, <b>7</b> (220 mg, 0.609 mmol) and 6-bromo-1-(chloromethyl)-2-methoxynaphthalene (261 mg, 0.913 mmol) were converted to <b>19</b> (190 mg, 57% 2 steps) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.95 (d, <i>J</i> = 7.9 Hz, 1H), 8.87 (br s, 2H), 8.17 (d, <i>J</i> = 9.1 Hz, 1H), 8.09 (d, <i>J</i> = 2.0 Hz, 1H), 7.79 (d, <i>J</i> = 9.3 Hz, 1H), 7.52â7.60 (m, 2H), 7.25â7.33 (m, 2H), 7.04â7.09 (m, 1H), 6.98â7.02 (m, 1H), 5.94 (d, <i>J</i> = 14.5 Hz, 1H), 5.24 (d, <i>J</i> = 14.5 Hz, 1H), 4.15â4.24 (m, 1H), 3.80 (q, <i>J</i> = 6.9 Hz, 1H), 3.71 (s, 3H), 2.43 (s, 3H), 2.19â2.29 (m, 1H), 2.05â2.17 (m, 2H), 1.90â2.02 (m, 1H), 1.42 (d, <i>J</i> = 6.9 Hz, 3H). HRMS <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>29</sub>O<sub>3</sub>N<sub>3</sub>Br [M + H]<sup>+</sup> 510.13868, found 510.13901.</div></div><div id="sec3_1_4_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>R</i>)-<i>N</i>-((<i>S</i>)-1-((6-Bromo-2-methoxynaphthalen-1-yl)methyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>]azepin-3-yl)-2-(methylamino)propanamide Hydrochloride (<b>20</b>)</h4><div class="NLM_p last">According to general procedure B, <b>8</b> (0.20 g, 0.55 mmol) and 6-bromo-1-(chloromethyl)-2-methoxynaphthalene (261 mg, 0.913 mmol) were reacted to provide <i>tert</i>-butyl (<i>R</i>)-1-((<i>S</i>)-1-((6-bromo-2-methoxynaphthalen-1-yl)methyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>]azepin-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate (174 mg, 52%). A portion of this material (60 mg, 0.098 mmol) was reacted according to general procedure C to provide <b>20</b> (50.0 mg, 93%) as a white solid. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) Î´ 8.21 (d, <i>J</i> = 9.1 Hz, 1H), 7.94 (d, <i>J</i> = 2.0 Hz, 1H), 7.70 (d, <i>J</i> = 9.1 Hz, 1H), 7.49â7.56 (m, 2H), 7.26 (t, <i>J</i> = 7.9 Hz, 1H), 7.22 (d, <i>J</i> = 9.1 Hz, 1H), 7.08 (t, <i>J</i> = 7.2 Hz, 1H), 6.98 (d, <i>J</i> = 6.7 Hz, 1H), 6.01 (d, <i>J</i> = 14.5 Hz, 1H), 5.37 (d, <i>J</i> = 14.5 Hz, 1H), 4.26 (dd, <i>J</i> = 11.8, 6.95 Hz, 1H), 3.82â3.91 (m, 1H), 3.75 (s, 3H), 2.71 (s, 3H), 2.14â2.37 (m, 3H), 1.96â2.08 (m, 1H), 1.46 (d, <i>J</i> = 6.9 Hz, 3H). HRMS <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>29</sub>O<sub>3</sub>N<sub>3</sub>Br [M + H]<sup>+</sup> 510.13868, found 510.13852.</div></div><div id="sec3_1_4_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>S</i>)-<i>N</i>-((<i>S</i>)-1-((6-Bromo-2-methoxynaphthalen-1-yl)methyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>]azepin-3-yl)-2-(methylamino)butanamide 2,2,2-trifluoroacetate (<b>21</b>)</h4><div class="NLM_p last">According to general procedure B, <b>9</b> (121 mg, 0.322 mmol) and 6-bromo-1-(chloromethyl)-2-methoxynaphthalene (138 mg, 0.483 mmol) were converted to <i>tert</i>-butyl (<i>S</i>)-1-((<i>S</i>)-1-((6-bromo-2-methoxynaphthalen-1-yl)methyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>]azepin-3-ylamino)-1-oxobutan-2-yl(methyl)carbamate (88 mg, 44%). To a rt solution of this material in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added TFA (0.4 mL). The reaction was stirred at rt for 30 min, then concentrated in vacuo and lyophilized from MeCNâH<sub>2</sub>O to provide <b>21</b> (76.5 mg, 85%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.99 (d, <i>J</i> = 7.8 Hz, 1H), 8.86 (br s, 1H), 8.74 (br s, 1H), 8.16 (d, <i>J</i> = 9.0 Hz, 1H), 8.09 (d, <i>J</i> = 2.0 Hz, 1H), 7.79 (d, <i>J</i> = 9.4 Hz, 1H), 7.52â7.59 (m, 2H), 7.23â7.34 (m, 2H), 7.04â7.09 (m, 1H), 6.99â7.02 (m, 1H), 5.93 (d, <i>J</i> = 14.5 Hz, 1H), 5.26 (d, <i>J</i> = 14.5 Hz, 1H), 4.20â4.31 (m, 1H), 3.68â3.74 (m, 1H), 2.39â2.46 (m, 3H), 1.70â2.29 (m, 6H), 0.99 (t, <i>J</i> = 7.4 Hz, 3H). HRMS <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>31</sub>O<sub>3</sub>N<sub>3</sub>Br [M + H]<sup>+</sup> 524.15433, found 524.15430.</div></div><div id="sec3_1_4_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (2<i>S</i>,3<i>S</i>)-2-Amino-<i>N</i>-((<i>S</i>)-1-((6-bromo-2-methoxynaphthalen-1-yl)methyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>]azepin-3-yl)-3-hydroxybutanamide hydrochloride (<b>22</b>)</h4><div class="NLM_p last">According to general procedures B and C, <b>10</b> (104 mg, 0.276 mmol) and 6-bromo-1-(chloromethyl)-2-methoxynaphthalene (102 mg, 0.358 mmol) were converted to <b>22</b> (61 mg, 41% 2 steps) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.80 (d, <i>J</i> = 7.9 Hz, 1H), 8.16 (d, <i>J</i> = 9.3 Hz, 1H), 8.09 (d, <i>J</i> = 1.8 Hz, 1H), 7.96 (br s, 3H), 7.80 (d, <i>J</i> = 9.3 Hz, 1H), 7.57 (dd, <i>J</i> = 9.1, 2.0 Hz, 1H), 7.52 (d, <i>J</i> = 8.1 Hz, 1H), 7.31 (d, <i>J</i> = 9.3 Hz, 1H), 7.26 (t, <i>J</i> = 7.1 Hz, 1H), 7.04â7.09 (m, 1H), 6.98â7.02 (m, 1H), 5.92 (d, <i>J</i> = 14.5 Hz, 1H), 5.51 (d, <i>J</i> = 4.4 Hz, 1H), 5.26 (d, <i>J</i> = 14.5 Hz, 1H), 4.12â4.25 (m, 2H), 3.81 (d, <i>J</i> = 4.1 Hz, 1H), 3.71 (s, 3H), 1.90â2.28 (m, 4H), 1.15 (d, <i>J</i> = 6.7 Hz, 3H). HRMS <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>29</sub>O<sub>4</sub>N<sub>3</sub>Br [M + H]<sup>+</sup> 526.13360, found 526.13416.</div></div><div id="sec3_1_4_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>S</i>)-<i>N</i>-((<i>S</i>)-1-((6-Bromo-2-methoxynaphthalen-1-yl)methyl)-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>]azepin-3-yl)-2-(ethylamino)propanamide Hydrochloride (<b>23</b>)</h4><div class="NLM_p last">According to general procedures B and C, <b>11</b> (205 mg, 0.545 mmol) and 6-bromo-1-(chloromethyl)-2-methoxynaphthalene (234 mg, 0.818 mmol) were converted to <b>23</b> (206 mg, 67% 2 steps) as a light-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.49 (br s, 1H), 9.00 (d, <i>J</i> = 7.8 Hz, 1H), 8.78 (br s, 1H), 8.17 (d, <i>J</i> = 9.4 Hz, 1H), 8.08 (d, <i>J</i> = 2.0 Hz, 1H), 7.79 (d, <i>J</i> = 9.0 Hz, 1H), 7.58 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H), 7.54 (d, <i>J</i> = 8.2 Hz, 1H), 7.24â7.32 (m, 2H), 7.03â7.08 (m, 1H), 6.97â7.01 (m, 1H), 5.93 (d, <i>J</i> = 14.5 Hz, 1H), 5.24 (d, <i>J</i> = 14.5 Hz, 1H), 4.14â4.23 (m, 1H), 3.83â3.93 (m, 1H), 3.71 (s, 3H), 2.71â2.86 (m, 2H), 1.90â2.29 (m, 4H), 1.44 (d, <i>J</i> = 6.64 Hz, 3H), 1.14 (t, <i>J</i> = 7.2 Hz, 3H). HRMS <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>31</sub>O<sub>3</sub>N<sub>3</sub>Br [M + H]<sup>+</sup> 524.15433, found 524.15466.</div></div><div id="sec3_1_4_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (<i>S</i>)-2-<i>tert</i>-Butoxycarbonylamino-3-(2-nitrophenoxy)propionic Acid (<b>25</b>)</h4><div class="NLM_p last">To a 0 Â°C suspension of NaH (60% w/w in mineral oil, 2.9 g, 72 mmol) in DMF (25 mL) was added a solution of (<i>S</i>)-2-(<i>tert</i>-butoxycarbonylamino)-3-hydroxypropanoic acid (7 g, 34 mmol) in DMF (25 mL). After 2 h, a solution of 1-fluoro-2-nitrobenzene (5.29 g, 37.5 mmol) in DMF (25 mL) was added and the resulting mixture was stirred at 0 Â°C for 3 h. The mixture was poured into 0 Â°C H<sub>2</sub>O (200 mL), acidified to pH 5.0 with 1 N aq HCl, and extracted with EtOAc. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude material was purified by flash chromatography to provide <b>25</b> (10.9 g, 97%). MS <i>m</i>/<i>z</i> 349 [M + Na]<sup>+</sup>.</div></div><div id="sec3_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (<i>S</i>)-3-Amino-2,3-dihydrobenzo[<i>b</i>][1,4]oxazepin-4(5<i>H</i>)-one (<b>26</b>)</h4><div id="sec3_1_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> Step 1</h5><div class="NLM_p last">A mixture of <b>25</b> (7.20 g, 22.1 mmol) and 10% w/w palladium on carbon (720 mg, 0.677 mmol) in EtOH (250 mL) was stirred under hydrogen (1 atm) for 4 h. The reaction was filtered through Celite, and the filtrate was concentrated in vacuo to provide (<i>S</i>)-3-(2-aminophenoxy)-2-(<i>tert</i>-butoxycarbonylamino)propionic acid (6.2 g, 95%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.44 (d, <i>J</i> = 8.5 Hz, 1H), 6.63â6.76 (m, 2H), 6.56â6.62 (m, 1H), 6.42â6.50 (m, 1H), 4.38â4.45 (m, 1H), 4.24 (dd, <i>J</i> = 9.5, 4.7 Hz, 1H), 3.94â4.03 (m, 1H), 1.40 (s, 9H). MS <i>m</i>/<i>z</i> 297 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> Step 2</h5><div class="NLM_p last">To a rt mixture of (<i>S</i>)-3-(2-aminophenoxy)-2-(<i>tert</i>-butoxycarbonylamino)propionic acid (5.8 g, 19.6 mmol) in DMF was added EDCI (3.75 g, 19.6 mmol). The reaction was stirred at rt for 1.5 h then diluted with EtOAc, washed with H<sub>2</sub>O and satd aq NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude material was triturated with hexanes to provide (<i>S</i>)-<i>tert</i>-butyl 4-oxo-2,3,4,5-tetrahydrobenzo[<i>b</i>][1,4]oxazepin-3-ylcarbamate (3.4 g, 62%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.92 (s, 1H), 7.04â7.18 (m, 5H), 4.20â4.39 (m, 3H), 1.36 (s, 9H). MS <i>m</i>/<i>z</i> 301 [M + Na]<sup>+</sup>.</div></div><div id="sec3_1_5_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> Step 3</h5><div class="NLM_p last">To a 0 Â°C solution of (<i>S</i>)-<i>tert</i> butyl 4-oxo-2,3,4,5-tetrahydrobenzo[<i>b</i>][1,4]oxazepin-3-ylcarbamate (3.4 g, 7.2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was added TFA (20 mL). The reaction was stirred for 1 h, then concentrated in vacuo. The residue was diluted with satd aq NaHCO<sub>3</sub> and extracted with CH<sub>2</sub>Cl<sub>2</sub> (4Ã). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to provide <b>26</b> (2.2 g, quant). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.88 (s, 1H), 7.02â7.11 (m, 4H), 4.28 (dd, <i>J</i> = 10.4, 6.2 Hz, 1H), 4.01 (t, <i>J</i> = 10.6 Hz, 1H), 3.60 (dd, <i>J</i> = 10.6, 6.3 Hz, 1H), 1.81 (br s, 2H). MS <i>m</i>/<i>z</i> 179 [M + H]<sup>+</sup>.</div></div></div><div id="sec3_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (<i>S</i>)-<i>N</i>-((<i>S</i>)-5-((6-Bromo-2-methoxynaphthalen-1-yl)methyl)-4-oxo-2,3,4,5-tetrahydrobenzo[<i>b</i>][1,4]oxazepin-3-yl)-2-(methylamino)propanamide 2,2,2-Trifluoroacetate (<b>27</b>)</h4><div id="sec3_1_6_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> Step 1</h5><div class="NLM_p last">According to general procedure A, <b>26</b> (2.2 g, 12 mmol) and BOC-<i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine (2.48 g, 12.2 mmol) were converted to <i>tert</i>-butyl methyl((<i>S</i>)-1-oxo-1-((<i>S</i>)-4-oxo-2,3,4,5-tetrahydrobenzo[<i>b</i>][1,4]oxazepin-3-ylamino)propan-2-yl)carbamate (4.2 g, 95%) as a light-yellow foam. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.04 (s, 1H), 8.04 (d, <i>J</i> = 8.2 Hz, 1H), 7.05â7.16 (m, 4H), 4.24â4.71 (m, 4H), 2.68â2.72 (m, 3H), 1.38 (s, 9H), 1.24 (d, <i>J</i> = 6.9 Hz, 3H). MS <i>m</i>/<i>z</i> 386 [M + Na]<sup>+</sup>.</div></div><div id="sec3_1_6_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> Step 2</h5><div class="NLM_p last">According to general procedure B, <i>tert</i>-butyl methyl((<i>S</i>)-1-oxo-1-((<i>S</i>)-4-oxo-2,3,4,5-tetrahydrobenzo[<i>b</i>][1,4]oxazepin-3-ylamino)propan-2-yl)carbamate (1.1 g, 3.03 mmol) and 6-bromo-1-(chloromethyl)-2-methoxynaphthalene (951 mg, 3.33 mmol) were converted to <i>tert</i>-butyl (<i>S</i>)-1-((<i>S</i>)-5-((6-bromo-2-methoxynaphthalen-1-yl)methyl)-4-oxo-2,3,4,5-tetrahydrobenzo[<i>b</i>][1,4]oxazepin-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate (1.00 g, 54%) as a light-yellow foam. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.18 (d, <i>J</i> = 8.2 Hz, 1H), 7.99â8.07 (m, 2H), 7.78 (d, <i>J</i> = 9.1 Hz, 1H), 7.46â7.54 (m, 2H), 7.33 (d, <i>J</i> = 9.4 Hz, 1H), 7.02â7.17 (m, 2H), 6.89 (d, <i>J</i> = 7.6 Hz, 1H), 5.86 (d, <i>J</i> = 14.8 Hz, 1H), 5.24 (d, <i>J</i> = 14.5 Hz, 1H), 4.35â4.75 (m, 2H), 4.22â4.31 (m, 1H), 4.10â4.20 (m, 1H), 3.80 (s, 3H), 2.70 (s, 3H), 1.37 (s, 9H), 1.27 (d, <i>J</i> = 6.9 Hz, 3H).</div></div><div id="sec3_1_6_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> Step 3</h5><div class="NLM_p last">To a 0 Â°C solution of <i>tert</i>-butyl (<i>S</i>)-1-((<i>S</i>)-5-((6-bromo-2-methoxynaphthalen-1-yl)methyl)-4-oxo-2,3,4,5-tetrahydrobenzo[<i>b</i>][1,4]oxazepin-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate (52 mg, 0.085 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was added TFA (1 mL). The reaction was stirred at 0 Â°C for 1 h, then concentrated in vacuo and triturated with Et<sub>2</sub>O to provide <b>27</b> (30 mg, 56%) as a light-brown solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.06 (d, <i>J</i> = 7.9 Hz, 1H), 8.67â8.90 (m, 2H), 8.00â8.07 (m, 2H), 7.79 (d, <i>J</i> = 9.1 Hz, 1H), 7.47â7.57 (m, 2H), 7.34 (d, <i>J</i> = 9.4 Hz, 1H), 7.05â7.20 (m, 2H), 6.92 (d, <i>J</i> = 6.6 Hz, 1H), 5.87 (d, <i>J</i> = 14.5 Hz, 1H), 5.26 (d, <i>J</i> = 14.5 Hz, 1H), 4.67â4.79 (m, 1H), 4.12â4.31 (m, 2H), 3.81â3.90 (m, 1H), 3.79 (s, 3H), 2.45â2.48 (m, 3H), 1.42 (d, <i>J</i> = 6.9 Hz, 3H). HRMS <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>27</sub>O<sub>4</sub>N<sub>3</sub>Br [M + H]<sup>+</sup> 512.11795, found 512.11705.</div></div></div><div id="sec3_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 2-(Dibenzylamino)-2-(4-hydroxytetrahydro-2<i>H</i>-pyran-4-yl)acetic Acid (<b>29</b>)</h4><div id="sec3_1_7_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> Step 1</h5><div class="NLM_p last">To a â78 Â°C solution of ethyl 2-(dibenzylamino)acetate (10 g, 35 mmol) in THF (100 mL) was added LDA (2.0 M solution, 38.8 mL, 77.6 mmol). After 30 min, a solution of dihydro-2<i>H</i>-pyran-4(3<i>H</i>)-one (3.91 mL, 42.3 mmol) in THF (20 mL) was added. The reaction was warmed to rt and stirred for 1 h, then quenched with satd aq NH<sub>4</sub>Cl, concentrated in vacuo, poured into H<sub>2</sub>O (300 mL), and extracted with EtOAc (2 Ã 250 mL). The combined organic layers were washed with H<sub>2</sub>O (2 Ã 200 mL) and satd aq NaCl (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude material was purified by flash chromatography to provide ethyl 2-(dibenzylamino)-2-(4-hydroxytetrahydro-2<i>H</i>-pyran-4-yl)acetate (6.72 g, 50%) as a thick yellow oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.32â7.38 (m, 8H), 7.22â7.30 (m, 2H), 4.57 (s, 1H), 4.10â4.29 (m, 4H), 3.36â3.58 (m, 6H), 3.09 (s, 1H), 1.77â1.86 (m, 1H), 1.49â1.59 (m, 1H), 1.38â1.48 (m, 1H), 1.29 (t, <i>J</i> = 7.0 Hz, 3H), 1.19â1.25 (m, 1H). MS <i>m</i>/<i>z</i> 384 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_7_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> Step 2</h5><div class="NLM_p last">To a rt solution of ethyl 2-(dibenzylamino)-2-(4-hydroxytetrahydro-2<i>H</i>-pyran-4-yl)acetate (6.72 g, 17.5 mmol) in MeOH (150 mL) was added potassium hydroxide (5.9 g, 105 mmol) in H<sub>2</sub>O (50 mL). The mixture was stirred at 60 Â°C for 15 h, then cooled to rt and diluted with H<sub>2</sub>O (200 mL). The pH was adjusted to â¼4 by the addition of satd aq KHSO<sub>4</sub>, and the mixture was extracted with EtOAc (2 Ã 200 mL). The combined organic layers were washed with H<sub>2</sub>O (2 Ã 200 mL) and satd aq NaCl (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to provide <b>29</b> (5.72 g, 92%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 12.65 (br s, 1H), 7.32â7.38 (m, 8H), 7.23â7.29 (m, 2H), 4.12â4.21 (m, 2H), 3.46â3.58 (m, 4H), 3.29â3.41 (m, 2H), 3.01 (s, 1H), 1.76â1.85 (m, 1H), 1.47â1.57 (m, 1H), 1.34â1.44 (m, 1H), 1.26â1.33 (m, 1H). MS <i>m</i>/<i>z</i> 356 [M + H]<sup>+</sup>.</div></div></div><div id="sec3_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2-(Dibenzylamino)-2-(4-(2-nitrophenoxy)tetrahydro-2<i>H</i>-pyran-4-yl)acetic Acid (<b>30</b>)</h4><div class="NLM_p last">To a rt solution of <b>29</b> (5.72 g, 16.1 mmol) in THF (90 mL) was added KHMDS (1.0 M solution in THF, 35.4 mL, 35.4 mmol), followed by 1-fluoro-2-nitrobenzene (1.87 mL, 17.7 mmol). The reaction was stirred at rt for 2 h, then additional KHMDS (10 mL, 10 mmol) and 1-fluoro-2-nitrobenzene (1 mL, 9.5 mmol) were added and the reaction was stirred for an additional 2 h. The reaction was diluted with H<sub>2</sub>O (200 mL), acidified with satd aq KHSO<sub>4</sub>, and extracted with EtOAc (2 Ã 250 mL). The combined organic layers were washed with H<sub>2</sub>O (2 Ã 300 mL) and satd aq NaCl (200 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude material was purified by flash chromatography to provide <b>30</b> (7.06 g, 92%) as a yellow foam. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 13.00 (br s, 1H), 7.77 (dd, <i>J</i> = 8.2, 1.6 Hz, 1H), 7.33â7.41 (m, 9H), 7.26â7.32 (m, 2H), 7.16 (t, <i>J</i> = 7.6 Hz, 1H), 6.73 (d, <i>J</i> = 8.6 Hz, 1H), 4.08â4.17 (m, 2H), 3.89 (s, 1H), 3.60â3.69 (m, 2H), 3.30â3.50 (m, 2H), 3.14â3.22 (m, 1H), 2.98â3.08 (m, 1H), 2.04â2.15 (m, 2H), 1.84â1.94 (m, 1H), 1.43â1.52 (m, 1H). MS 477 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 3-Amino-2â²,3â²,5â²,6â²-tetrahydro-3<i>H</i>-spiro[benzo[<i>b</i>][1,4]oxazepine-2,4â²-pyran]-4(5<i>H</i>)-one (<b>31</b>)</h4><div id="sec3_1_9_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> Step 1</h5><div class="NLM_p last">A mixture of <b>30</b> (7.06 g, 14.8 mmol), ammonium chloride (1.59 g, 29.6 mmol), and zinc (15.0 g, 230 mmol) in MeOH (300 mL) was stirred at 65 Â°C for 15 h. The reaction was cooled to rt, filtered through Celite, concentrated in vacuo, then partitioned between satd aq NaOAc (400 mL) and EtOAc (400 mL). The aqueous layer was separated and extracted with EtOAc (2 Ã 200 mL). The combined organic layers were washed with satd aq NaCl (3 Ã 200 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to provide 2-(4-(2-aminophenoxy)tetrahydro-2<i>H</i>-pyran-4-yl)-2-(dibenzylamino)acetic acid (6.75 g, quant) as a brown foam. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.35â7.48 (m, 4H), 7.14â7.30 (m, 6H), 6.68â6.76 (m, 2H), 6.50â6.59 (m, 1H), 6.34 (t, <i>J</i> = 7.4 Hz, 1H), 5.52 (br s, 2H), 4.11â4.41 (m, 2H), 3.71â3.97 (m, 3H), 3.35â3.46 (m, 1H), 3.10â3.23 (m, 1H), 2.84â2.98 (m, Hz, 1H), 2.34â2.46 (m, 1H), 2.24 (d, <i>J</i> = 8.6 Hz, 1H), 1.81â1.95 (m, 2H), 1.41â1.54 (m, 1H). MS <i>m</i>/<i>z</i> 447 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_9_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> Step 2</h5><div class="NLM_p last">A solution of 2-(4-(2-aminophenoxy)tetrahydro-2<i>H</i>-pyran-4-yl)-2-(dibenzylamino)acetic acid (6.75 g, 15.1 mmol), HOBt (3.24 g, 21.2 mmol), and EDCI (2.9 g, 15.1 mmol) in DMF (100 mL) was stirred at rt for 1 h, then diluted with EtOAc (500 mL), washed with 1:1 satd aq NaHCO<sub>3</sub>âsatd aq NaCl (3 Ã 200 mL) and satd aq NaCl (200 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude material was purified by flash chromatography to provide 3-(dibenzylamino)-2â²,3â²,5â²,6â²-tetrahydro-3<i>H</i>-spiro[benzo[<i>b</i>][1,4]oxazepine-2,4â²-pyran]-4(5<i>H</i>)-one (4.77 g, 74%) as a beige solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.27 (s, 1H), 7.30â7.36 (m, 8H), 7.22â7.29 (m, 2H), 7.18 (dd, <i>J</i> = 7.8, 1.2 Hz, 1H), 6.92â7.06 (m, 3H), 3.89 (d, <i>J</i> = 12.9 Hz, 2H), 3.65â3.74 (m, 1H), 3.57 (d, <i>J</i> = 13.3 Hz, 2H), 3.41â3.50 (m, 2H), 3.31â3.39 (m, 1H), 3.28 (s, 1H), 2.08â2.14 (m, 1H), 1.45â1.55 (m, 1H), 1.35â1.42 (m, 1H), 1.12â1.22 (m, 1H). MS <i>m</i>/<i>z</i> 429 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_9_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> Step 3</h5><div class="NLM_p last">A mixture of 3-(dibenzylamino)-2â²,3â²,5â²,6â²-tetrahydro-3<i>H</i>-spiro[benzo[<i>b</i>][1,4]oxazepine-2,4â²-pyran]-4(5<i>H</i>)-one (4.77 g, 11.1 mmol; equiv, 1.00) and 20% palladium hydroxide on carbon (2 g) in MeOH (150 mL) was stirred under H<sub>2</sub> overnight. The reaction was treated with additional catalyst and H<sub>2</sub> and stirred overnight, then filtered through Celite and concentrated in vacuo to provide <b>31</b> (2.75 g, quant) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.00 (s, 1H), 7.02â7.18 (m, 4H), 3.84â3.92 (m, 1H), 3.75â3.83 (m, 2H), 3.61â3.70 (m, 1H), 3.25 (s, 1H), 2.63â3.00 (m, 2H), 1.93â2.07 (m, 2H), 1.36â1.50 (m, 2H). MS <i>m</i>/<i>z</i> 249 [M + H]<sup>+</sup>.</div></div></div><div id="sec3_1_9_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>tert</i>-Butyl Methyl((<i>S</i>)-1-oxo-1-((<i>S</i>)-4-oxo-2â²,3â²,4,5,5â²,6â²-hexahydro-3<i>H</i>-spiro[benzo[<i>b</i>][1,4]oxazepine-2,4â²-pyran]-3-ylamino)propan-2-yl)carbamate (<b>32</b>)</h4><div class="NLM_p last">A solution of HBTU (43.2 g, 114 mmol) and HOBtÂ·H<sub>2</sub>O (17.4 g, 114 mmol) in DMF (300 mL) was added to a mixture of 3-amino-2â²,3â²,5â²,6â²-tetrahydro-3<i>H</i>-spiro[benzo[<i>b</i>][1,4]oxazepine-2,4â²-pyran]-4(5<i>H</i>)-one hydrochloride (27 g, 94.8 mmol), BOC-<i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine (23.1 g, 114 mmol), and Et<sub>3</sub>N (52.9 mL, 379 mmol) in DMF (300 mL). After 18 h, the mixture was poured into satd aq NaCl (750 mL) and extracted with EtOAc. The combined extracts were washed with 1:1 sat NaHCO<sub>3</sub>âsatd aq NaCl and satd aq NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by flash chromatography and the diastereomers were separated by SFC (Daicel AD column (5 cm Ã 25 cm) eluted with 15% MeOHâCO<sub>2</sub> at 200 mL/min; 220 nM detection; 100 bar backpressure; 35 Â°C oven). The first peak to elute from the column provided <b>32</b> (15.29 g, 37%) as an off-white foam. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.14 (s, 1H), 7.06â7.24 (m, 4H), 4.60 (q, <i>J</i> = 7.2 Hz, 1H), 4.51 (d, <i>J</i> = 9.0 Hz, 1H), 3.62â3.95 (m, 4H), 2.74 (s, 3H), 2.01â2.06 (m, 1H), 1.50â1.61 (m, 3H), 1.38 (s, 9H), 1.20â1.30 (m, 3H). MS <i>m</i>/<i>z</i> 434 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_9_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (<i>S</i>)-<i>N</i>-((<i>S</i>)-5-((6-Bromo-2-methoxynaphthalen-1-yl)methyl)-4-oxo-2â²,3â²,4,5,5â²,6â²-hexahydro-3<i>H</i>-spiro[benzo[<i>b</i>][1,4]oxazepine-2,4â²-pyran]-3-yl)-2-(methylamino)propanamide Hydrochloride (<b>33</b>)</h4><div class="NLM_p last">According to general procedure B, <b>32</b> (332 mg, 0.766 mmol) and 6-bromo-1-(chloromethyl)-2-methoxynaphthalene (328 mg, 1.15 mmol) were converted to <i>tert</i>-butyl (<i>S</i>)-1-((<i>S</i>)-5-((6-bromo-2-methoxynaphthalen-1-yl)methyl)-4-oxo-2â²,3â²,4,5,5â²,6â²-hexahydro-3<i>H</i>-spiro[benzo[<i>b</i>][1,4]oxazepine-2,4â²-pyran]-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate (281 mg, 54%). According to general procedure C, a portion of this (92.3 mg, 0.135 mmol) was converted to <b>33</b> (67.7 mg, 81%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.10â9.19 (m, 1H), 9.08 (d, <i>J</i> = 9.29 Hz, 1H), 8.76â8.85 (m, 1H), 8.01â8.06 (m, 2H), 7.79 (d, <i>J</i> = 9.0 Hz, 1H), 7.56 (dd, <i>J</i> = 8.0, 1.3 Hz, 1H), 7.47 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H), 7.34 (d, <i>J</i> = 9.0 Hz, 1H), 7.13â7.18 (m, 1H), 7.05â7.10 (m, 1H), 6.84â6.88 (m, 1H), 5.90 (d, <i>J</i> = 14.8 Hz, 1H), 5.27 (d, <i>J</i> = 14.6 Hz, 1H), 4.54 (d, <i>J</i> = 9.3 Hz, 1H), 3.93â4.02 (m, 1H), 3.83 (s, 3H), 3.79â3.86 (m, 1H), 3.64â3.78 (m, 2H), 3.44 (t, <i>J</i> = 11.2 Hz, 1H), 2.45â2.49 (m, 3H), 2.11 (dt, <i>J</i> = 12.9. 5.3 Hz, 1H), 1.48â1.63 (m, 2H), 1.39 (d, <i>J</i> = 6.8 Hz, 3H), 1.34â1.38 (m, 1H). HRMS <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>33</sub>O<sub>5</sub>N<sub>3</sub>Br [M + H]<sup>+</sup> 582.15981, found 582.15938.</div></div><div id="sec3_1_9_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (<i>S</i>)-2-(Methylamino)-<i>N</i>-((<i>S</i>)-5-((2-methylnaphthalen-1-yl)methyl)-4-oxo-2â²,3â²,4,5,5â²,6â²-hexahydro-3<i>H</i>-spiro[benzo[<i>b</i>][1,4]oxazepine-2,4â²-pyran]-3-yl)propanamide Hydrochloride (<b>34</b>)</h4><div class="NLM_p last">According to general procedure B, except the reaction was carried out at rt, and general procedure C, <b>32</b> (100 mg, 0.231 mmol) and 1-(chloromethyl)-2-methylnaphthalene (66.0 mg, 0.346 mmol) were converted to <b>34</b> (58.4 mg, 48% 2 steps) as a light-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.13â9.23 (m, 1H), 9.10 (d, <i>J</i> = 8.9 Hz, 1H), 8.76â8.88 (m, 1H), 8.19â8.26 (m, 1H), 7.77 (dd, <i>J</i> = 6.3, 3.5 Hz, 1H), 7.65 (d, <i>J</i> = 8.6 Hz, 1H), 7.38â7.43 (m, 3H), 7.21 (d, <i>J</i> = 8.2 Hz, 1H), 7.00â7.08 (m, 2H), 6.89â6.94 (m, 1H), 5.97 (d, <i>J</i> = 15.2 Hz, 1H), 5.37 (d, <i>J</i> = 15.2 Hz, 1H), 4.55 (d, <i>J</i> = 9.0 Hz, 1H), 3.94â4.04 (m, 1H), 3.67â3.89 (m, 3H), 3.45â3.59 (m, 1H), 2.49â2.51 (m, 3H), 2.46â2.49 (m, 3H), 2.06â2.19 (m, 1H), 1.66 (d, <i>J</i> = 13.3 Hz, 1H), 1.54 (td, <i>J</i> = 13.2, 5.7 Hz, 1H), 1.41 (d, <i>J</i> = 7.0 Hz, 3H), 1.35â1.39 (m, 1H). MS <i>m</i>/<i>z</i> 488 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (<i>S</i>)-<i>N</i>-((<i>S</i>)-5-((2-(Difluoromethoxy)naphthalen-1-yl)methyl)-4-oxo-2â²,3â²,4,5,5â²,6â²-hexahydro-3<i>H</i>-spiro[benzo[<i>b</i>][1,4]oxazepine-2,4â²-pyran]-3-yl)-2-(methylamino)propanamide Hydrochloride (<b>35</b>)</h4><div class="NLM_p last">To a rt solution of <b>32</b> in which the diastereomers had not been separated (118 mg, 0.272 mmol) was added (2-(difluoromethoxy)naphthalen-1-yl)methyl methanesulfonate (98.7 mg, 0.327 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (115 mg, 0.354 mmol). The reaction was stirred at rt for 20 h, then diluted with EtOAc (25 mL), washed with H<sub>2</sub>O (25 mL) and satd aq NaCl (25 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude material was purified by flash chromatography then by SFC to separate the diastereomers and provide <i>tert</i>-butyl (<i>S</i>)-1-((<i>S</i>)-5-((2-(difluoromethoxy)naphthalen-1-yl)methyl)-4-oxo-2â²,3â²,4,5,5â²,6â²-hexahydro-3<i>H</i>-spiro[benzo[<i>b</i>][1,4]oxazepine-2,4â²-pyran]-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate (52.6 mg, 30%) as a white foam. This material was reacted according to general procedure C to provide <b>35</b> (46.3 mg, 98%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.08 (d, <i>J</i> = 9.06 Hz, 1H), 8.78 (br s, 2H), 8.19 (d, <i>J</i> = 9.1 Hz, 1H), 7.82â7.93 (m, 2H), 7.43â7.56 (m, 3H), 7.27 (d, <i>J</i> = 8.7 Hz, 1H), 7.25 (t, <i>J</i> = 73.3 Hz, 1H), 7.04â7.18 (m, 2H), 6.87 (d, <i>J</i> = 7.2 Hz, 1H), 6.06 (d, <i>J</i> = 15.1 Hz, 1H), 5.27 (d, <i>J</i> = 15.1 Hz, 1H), 4.56 (d, <i>J</i> = 9.1 Hz, 1H), 3.90â4.02 (m, 1H), 3.63â3.85 (m, 3H), 3.43 (t, <i>J</i> = 11.9 Hz, 1H), 2.47â2.49 (m, 3H), 2.04â2.18 (m, 1H), 1.65 (d, <i>J</i> = 13.6 Hz, 1H), 1.46â1.59 (m, 1H), 1.39 (d, <i>J</i> = 6.4 Hz, 3H), 1.34â1.38 (m, 1H). HRMS <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>32</sub>O<sub>5</sub>N<sub>3</sub>F<sub>2</sub> [M + H]<sup>+</sup> 540.23045, found 540.22913.</div></div><div id="sec3_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 6-Methoxy-5-(((<i>S</i>)-3-((<i>S</i>)-2-(methylamino)propanamido)-4-oxo-2â²,3â²,5â²,6â²-tetrahydro-3<i>H</i>-spiro[benzo[<i>b</i>][1,4]oxazepine-2,4â²-pyran]-5(4<i>H</i>)-yl)methyl)-2-naphthoic Acid 2,2,2-Trifluoroacetate (<b>36</b>)</h4><div id="sec3_1_11_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> Step 1</h5><div class="NLM_p last">A mixture of <i>tert</i>-butyl (<i>S</i>)-1-((<i>S</i>)-5-((6-bromo-2-methoxynaphthalen-1-yl)methyl)-4-oxo-2â²,3â²,4,5,5â²,6â²-hexahydro-3<i>H</i>-spiro[benzo[<i>b</i>][1,4]oxazepine-2,4â²-pyran]-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate (0.17 g, 249 Î¼mol), Pd(OAc)<sub>2</sub> (2.24 mg, 9.96 Î¼mol), 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (Xantphos) (11.5 mg, 19.9 Î¼mol), MeOH (0.10 mL, 2.5 mmol), and Et<sub>3</sub>N (0.5 mL) was sparged with CO, sealed and stirred at 70 Â°C for 18 h. The reaction was cooled to rt, diluted with EtOAc, washed with 1 N aq HCl, H<sub>2</sub>O, and satd aq NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude material was purified by flash chromatography to provide methyl 5-(((<i>S</i>)-3-((<i>S</i>)-2-(<i>tert</i>-butoxycarbonyl(methyl)amino)propanamido)-4-oxo-2â²,3â²,5â²,6â²-tetrahydro-3<i>H</i>-spiro[benzo[<i>b</i>][1,4]oxazepine-2,4â²-pyran]-5(4<i>H</i>)-yl)methyl)-6-methoxy-2-naphthoate (111 mg, 67%) as a light-yellow foam. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.48 (s, 1H), 8.28â8.40 (m, 1H), 8.18 (d, <i>J</i> = 8.6 Hz, 1H), 8.02 (d, <i>J</i> = 9.0 Hz, 1H), 7.81 (d, <i>J</i> = 9.8 Hz, 1H), 7.54 (d, <i>J</i> = 7.8 Hz, 1H), 7.39 (d, <i>J</i> = 9.0 Hz, 1H), 7.13 (t, <i>J</i> = 7.4 Hz, 1H), 7.02â7.08 (m, 1H), 6.82 (d, <i>J</i> = 7.4 Hz, 1H), 5.93 (d, <i>J</i> = 14.8 Hz, 1H), 5.28 (d, <i>J</i> = 14.8 Hz, 1H), 4.63 (q, <i>J</i> = 7.0 Hz, 1H), 4.54 (d, <i>J</i> = 9.0 Hz, 1H), 3.88 (s, 3H), 3.86 (s, 3H), 3.59â3.80 (m, 3H), 3.34â3.45 (m, 1H), 2.75 (s, 3H), 2.01â2.16 (m, 1H), 1.59 (d, <i>J</i> = 13.3 Hz, 1H), 1.43â1.52 (m, 1H), 1.38 (s, 9H), 1.23â1.32 (m, 4H). MS <i>m</i>/<i>z</i> 662 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_11_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> Step 2</h5><div class="NLM_p last">To a solution of methyl 5-(((<i>S</i>)-3-((<i>S</i>)-2-(<i>tert</i>-butoxycarbonyl(methyl)amino)propanamido)-4-oxo-2â²,3â²,5â²,6â²-tetrahydro-3<i>H</i>-spiro[benzo[<i>b</i>][1,4]oxazepine-2,4â²-pyran]-5(4<i>H</i>)-yl)methyl)-6-methoxy-2-naphthoate (111 mg, 0.167 mmol) in THF (3 mL) was added a solution of LiOHÂ·H<sub>2</sub>O (35.0 mg, 835 Î¼mol) in H<sub>2</sub>O (4 mL). The reaction was stirred at rt for 18 h, then diluted with 1 M aq HCl (20 mL) and extracted with EtOAc (2 Ã 15 mL). The combined organic extracts were washed with H<sub>2</sub>O (2 Ã 20 mL) and satd aq NaCl (20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated in vacuo, and lyophilized from MeCNâH<sub>2</sub>O to provide 5-(((<i>S</i>)-3-((<i>S</i>)-2-(<i>tert</i>-butoxycarbonyl(methyl)amino)propanamido)-4-oxo-2â²,3â²,5â²,6â²-tetrahydro-3<i>H</i>-spiro[benzo[<i>b</i>][1,4]oxazepine-2,4â²-pyran]-5(4<i>H</i>)-yl)methyl)-6-methoxy-2-naphthoic acid (95.2 mg, 88%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 12.90 (br s, 1H), 8.44 (s, 1H), 8.30â8.39 (m, 1H), 8.16 (d, <i>J</i> = 8.2 Hz, 1H), 7.99 (d, <i>J</i> = 9.0 Hz, 1H), 7.80 (d, <i>J</i> = 8.6 Hz, 1H), 7.55 (d, <i>J</i> = 7.8 Hz, 1H), 7.37 (d, <i>J</i> = 9.4 Hz, 1H), 7.13 (t, <i>J</i> = 7.6 Hz, 1H), 7.02â7.08 (m, 1H), 6.82 (d, <i>J</i> = 7.8 Hz, 1H), 5.93 (d, <i>J</i> = 14.8 Hz, 1H), 5.29 (d, <i>J</i> = 14.5 Hz, 1H), 4.63 (q, <i>J</i> = 7.4 Hz, 1H), 4.54 (d, <i>J</i> = 9.0 Hz, 1H), 3.86 (s, 3H), 3.59â3.81 (m, 3H), 3.41 (t, <i>J</i> = 11.5 Hz, 1H), 2.75 (s, 3H), 2.02â2.15 (m, 1H), 1.60 (d, <i>J</i> = 13.3 Hz, 1H), 1.43â1.52 (m, 1H), 1.38 (s, 9H), 1.21â1.32 (m, 4H). MS <i>m</i>/<i>z</i> 648 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_11_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> Step 3</h5><div class="NLM_p last">To a rt solution of 5-(((<i>S</i>)-3-((<i>S</i>)-2-(<i>tert</i>-butoxycarbonyl(methyl)amino)propanamido)-4-oxo-2â²,3â²,5â²,6â²-tetrahydro-3<i>H</i>-spiro[benzo[<i>b</i>][1,4]oxazepine-2,4â²-pyran]-5(4<i>H</i>)-yl)methyl)-6-methoxy-2-naphthoic acid (36.5 mg, 0.056 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was added TFA (0.2 mL). The reaction was stirred at rt for 1 h, then it was concentrated in vacuo and lyophilized from MeCNâH<sub>2</sub>O to provide <b>36</b> (31.0 mg, 83%) as an off-white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 12.93 (br s, 1H), 9.11 (d, <i>J</i> = 9.2 Hz, 1H), 8.66â8.90 (m, 2H), 8.45 (d, <i>J</i> = 1.3 Hz, 1H), 8.17 (d, <i>J</i> = 9.0 Hz, 1H), 8.00 (d, <i>J</i> = 9.0 Hz, 1H), 7.80 (dd, <i>J</i> = 9.0, 1.5 Hz, 1H), 7.58 (dd, <i>J</i> = 7.9, 1.3 Hz, 1H), 7.37 (d, <i>J</i> = 9.2 Hz, 1H), 7.13â7.19 (m, 1H), 7.04â7.11 (m, 1H), 6.82â6.88 (m, 1H), 5.94 (d, <i>J</i> = 14.7 Hz, 1H), 5.30 (d, <i>J</i> = 14.7 Hz, 1H), 4.55 (d, <i>J</i> = 9.2 Hz, 1H), 3.98 (d, <i>J</i> = 6.4 Hz, 1H), 3.86 (s, 3H), 3.63â3.84 (m, 3H), 3.32â3.47 (m, 1H), 2.49â2.51 (m, 3H), 2.10 (td, <i>J</i> = 13.0, 5.3 Hz, 1H), 1.46â1.68 (m, 2H), 1.39 (d, <i>J</i> = 6.8 Hz, 3H), 1.27â1.37 (m, 1H). MS <i>m</i>/<i>z</i> 548 [M + H]<sup>+</sup>.</div></div></div><div id="sec3_1_11_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (<i>S</i>)-<i>N</i>-((<i>S</i>)-5-((3-Methoxyquinolin-4-yl)methyl)-4-oxo-2â²,3â²,4,5,5â²,6â²-hexahydro-3<i>H</i>-spiro[benzo[<i>b</i>][1,4]oxazepine-2,4â²-pyran]-3-yl)-2-(methylamino)propanamide Hydrochloride (<b>37</b>)</h4><div class="NLM_p last">According to general procedures B, except that the reaction was conducted at rt, and general procedure C, <b>32</b> (100 mg, 0.231 mmol) and 4-(chloromethyl)-3-methoxyquinoline (71.9 mg, 0.346 mmol) were converted to <b>37</b> (75.9 mg, 57% 2 steps) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.25â9.34 (m, 1H), 9.08 (d, <i>J</i> = 9.4 Hz, 1H), 8.90 (s, 1H), 8.79â8.88 (m, 1H), 8.27 (d, <i>J</i> = 8.6 Hz, 1H), 8.03 (d, <i>J</i> = 8.6 Hz, 1H), 7.54â7.72 (m, 3H), 7.22 (t, <i>J</i> = 7.6 Hz, 1H), 7.11â7.17 (m, 1H), 6.93 (d, <i>J</i> = 7.8 Hz, 1H), 5.99 (d, <i>J</i> = 14.5 Hz, 1H), 5.31 (d, <i>J</i> = 14.8 Hz, 1H), 4.56 (d, <i>J</i> = 9.0 Hz, 1H), 3.95â4.01 (m, 1H), 3.95 (s, 3H), 3.65â3.82 (m, 3H), 3.43 (t, <i>J</i> = 11.3 Hz, 1H), 2.45 (t, <i>J</i> = 5.3 Hz, 3H), 2.08 (td, <i>J</i> = 13.0, 5.3 Hz, 1H), 1.45â1.59 (m, 2H), 1.39 (d, <i>J</i> = 6.6 Hz, 3H), 1.20â1.36 (m, 1H). HRMS <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>33</sub>O<sub>5</sub>N<sub>4</sub> [M + H]<sup>+</sup> 505.24455, found 505.24310.</div></div><div id="sec3_1_11_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (<i>S</i>)-<i>N</i>-((<i>S</i>)-5-(Benzo[<i>d</i>]isoxazol-3-ylmethyl)-4-oxo-2â²,3â²,4,5,5â²,6â²-hexahydro-3<i>H</i>-spiro[benzo[<i>b</i>][1,4]oxazepine-2,4â²-pyran]-3-yl)-2-(methylamino)propanamide Hydrochloride (<b>38</b>)</h4><div class="NLM_p last">To a rt solution of <b>32</b> in which the diastereomers had not been separated (156 mg, 0.360 mmol) was added 3-(bromomethyl)benzo[<i>d</i>]isoxazole (83.9 mg, 0.396 mmol), Cs<sub>2</sub>CO<sub>3</sub> (141 mg, 0.432 mmol), and NaI (65 mg, 0.43 mmol). The reaction was stirred at rt for 18 h, then diluted with EtOAc (25 mL), washed with H<sub>2</sub>O (25 mL) and satd aq NaCl (25 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude material was purified by flash chromatography then by SFC to separate the diastereomers and provide <i>tert</i>-butyl (<i>S</i>)-1-((<i>S</i>)-5-(benzo[<i>d</i>]isoxazol-3-ylmethyl)-4-oxo-2â²,3â²,4,5,5â²,6â²-hexahydro-3<i>H</i>-spiro[benzo[<i>b</i>][1,4]oxazepine-2,4â²-pyran]-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate (54 mg, 27%) as a white foam. This material was reacted according to general procedure C to provide <b>38</b> (42 mg, 92%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.08 (d, <i>J</i> = 9.1 Hz, 1H), 8.92 (br s, 2H), 7.80 (d, <i>J</i> = 7.9 Hz, 1H), 7.59â7.74 (m, 3H), 7.23â7.39 (m, 3H), 7.11 (d, <i>J</i> = 7.2 Hz, 1H), 5.71 (d, <i>J</i> = 15.5 Hz, 1H), 5.35 (d, <i>J</i> = 15.5 Hz, 1H), 4.65 (d, <i>J</i> = 9.1 Hz, 1H), 3.95 (q, <i>J</i> = 6.4 Hz, 1H), 3.70â3.89 (m, 3H), 3.54 (t, <i>J</i> = 11.3 Hz, 1H), 2.47 (s, 3H), 2.11 (td, <i>J</i> = 12.9, 5.1 Hz, 1H), 1.43â1.66 (m, 3H), 1.35 (d, <i>J</i> = 6.8 Hz, 3H). HRMS <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>29</sub>O<sub>5</sub>N<sub>4</sub> [M + H]<sup>+</sup> 465.21325, found 465.21185.</div></div><div id="sec3_1_11_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (<i>S</i>)-<i>N</i>-((<i>S</i>)-5-((1-(2-Cyanophenyl)-1<i>H</i>-indazol-3-yl)methyl)-4-oxo-2â²,3â²,4,5,5â²,6â²-hexahydro-3<i>H</i>-spiro[benzo[<i>b</i>][1,4]oxazepine-2,4â²-pyran]-3-yl)-2-(methylamino)propanamide (<b>39</b>)</h4><div class="NLM_p last">According to general procedure B, <b>32</b> (55 mg, 0.127 mmol) and 2-(3-(bromomethyl)-1<i>H</i>-indazol-1-yl)benzonitrile (78 mg, 0.25 mmol) were converted to (<i>S</i>)-2-amino-<i>N</i>-((<i>S</i>)-5-((1-(2-cyanophenyl)-1<i>H</i>-indazol-3-yl)methyl)-4-oxo-2,3,4,5-tetrahydrobenzo[<i>b</i>][1,4]oxazepin-3-yl)propanamide (60 mg, 71%). To a 0 Â°C solution of this material in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was added TFA (1.5 mL). The reaction was stirred at 0 Â°C for 1 h, then diluted with satd aq NaHCO<sub>3</sub> and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were concentrated in vacuo and the residue was purified by preparative TLC to provide <b>39</b> (48 mg, 94%) as a yellow solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.31 (d, <i>J</i> = 9.0 Hz, 1H), 8.09 (d, <i>J</i> = 7.7 Hz, 1H), 7.86â7.94 (m, 2H), 7.63â7.79 (m, 3H), 7.45â7.57 (m, 2H), 7.19â7.31 (m, 3H), 7.06â7.11 (m, 1H), 5.50 (s, 2H), 4.63 (d, <i>J</i> = 9.0 Hz, 1H), 3.70â3.90 (m, 3H), 3.60 (t, <i>J</i> = 11.4 Hz, 1H), 2.96â3.07 (m, 1H), 2.18 (s, 3H), 1.91â2.06 (m, 1H), 1.66 (d, <i>J</i> = 13.4 Hz, 1H), 1.38â1.57 (m, 2H), 1.10 (d, <i>J</i> = 7.0 Hz, 3H); HRMS <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>33</sub>O<sub>4</sub>N<sub>6</sub> [M + H]<sup>+</sup> 565.25578, found 565.25580.</div></div><div id="sec3_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (<i>S</i>)-<i>N</i>-((<i>S</i>)-5-((2-Cyano-1-(2-cyanophenyl)-1<i>H</i>-indol-3-yl)methyl)-4-oxo-2â²,3â²,4,5,5â²,6â²-hexahydro-3<i>H</i>-spiro[benzo[<i>b</i>][1,4]oxazepine-2,4â²-pyran]-3-yl)-2-(methylamino)propanamide (<b>40</b>)</h4><div id="sec3_1_12_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> Step 1</h5><div class="NLM_p last">To a rt solution <b>32</b> (8.5 g, 19.6 mmol) and 3-(bromomethyl)-1-(2-cyanophenyl)-1<i>H</i>-indole-2-carbonitrile (9.89 g, 29.4 mmol) in DMF (20 mL) was added Cs<sub>2</sub>CO<sub>3</sub> (9.58 g, 29.4 mmol). The reaction was stirred at 70 Â°C for 1 h, then cooled to rt, diluted with satd aq NH<sub>4</sub>Cl, and extracted with EtOAc. The combined organic layers were washed with H<sub>2</sub>O, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude material was purified by flash chromatography to provide <i>tert</i>-butyl (<i>S</i>)-1-((<i>S</i>)-5-((2-cyano-1-(2-cyanophenyl)-1<i>H</i>-indol-3-yl)methyl)-4-oxo-2â²,3â²,4,5,5â²,6â²-hexahydro-3<i>H</i>-spiro[benzo[<i>b</i>][1,4]oxazepine-2,4â²-pyran]-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate (13 g, 96%) as a light-yellow solid. MS <i>m</i>/<i>z</i> 689 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_12_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> Step 2</h5><div class="NLM_p last">To a 0 Â°C solution of <i>tert</i>-butyl (<i>S</i>)-1-((<i>S</i>)-5-((2-cyano-1-(2-cyanophenyl)-1<i>H</i>-indol-3-yl)methyl)-4-oxo-2â²,3â²,4,5,5â²,6â²-hexahydro-3<i>H</i>-spiro[benzo[<i>b</i>][1,4]oxazepine-2,4â²-pyran]-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate (4 g, 5.81 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) was added TFA (25 mL) dropwise over 2 h. The reaction was stirred for 30 min at 0 Â°C, then diluted with 1:1 satd aq NaHCO<sub>3</sub> and H<sub>2</sub>O. The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to provide <b>40</b> (3.4 g, 97%) as a light-yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.13â8.24 (m, 1H), 7.76â7.91 (m, 3H), 7.62â7.68 (m, 1H), 7.46â7.52 (m, 1H), 7.33â7.45 (m, 2H), 7.16â7.31 (m, 3H), 7.01â7.06 (m, 1H), 6.91â6.97 (m, 1H), 5.85â5.94 (m, 1H), 5.11â5.18 (m, 1H), 4.76â4.83 (m, 1H), 3.60â3.94 (m, 4H), 3.06â3.15 (m, 1H), 2.47â2.51 (m, 3H), 1.94â2.07 (m, 1H), 1.55â1.78 (m, 3H), 1.31â1.35 (m, 3H). HRMS <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>33</sub>O<sub>4</sub>N<sub>6</sub> [M + H]<sup>+</sup> 589.25578, found 589.25482.</div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Biology</h3><div id="sec3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> XIAP BIR2 and BIR3 TR-FRET Assay</h4><div class="NLM_p last">Ten nanomolar of 6Ã histidine-tagged BIR2 (amino acids 124â240) or BIR3 (amino acids 241â356) domain of the XIAP protein was mixed with 20 nM of the peptide AVPIAQKSEK (Îµ-biotin)âOH 1:2 TFA in the presence of 50 mM Tris-Cl (pH 7.5), 100 mM NaCl, 1 mM dithiothreitol (DTT), and 0.1 mg/mL bovine serum albumin (BSA). Following a 45 min incubation at 37 Â°C, europiumâstreptavidin and allophycocyanin conjugated anti-histidine antibody were added to a final concentration of 1.5 and 15 nM, respectively. Time-resolved fluorescence resonance energy transfer (TR-FRET) signals were measured after 1 h at rt. Compound potency was assessed at 10 serially diluted concentrations. Percentage of inhibition at each concentration was determined to generate an IC<sub>50</sub> value for each compound. Typically, <i>Z</i>â² = â¼0.9.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> A measure of the overall variability of the assay is provided by the positive control: BIR2 IC<sub>50</sub> = 1.25 Â± 0.91 Î¼M (<i>n</i> = 160), BIR3 IC<sub>50</sub> = 0.039 Â± 0.025 Î¼M (<i>n</i> = 168).</div></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> cIAP1 BIR2 and BIR3 TR-FRET Assay</h4><div class="NLM_p last">Thirty nanomolar of 6Ã histidineâthrombinâTEV tagged BIR2 (amino acids 174â256) or BIR3 (amino acids 260â352) domain of the cIAP protein was mixed with 50 nM of the peptide AVPIAQKSEK (Îµ-biotin)âOH 1:2 TFA in the presence of 50 mM Tris-Cl (pH 7.5), 100 mM NaCl, 1 mM dithiothreitol (DTT), and 0.1 mg/mL bovine serum albumin (BSA). Following a 45 min incubation at 37 Â°C, europiumâstreptavidin and allophycocyanin conjugated anti-histidine antibody were added to a final concentration of 1.5 and 15 nM, respectively. Time-resolved fluorescence resonance energy transfer (TR-FRET) signals were measured after 1 h at rt. Compound potency was assessed at 10 serially diluted concentrations. Percentage of inhibition at each concentration was determined to generate an IC<sub>50</sub> value for each compound.</div></div><div id="sec3_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Rat Blood Stability Assay</h4><div class="NLM_p last">A 10 mM DMSO solution of test compound was diluted to 200 Î¼M with MeCN and then further diluted to 1 Î¼M (total volume 1.0 mL) with heparin-treated rat blood and then incubated at 37 Â°C with 5% CO<sub>2</sub> for 4 h. Aliquots (50 Î¼L) were removed at 0, 15, 60, and 240 min, then treated with 0.6 mL of 0.1% formic acid in MeCN with 2 mg/mL 7-hydroxycoumarin internal standard, vortexed, and centrifuged (4000 rpm) for 10 min. The supernatants (150 Î¼L) were transferred to injection plates containing 150 Î¼L of 0.1% formic acid in water, vortexed, and centrifuged (4000 rpm) for 5 min, then analyzed by LC-MS/MS.</div></div><div id="sec3_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> XIAP-Caspase Reactivation Assay</h4><div class="NLM_p last">The caspase reactivation assay was performed in 20 mM HEPES buffer (pH 7.0), containing 1.5 mM MgCl<sub>2</sub>, 5 mM KCl, 1 mM ethylene diamine tetraacetic acid (EDTA), 1 mM ethylene glycol tetraacetic acid (EGTA), 1 mM DTT, and 0.1 mg/mL BSA. S-100 cell extract served as the source of cellular caspases. Then 2 Î¼M cytochrome C and 19.2 Î¼M dATP were added to activate the caspases. The cleavage of a fluorogenic substrate specific for caspase-3 and -7, Ac-DEVD-AFC at 10 Î¼M, was monitored at 530 nm after 4 h of incubation at rt. The addition of 0.75 nM glutathione S-transferase (GST)-tagged full length XIAP inhibited the caspase activation by â¼85%. The effect of serially diluted compounds to restore caspase activation was determined to generate an EC<sub>50</sub> value for each compound.</div></div><div id="sec3_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Cell-Based Assay</h4><div class="NLM_p last">SW-620 cells (1500 cells/well) were seeded into a 96 well plate one day prior to treatment. Cells were treated with indicated compounds and/or antibody and further incubated at 37 Â°C with 5% CO<sub>2</sub> for 5 days. Cell Titer 96 Aqueous One solution (25 Î¼L/well, Promega cat. no. G3580) was added, and the plates were further incubated for 2â3 h. Plateâs OD at 490 nm was determined using Envision 2101 plate reader (PerkinElmer), and EC<sub>50</sub> values were determined for compounds or antibody. A similar protocol was used to evaluate the other cell lines.</div></div><div id="sec3_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> in Vitro Caspase 3/7 Assay</h4><div class="NLM_p last">SW620 cells were treated with indicated compounds and/or antibody and incubated for 4 h. Cell lysate (25 Î¼g) and caspase-3/7 assay buffer (1% NP40, 50 Î¼M DEVD-AMC (Biomol)) were added to a solid white 96 well plate. Lysates were incubated at rt for 20 min, and cleavage of DEVD-AMC substrate was measured with a plate reader (Molecular Devices Spectramax M5) at 385/460 nm.</div></div><div id="sec3_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> TNFÎ± ELISA Assay</h4><div class="NLM_p last">MDA-MB-231 cells (400,000 cells/well) were seeded into 24 well plates and incubated for 24 h. Media was aspirated from wells and replaced with either compound or media alone (400 Î¼L/well) and further incubated at 37 Â°C with 5% CO<sub>2</sub> for 19 h. Total media volume was then collected and centrifuged (1000<i>g</i>) at 4 Â°C to pellet debris. TNF of media was quantitated by ELISA (TNF Human ELISA kit, R&D Systems cat. no. DTA00B), and the results were plotted following subtraction of background values (media, no cells).</div></div><div id="sec3_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> in Vivo Caspase 3/7 Assay and Western Blot Analysis</h4><div class="NLM_p">A single dose of compound was administered as follows to female nude mice with LOX xenografts: conatumumab 1 mg/kg ip, <b>3</b> 100 mg/kg po, <b>40</b> 200 mg/kg po, or a combination. Xenografts were removed 8 h postdose, frozen (â80 Â°C), transferred to 15 mL conical tubes on dry ice, and treated with 1Ã lysis buffer (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% TX-100, 5 mM sodium pyrophosphate, 1 mM Î²-glycerophosphate, 10 mM sodium fluoride, 1 mM Na<sub>3</sub>VO<sub>4</sub>, 1 mM benzamidine, EMD proteinase inhibitor cocktail V). Tumors were homogenized at full speed, diluted with the same volume of lysis buffer, and kept on ice for 20 min. A portion of the homogenate (2 mL) was transferred to a microcentrifuge tube and thawed at full speed for 20 min at 4 Â°C. The supernatant was optionally centrifuged again. Protein was quantitated and samples were prepared for caspase assay and Western blot analysis (50 Î¼g of total protein was used for caspase assay/60 Î¼g of total protein was used for Western blot).</div><div id="sec3_2_8_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i76" class="anchor-spacer"></div><h5 class="article-section__title" id="_i76"> Caspase 3/7 Assay</h5><div class="NLM_p last">Tumor lysate (10 Î¼L, 5 Î¼g/Î¼L) was added into white solid 96 well plate. Caspase-3/7 assay buffer (final concentration: 10 mM Tris, 5 mM DTT, 1 mM EDTA, 50 Î¼M DEVD-AMC, 20 mM NaCl, 1% NP-40) (90 Î¼L) was added into each well. The plate was incubated for 2 h at rt with shaking and read at 385/460 nM.</div></div><div id="sec3_2_8_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i77" class="anchor-spacer"></div><h5 class="article-section__title" id="_i77"> Western Blot Analysis</h5><div class="NLM_p last">Proteins were electrophoresed on 4â12% NuPAGE Bis-Tris midi-gel (Invitrogen) and transferred to PVDF membrane (Invitrogen). Membranes were blocked in 5% milk, incubated with primary antibodies, washed, and incubated with horseradish peroxidase linked secondary antibody (Cell Signaling Technology). The blots were stripped and reprobed. The following primary antibodies were used in the study: anti-XIAP (R&D Systems), anticaspase-3 (Santa Cruz), anti-cIAP1, anti-PARP.</div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i78"><a href="/doi/suppl/10.1021/jm400731m">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45543" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45543" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">EC<sub>50</sub> values for activity in multiple cell lines, synthetic procedures for intermediates, crystallographic method, crystallographic data refinement and statistics.  This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400731m/suppl_file/jm400731m_si_001.pdf">jm400731m_si_001.pdf (163.38 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB ID code for <b>36</b> bound to XIAP BIR2 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KJV">4KJV</a>.</p><div class="testing" data-doi="10.1021/jm400731m" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60832" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60832" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew F. Donnell</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#debfb0baacbba9f0b8f0bab1b0b0bbb2b29eb9b3bfb7b2f0bdb1b3"><span class="__cf_email__" data-cfemail="b5d4dbd1c7d0c29bd39bd1dadbdbd0d9d9f5d2d8d4dcd99bd6dad8">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christophe Michoud</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth C. Rupert</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaochun Han</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas Aguilar</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karl B. Frank</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adrian J. Fretland</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lin Gao</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barry Goggin</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">J. Heather Hogg</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kyoungja Hong</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheryl A. Janson</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert F. Kester</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Norman Kong</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kang Le</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shirley Li</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weiling Liang</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Louis J. Lombardo</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan Lou</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine M. Lukacs</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Mischke</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John A. Moliterni</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ann Polonskaia</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew D. Schutt</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dave S. Solis</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony Specian</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert T. Taylor</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Weisel</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stacy W. Remiszewski</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery
Chemistry, â¡Discovery Technologies, Â§Non-clinical Safety,
Early ADME, and â¥Discovery Oncology, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d3412e5299-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i81">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57735" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57735" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Pamela Carroll and Dr. David Heimbrook for their support of this program. We also thank Charles Belunis for protein purification and Santina Russo and Joachim Diez of Expose for data collection at SLS.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i82" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i82"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i83" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i83"> Abbreviations Used</h2><tr><td class="NLM_term">IAP</td><td class="NLM_def"><p class="first last">inhibitor of apoptosis protein</p></td></tr><tr><td class="NLM_term">XIAP</td><td class="NLM_def"><p class="first last">X-linked inhibitor of apoptosis</p></td></tr><tr><td class="NLM_term">cIAP</td><td class="NLM_def"><p class="first last">cellular inhibitor of apoptosis protein</p></td></tr><tr><td class="NLM_term">BIR</td><td class="NLM_def"><p class="first last">baculovirus IAP repeat</p></td></tr><tr><td class="NLM_term">Smac</td><td class="NLM_def"><p class="first last">second mitochondria-derived activator of caspases</p></td></tr><tr><td class="NLM_term">DIABLO</td><td class="NLM_def"><p class="first last">direct IAP-binding protein with a low p<i>I</i></p></td></tr><tr><td class="NLM_term">DR5</td><td class="NLM_def"><p class="first last">death receptor 5</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last"><i>N</i>-(3-dimethylaminopropyl)-<i>N</i>â²-ethylcarbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">hydroxybenzotriazole, HBTU, <i>O</i>-(benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>â²,<i>N</i>â²-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">PARP</td><td class="NLM_def"><p class="first last">poly ADP ribose polymerase</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10417" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10417" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 36 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hanahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span> </span><span class="NLM_article-title">Hallmarks of Cancer: The Next Generation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">646</span><span class="NLM_x">â</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+Cancer%3A+The+Next+Generation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0ljZ2M6KBfOngQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520Cancer%253A%2520The%2520Next%2520Generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26spage%3D646%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Fulda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucic, D.</span><span> </span><span class="NLM_article-title">Targeting IAP proteins for therapeutic intervention in cancer</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">â</span> <span class="NLM_lpage">123</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=109-123&author=S.+Fuldaauthor=D.+Vucic&title=Targeting+IAP+proteins+for+therapeutic+intervention+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DTargeting%2520IAP%2520proteins%2520for%2520therapeutic%2520intervention%2520in%2520cancer%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D109%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Gyrd-Hansen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, P.</span><span> </span><span class="NLM_article-title">IAPs: from caspase inhibitors to modulators of NF-ÎºB, inflammation and cancer</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">â</span> <span class="NLM_lpage">573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1038%2Fnrc2889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=20651737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1Gjtbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=561-573&author=M.+Gyrd-Hansenauthor=P.+Meier&title=IAPs%3A+from+caspase+inhibitors+to+modulators+of+NF-%CE%BAB%2C+inflammation+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">IAPs: from caspase inhibitors to modulators of NF-ÎºB, inflammation and cancer</span></div><div class="casAuthors">Gyrd-Hansen, Mads; Meier, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">561-574</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The realization that alterations in inhibitor of apoptosis (IAP) proteins are found in many types of human cancer and are assocd. with chemoresistance, disease progression, and poor prognosis, has sparked a worldwide frenzy in the development of small pharmacol. inhibitors of IAPs.  The development of such inhibitors has radically changed our knowledge of the signaling processes that are regulated by IAPs.  Recent studies indicate that IAPs not only regulate caspases and apoptosis, but also modulate inflammatory signaling and immunity, mitogenic kinase signaling, proliferation and mitosis, as well as cell invasion and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNNte9JiwXrbVg90H21EOLACvtfcHk0liazTfnWenLXw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1Gjtbw%253D&md5=7cf8b18a0d79f00b36aa0b9caf9d66ed</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc2889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2889%26sid%3Dliteratum%253Aachs%26aulast%3DGyrd-Hansen%26aufirst%3DM.%26aulast%3DMeier%26aufirst%3DP.%26atitle%3DIAPs%253A%2520from%2520caspase%2520inhibitors%2520to%2520modulators%2520of%2520NF-%25CE%25BAB%252C%2520inflammation%2520and%2520cancer%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D561%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Dean, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackhall, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dive, C.</span><span> </span><span class="NLM_article-title">X-linked inhibitor of apoptosis protein as a therapeutic target</span> <span class="citation_source-journal">Expert. Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1459</span><span class="NLM_x">â</span> <span class="NLM_lpage">1471</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1517%2F14728222.11.11.1459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1amsbbM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=1459-1471&author=E.+J.+Deanauthor=M.+Ransonauthor=F.+Blackhallauthor=C.+Dive&title=X-linked+inhibitor+of+apoptosis+protein+as+a+therapeutic+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">X-linked inhibitor of apoptosis protein as a therapeutic target</span></div><div class="casAuthors">Dean, Emma J.; Ranson, Malcolm; Blackhall, Fiona; Dive, Caroline</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1459-1471</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Dysregulation of apoptosis has been shown to contribute to many diseases, including cancer formation, development and resistance, as well as neurodegenerative and autoimmune disorders.  One mechanism through which tumor cells are believed to acquire resistance to apoptosis is by overexpression of X-linked inhibitor of apoptosis protein (XIAP), which belongs to a family of inhibitor of apoptosis proteins.  When XIAP is overexpressed, cancer cells are rendered resistant to apoptosis, both intrinsically and in response to chemotherapy and radiotherapy.  Significant progress has been made in targeting XIAP therapeutically, both directly and indirectly through the modulation of other mols. involved in the apoptotic pathway.  This review introduces XIAP from its mol. origins, discusses its modulation and potential as a novel drug target, and considers future therapeutic perspectives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU2krTm9JIOLVg90H21EOLACvtfcHk0liazTfnWenLXw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1amsbbM&md5=378d6c00969aa089bc28f07fa644cb6f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1517%2F14728222.11.11.1459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.11.11.1459%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DE.%2BJ.%26aulast%3DRanson%26aufirst%3DM.%26aulast%3DBlackhall%26aufirst%3DF.%26aulast%3DDive%26aufirst%3DC.%26atitle%3DX-linked%2520inhibitor%2520of%2520apoptosis%2520protein%2520as%2520a%2520therapeutic%2520target%26jtitle%3DExpert.%2520Opin.%2520Ther.%2520Targets%26date%3D2007%26volume%3D11%26spage%3D1459%26epage%3D1471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Hunter, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaCasse, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korneluk, R. G.</span><span> </span><span class="NLM_article-title">The inhibitors of apoptosis (IAPs) as cancer targets</span> <span class="citation_source-journal">Apoptosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1543</span><span class="NLM_x">â</span> <span class="NLM_lpage">1568</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=1543-1568&author=A.+M.+Hunterauthor=E.+C.+LaCasseauthor=R.+G.+Korneluk&title=The+inhibitors+of+apoptosis+%28IAPs%29+as+cancer+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHunter%26aufirst%3DA.%2BM.%26aulast%3DLaCasse%26aufirst%3DE.%2BC.%26aulast%3DKorneluk%26aufirst%3DR.%2BG.%26atitle%3DThe%2520inhibitors%2520of%2520apoptosis%2520%2528IAPs%2529%2520as%2520cancer%2520targets%26jtitle%3DApoptosis%26date%3D2007%26volume%3D12%26spage%3D1543%26epage%3D1568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Eckelman, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvesen, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, F. L.</span><span> </span><span class="NLM_article-title">Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">988</span><span class="NLM_x">â</span> <span class="NLM_lpage">994</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1038%2Fsj.embor.7400795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=17016456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVajtr7K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=988-994&author=B.+P.+Eckelmanauthor=G.+S.+Salvesenauthor=F.+L.+Scott&title=Human+inhibitor+of+apoptosis+proteins%3A+why+XIAP+is+the+black+sheep+of+the+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family</span></div><div class="casAuthors">Eckelman, Brendan P.; Salvesen, Guy S.; Scott, Fiona L.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">988-994</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Several of the inhibitor of apoptosis protein (IAP) family members regulate apoptosis in response to various cellular assaults.  Some members are also involved in cell signaling, mitosis and targeting proteins to the ubiquitin-proteasome degrdn. machinery.  The most intensively studied family member, X-linked IAP (XIAP), is a potent inhibitor of caspase activity; hence, it is generally assumed that direct caspase inhibition is an important conserved function of most members of the family.  Biochem. and structural studies have precisely mapped the elements of XIAP required for caspase inhibition.  Intriguingly, these elements are not conserved among IAPs.  Here, we review current knowledge of the caspase-inhibitory potential of the human IAPs and show that XIAP is probably the only bona fide caspase inhibitor, suggesting that the other family members never gained the ability to directly inhibit caspase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi2WCkDI8Vs7Vg90H21EOLACvtfcHk0liazTfnWenLXw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVajtr7K&md5=7db7a68e171e0303dd25ba6e2a97be34</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.embor.7400795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.embor.7400795%26sid%3Dliteratum%253Aachs%26aulast%3DEckelman%26aufirst%3DB.%2BP.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DScott%26aufirst%3DF.%2BL.%26atitle%3DHuman%2520inhibitor%2520of%2520apoptosis%2520proteins%253A%2520why%2520XIAP%2520is%2520the%2520black%2520sheep%2520of%2520the%2520family%26jtitle%3DEMBO%2520Rep.%26date%3D2006%26volume%3D7%26spage%3D988%26epage%3D994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Srinivasa, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegde, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saleh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Datta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiozaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes-Alnemri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alnemri, E. S.</span><span> </span><span class="NLM_article-title">A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">410</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">â</span> <span class="NLM_lpage">116</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=2001&pages=112-116&author=S.+M.+Srinivasaauthor=R.+Hegdeauthor=A.+Salehauthor=P.+Dattaauthor=E.+Shiozakiauthor=J.+Chaiauthor=R.-A.+Leeauthor=P.+D.+Robbinsauthor=T.+Fernandes-Alnemriauthor=Y.+Shiauthor=E.+S.+Alnemri&title=A+conserved+XIAP-interaction+motif+in+caspase-9+and+Smac%2FDIABLO+regulates+caspase+activity+and+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSrinivasa%26aufirst%3DS.%2BM.%26aulast%3DHegde%26aufirst%3DR.%26aulast%3DSaleh%26aufirst%3DA.%26aulast%3DDatta%26aufirst%3DP.%26aulast%3DShiozaki%26aufirst%3DE.%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DR.-A.%26aulast%3DRobbins%26aufirst%3DP.%2BD.%26aulast%3DFernandes-Alnemri%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DAlnemri%26aufirst%3DE.%2BS.%26atitle%3DA%2520conserved%2520XIAP-interaction%2520motif%2520in%2520caspase-9%2520and%2520Smac%252FDIABLO%2520regulates%2520caspase%2520activity%2520and%2520apoptosis%26jtitle%3DNature%26date%3D2001%26volume%3D410%26spage%3D112%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Shiozaki, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigotti, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedl, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasula, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alnemri, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Mechanism of XIAP-Mediated Inhibition of Caspase-9</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">â</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1016%2FS1097-2765%2803%2900054-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=12620238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1WgsLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=519-527&author=E.+N.+Shiozakiauthor=J.+Chaiauthor=D.+J.+Rigottiauthor=S.+J.+Riedlauthor=P.+Liauthor=S.+M.+Srinivasulaauthor=E.+S.+Alnemriauthor=R.+Fairmanauthor=Y.+Shi&title=Mechanism+of+XIAP-Mediated+Inhibition+of+Caspase-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of XIAP-mediated inhibition of caspase-9</span></div><div class="casAuthors">Shiozaki, Eric N.; Chai, Jijie; Rigotti, Daniel J.; Riedl, Stefan J.; Li, Pingwei; Srinivasula, Srinivasa M.; Alnemri, Emad S.; Fairman, Robert; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">519-527</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis (IAP) proteins potently inhibit the catalytic activity of caspases.  While profound insight into the inhibition of the effector caspases has been gained in recent years, the mechanism of how the initiator caspase-9 is regulated by IAPs remains enigmatic.  This paper reports the crystal structure of caspase-9 in an inhibitory complex with the third baculoviral IAP repeat (BIR3) of XIAP at 2.4 Ã resoln.  The structure reveals that the BIR3 domain forms a heterodimer with a caspase-9 monomer.  Strikingly, the surface of caspase-9 that interacts with BIR3 also mediates its homodimerization.  We demonstrate that monomeric caspase-9 is catalytically inactive due to the absence of a supporting sequence element that could be provided by homodimerization.  Thus, XIAP sequesters caspase-9 in a monomeric state, which serves to prevent catalytic activity.  These studies, in conjunction with other observations, define a unified mechanism for the activation of all caspases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2rbChsxBIPbVg90H21EOLACvtfcHk0ljbfUi3kRibtA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1WgsLg%253D&md5=9e01d0078d4f8d676cb96d37c4027827</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900054-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900054-6%26sid%3Dliteratum%253Aachs%26aulast%3DShiozaki%26aufirst%3DE.%2BN.%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DRigotti%26aufirst%3DD.%2BJ.%26aulast%3DRiedl%26aufirst%3DS.%2BJ.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DSrinivasula%26aufirst%3DS.%2BM.%26aulast%3DAlnemri%26aufirst%3DE.%2BS.%26aulast%3DFairman%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DMechanism%2520of%2520XIAP-Mediated%2520Inhibition%2520of%2520Caspase-9%26jtitle%3DMol.%2520Cell%26date%3D2003%26volume%3D11%26spage%3D519%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Chai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiozaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasula, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dataa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alnemri, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Structural Basis of Caspase-7 Inhibition by XIAP</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">â</span> <span class="NLM_lpage">780</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1016%2FS0092-8674%2801%2900272-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=11257230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitFakurg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2001&pages=769-780&author=J.+Chaiauthor=E.+Shiozakiauthor=S.+M.+Srinivasulaauthor=Q.+Wuauthor=P.+Dataaauthor=E.+S.+Alnemriauthor=Y.+Shi&title=Structural+Basis+of+Caspase-7+Inhibition+by+XIAP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of caspase-7 inhibition by XIAP</span></div><div class="casAuthors">Chai, Jijie; Shiozaki, Eric; Srinivasula, Srinivasa M.; Wu, Qi; Dataa, Pinaki; Alnemri, Emad S.; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">769-780</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis (IAP) proteins suppress cell death by inhibiting the catalytic activity of caspases.  Here we present the crystal structure of caspase-7 in complex with a potent inhibitory fragment from XIAP at 2.45 Ã resoln.  An 18-residue XIAP peptide binds the catalytic groove of caspase-7, making extensive contacts to the residues that are essential for its catalytic activity.  Strikingly, despite a reversal of relative orientation, a subset of interactions between caspase-7 and XIAP closely resemble those between caspase-7 and its tetrapeptide inhibitor DEVD-CHO.  Our biochem. and structural analyses reveal that the BIR domains are dispensable for the inhibition of caspase-3 and -7.  This study provides a structural basis for the design of the next-generation caspase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolipWoAs9habVg90H21EOLACvtfcHk0ljbfUi3kRibtA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitFakurg%253D&md5=fe072a2bacd6c76e3763fff9bc678897</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2801%2900272-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252801%252900272-0%26sid%3Dliteratum%253Aachs%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DShiozaki%26aufirst%3DE.%26aulast%3DSrinivasula%26aufirst%3DS.%2BM.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DDataa%26aufirst%3DP.%26aulast%3DAlnemri%26aufirst%3DE.%2BS.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520Basis%2520of%2520Caspase-7%2520Inhibition%2520by%2520XIAP%26jtitle%3DCell%26date%3D2001%26volume%3D104%26spage%3D769%26epage%3D780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myszka, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span> </span><span class="NLM_article-title">Structural Basis of Caspase Inhibition by XIAP: Differential Roles of the Linker versus the BIR Domain</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">â</span> <span class="NLM_lpage">790</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=11257231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitFakurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2001&pages=781-790&author=Y.+Huangauthor=Y.+C.+Parkauthor=R.+L.+Richauthor=D.+Segalauthor=D.+G.+Myszkaauthor=H.+Wu&title=Structural+Basis+of+Caspase+Inhibition+by+XIAP%3A+Differential+Roles+of+the+Linker+versus+the+BIR+Domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain</span></div><div class="casAuthors">Huang, Yihua; Park, Young Chul; Rich, Rebecca L.; Segal, Deena; Myszka, David G.; Wu, Hao</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">781-790</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis proteins (IAPs) represent the only endogenous caspase inhibitors and are characterized by the presence of baculoviral IAP repeats (BIRs).  Here, we report the crystal structure of the complex between human caspase-7 and XIAP (BIR2 and the proceeding linker).  The structure surprisingly reveals that the linker is the only contacting element for the caspase, while the BIR2 domain is invisible in the crystal.  The linker interacts with and blocks the substrate groove of the caspase in a backward fashion, distinct from substrate recognition.  Structural analyses suggest that the linker is the energetic and specificity determinant of the interaction.  Further biochem. characterizations clearly establish that the linker harbors the major energetic determinant, while the BIR2 domain serves as a regulatory element for caspase binding and Smac neutralization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZjYs6k2CfhrVg90H21EOLACvtfcHk0ljbfUi3kRibtA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitFakurk%253D&md5=c12e25afe67e2979324ba5bf6151c6bf</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DY.%2BC.%26aulast%3DRich%26aufirst%3DR.%2BL.%26aulast%3DSegal%26aufirst%3DD.%26aulast%3DMyszka%26aufirst%3DD.%2BG.%26aulast%3DWu%26aufirst%3DH.%26atitle%3DStructural%2520Basis%2520of%2520Caspase%2520Inhibition%2520by%2520XIAP%253A%2520Differential%2520Roles%2520of%2520the%2520Linker%2520versus%2520the%2520BIR%2520Domain%26jtitle%3DCell%26date%3D2001%26volume%3D104%26spage%3D781%26epage%3D790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Riedl, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renatus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzenbacher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liddington, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvesen, G. S.</span><span> </span><span class="NLM_article-title">Structural Basis for the Inhibition of Caspase-3 by XIAP</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">â</span> <span class="NLM_lpage">800</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1016%2FS0092-8674%2801%2900274-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=11257232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitFakurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2001&pages=791-800&author=S.+J.+Riedlauthor=M.+Renatusauthor=R.+Schwarzenbacherauthor=Q.+Zhouauthor=C.+Sunauthor=S.+W.+Fesikauthor=R.+C.+Liddingtonauthor=G.+S.+Salvesen&title=Structural+Basis+for+the+Inhibition+of+Caspase-3+by+XIAP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the inhibition of caspase-3 by XIAP</span></div><div class="casAuthors">Riedl, Stefan J.; Renatus, Martin; Schwarzenbacher, Robert; Zhou, Qiao; Sun, Chaohong; Fesik, Stephen W.; Liddington, Robert C.; Salvesen, Guy S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">791-800</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The mol. mechanism(s) that regulate apoptosis by caspase inhibition remain poorly understood.  The main endogenous inhibitors are members of the IAP family and are exemplified by XIAP, which regulates the initiator caspase-9, and the executioner caspases-3 and -7.  We report the crystal structure of the second BIR domain of XIAP (BIR2) in complex with caspase-3, at a resoln. of 2.7 Ã, revealing the structural basis for inhibition.  The inhibitor makes limited contacts through its BIR domain to the surface of the enzyme, and most contacts to caspase-3 originate from the N-terminal extension.  This lies across the substrate binding cleft, but in reverse orientation compared to substrate binding.  The mechanism of inhibition is due to a steric blockade prohibitive of substrate binding, and is distinct from the mechanism utilized by synthetic substrate analog inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaCJZgSAEzrLVg90H21EOLACvtfcHk0lh-5tfX6c-2kg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitFakurY%253D&md5=7a06c657d5b3700b4dd8e77ab8569613</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2801%2900274-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252801%252900274-4%26sid%3Dliteratum%253Aachs%26aulast%3DRiedl%26aufirst%3DS.%2BJ.%26aulast%3DRenatus%26aufirst%3DM.%26aulast%3DSchwarzenbacher%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DLiddington%26aufirst%3DR.%2BC.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26atitle%3DStructural%2520Basis%2520for%2520the%2520Inhibition%2520of%2520Caspase-3%2520by%2520XIAP%26jtitle%3DCell%26date%3D2001%26volume%3D104%26spage%3D791%26epage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Du, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Smac, a Mitochondrial Protein that Promotes Cytochrome c-Dependent Caspase Activation by Eliminating IAP Inhibition</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">â</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1016%2FS0092-8674%2800%2900008-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=10929711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFCrsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=33-42&author=C.+Duauthor=M.+Fangauthor=Y.+Liauthor=L.+Liauthor=X.+Wang&title=Smac%2C+a+Mitochondrial+Protein+that+Promotes+Cytochrome+c-Dependent+Caspase+Activation+by+Eliminating+IAP+Inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition</span></div><div class="casAuthors">Du, Chunying; Fang, Min; Li, Yucheng; Li, Lily; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-42</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We report here the identification of a novel protein, Smac, which promotes caspase activation in the cytochrome c/Apaf-1/caspase-9 pathway.  Smac promotes caspase-9 activation by binding to inhibitor of apoptosis proteins, IAPs, and removing their inhibitory activity.  Smac is normally a mitochondrial protein but is released into the cytosol when cells undergo apoptosis.  Mitochondrial import and cleavage of its signal peptide are required for Smac to gain its apoptotic activity.  Overexpression of Smac increases cells' sensitivity to apoptotic stimuli.  Smac is the second mitochondrial protein, along with cytochrome c, that promotes apoptosis by activating caspases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEUyaGmAsnprVg90H21EOLACvtfcHk0lh-5tfX6c-2kg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFCrsbc%253D&md5=8321d44bed77ff7c2da398e1b02f9e20</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900008-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900008-8%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DC.%26aulast%3DFang%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DSmac%252C%2520a%2520Mitochondrial%2520Protein%2520that%2520Promotes%2520Cytochrome%2520c-Dependent%2520Caspase%2520Activation%2520by%2520Eliminating%2520IAP%2520Inhibition%26jtitle%3DCell%26date%3D2000%26volume%3D102%26spage%3D33%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Verhagen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekert, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pakusch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritz, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaux, D. L.</span><span> </span><span class="NLM_article-title">Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP Proteins</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">â</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1016%2FS0092-8674%2800%2900009-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=10929712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFCrtr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=43-53&author=A.+M.+Verhagenauthor=P.+G.+Ekertauthor=M.+Pakuschauthor=J.+Silkeauthor=L.+M.+Connollyauthor=G.+E.+Reidauthor=R.+L.+Moritzauthor=R.+J.+Simpsonauthor=D.+L.+Vaux&title=Identification+of+DIABLO%2C+a+Mammalian+Protein+that+Promotes+Apoptosis+by+Binding+to+and+Antagonizing+IAP+Proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins</span></div><div class="casAuthors">Verhagen, Anne M.; Ekert, Paul G.; Pakusch, Miha; Silke, John; Connolly, Lisa M.; Reid, Gavin E.; Moritz, Robert L.; Simpson, Richard J.; Vaux, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-53</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">To identify proteins that bind mammalian IAP homolog A (MIHA, also known as XIAP), we used coimmunopptn. and 2D immobilized pH gradient/SDS-PAGE, followed by electrospray ionization tandem mass spectrometry.  DIABLO (direct IAP binding protein with low pI) is a novel protein that can bind MIHA and can also interact with MIHB and MIHC and the baculoviral IAP, OpIAP.  The N-terminally processed, IAP-interacting form of DIABLO is concd. in membrane fractions in healthy cells but released into the MIHA-contg. cytosolic fractions upon UV irradn.  As transfection of cells with DIABLO was able to counter the protection afforded by MIHA against UV irradn., DIABLO may promote apoptosis by binding to IAPs and preventing them from inhibiting caspases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6-TYWHjxeE7Vg90H21EOLACvtfcHk0lh-5tfX6c-2kg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFCrtr4%253D&md5=475519bd43e9d625b06b0293895d9693</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900009-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900009-X%26sid%3Dliteratum%253Aachs%26aulast%3DVerhagen%26aufirst%3DA.%2BM.%26aulast%3DEkert%26aufirst%3DP.%2BG.%26aulast%3DPakusch%26aufirst%3DM.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DConnolly%26aufirst%3DL.%2BM.%26aulast%3DReid%26aufirst%3DG.%2BE.%26aulast%3DMoritz%26aufirst%3DR.%2BL.%26aulast%3DSimpson%26aufirst%3DR.%2BJ.%26aulast%3DVaux%26aufirst%3DD.%2BL.%26atitle%3DIdentification%2520of%2520DIABLO%252C%2520a%2520Mammalian%2520Protein%2520that%2520Promotes%2520Apoptosis%2520by%2520Binding%2520to%2520and%2520Antagonizing%2520IAP%2520Proteins%26jtitle%3DCell%26date%3D2000%26volume%3D102%26spage%3D43%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suber, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Structural basis of IAP recognition by Smac/DIABLO</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">1008</span><span class="NLM_x">â</span> <span class="NLM_lpage">1012</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1038%2F35050012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=11140638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslahsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=1008-1012&author=G.+Wuauthor=J.+Chaiauthor=T.+L.+Suberauthor=J.-W.+Wuauthor=C.+Duauthor=X.+Wangauthor=Y.+Shi&title=Structural+basis+of+IAP+recognition+by+Smac%2FDIABLO"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of IAP recognition by Smac/DIABLO</span></div><div class="casAuthors">Wu, Geng; Chai, Jijie; Suber, Tomeka L.; Wu, Jia-Wel; Du, Chunying; Wang, Xiaodong; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6815</span>),
    <span class="NLM_cas:pages">1008-1012</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Apoptosis is an essential process in the development and homeostasis of all metazoans.  The inhibitor-of-apoptosis (IAP) proteins suppress cell death by inhibiting the activity of caspases; this inhibition is performed by the zinc-binding BIR domains of the IAP proteins.  The mitochondrial protein Smac/DIABLO promotes apoptosis by eliminating the inhibitory effect of IAPs through phys. interactions.  Amino-terminal sequences in Smac/DIABLO are required for this function, as mutation of the very first amino acid leads to loss of interaction with LAPs and concomitant loss of Smac/DIABLO function.  Here we report the high-resoln. crystal structure of Smac/DIABLO complexed with the third BIR domain (BIR3) of XIAP.  Our results show that the N-terminal four residues (Ala-Val-Pro-Ile) in Smac/DIABLO recognize a surface groove on BIR3, with the first residue Ala binding a hydrophobic pocket and making five hydrogen bonds to neighboring residues on BIR3.  These observations provide a structural explanation for the roles of the Smac N terminus as well as the conserved N-terminal sequences in the Drosophila proteins Hid/Grim/Reaper.  In conjunction with other observations, our results reveal how Smac may relieve IAP inhibition of caspase-9 activity.  In addn. to explaining a no. of biol. observations, our structural anal. identifies potential targets for drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV3qy8uKazsrVg90H21EOLACvtfcHk0li5GkRwC3Ya8g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslahsQ%253D%253D&md5=fab609edfb1833053eeb78dd2d4ed536</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2F35050012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35050012%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DG.%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DSuber%26aufirst%3DT.%2BL.%26aulast%3DWu%26aufirst%3DJ.-W.%26aulast%3DDu%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520of%2520IAP%2520recognition%2520by%2520Smac%252FDIABLO%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D1008%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olejniczak, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meadows, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betz, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oost, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">1004</span><span class="NLM_x">â</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1038%2F35050006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=11140637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslaiug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=1004-1008&author=Z.+Liuauthor=C.+Sunauthor=E.+T.+Olejniczakauthor=R.+P.+Meadowsauthor=S.+F.+Betzauthor=T.+Oostauthor=J.+Herrmannauthor=J.+C.+Wuauthor=S.+W.+Fesik&title=Structural+basis+for+binding+of+Smac%2FDIABLO+to+the+XIAP+BIR3+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain</span></div><div class="casAuthors">Liu, Zhlhong; Sun, Chaohong; Olejniczak, Edward T.; Meadows, Robert P.; Betz, Stephen F.; Oost, Thorsten; Hemnann, Julia; Wu, Joe C.; Feslk, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6815</span>),
    <span class="NLM_cas:pages">1004-1008</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The inhibitor-of-apoptosis proteins (IAPs) regulate programmed cell death by inhibiting members of the caspase family of enzymes.  Recently, a mammalian protein called Smac (also named DIABLO) was identified that binds to the LAPs and promotes caspase activation.  Although undefined in the x-ray structure, the amino-terminal residues of Smac are crit. for its function.  To understand the structural basis for mol. recognition between Smac and the IAPs, we detd. the soln. structure of the BIR3 domain of X-linked IAP (XIAP) complexed with a functionally active nine-residue peptide derived from the N terminus of Smac.  The peptide binds across the third Î²-strand of the BIR3 domain in an extended conformation with only the first four residues contacting the protein.  The complex is stabilized by four intermol. hydrogen bonds, an electrostatic interaction involving the N terminus of the peptide, and several hydrophobic interactions.  This structural information, along with the binding data from BIR3 and Smac peptide mutants reported here, should aid in the design of small mols. that may be used for the treatment of cancers that overexpress IAPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM4pZbM96xmrVg90H21EOLACvtfcHk0li5GkRwC3Ya8g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslaiug%253D%253D&md5=d81bd94ecd9cf9c11d96ee228ff371aa</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2F35050006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35050006%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DBetz%26aufirst%3DS.%2BF.%26aulast%3DOost%26aufirst%3DT.%26aulast%3DHerrmann%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DStructural%2520basis%2520for%2520binding%2520of%2520Smac%252FDIABLO%2520to%2520the%2520XIAP%2520BIR3%2520domain%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D1004%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Condon, S. M.</span><span> </span><span class="NLM_article-title">The Discovery and Development of Smac MimeticsâSmall-Molecule Antagonists of the Inhibitor of Apoptosis Proteins</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">â</span> <span class="NLM_lpage">226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=211-226&author=S.+M.+Condon&title=The+Discovery+and+Development+of+Smac+Mimetics%E2%80%94Small-Molecule+Antagonists+of+the+Inhibitor+of+Apoptosis+Proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCondon%26aufirst%3DS.%2BM.%26atitle%3DThe%2520Discovery%2520and%2520Development%2520of%2520Smac%2520Mimetics%25E2%2580%2594Small-Molecule%2520Antagonists%2520of%2520the%2520Inhibitor%2520of%2520Apoptosis%2520Proteins%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D211%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Straub, C. S.</span><span> </span><span class="NLM_article-title">Targeting IAPs as an Approach to Anti-Cancer Therapy</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">â</span> <span class="NLM_lpage">316</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.2174%2F156802611794072623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=21320059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslahsLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=291-316&author=C.+S.+Straub&title=Targeting+IAPs+as+an+Approach+to+Anti-Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting IAPs as an approach to anti-cancer therapy</span></div><div class="casAuthors">Straub, Christopher S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-316</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Apoptosis is an essential process for embryonic and lymphocyte development, immune system modulation and tissue homeostasis.  Defects in apoptotic signaling often lead to diseases of immune deficiency, neurodegeneration and cancer.  In the cancer arena, these defects may contribute to the establishment and growth of tumors.  Moreover, many cytotoxic chemotherapies act in part by activating these apoptotic networks.  Occasionally apoptotic pathways are activated, however key players downstream of initiation are inhibited by neg. regulators that have been dysregulated by the diseased state of the cell.  Removal of these barriers to apoptosis signaling, it has been rationalized, could restore cell death in diseased cells while sparing those that are not primed for programmed cell death.  Addnl., the subversion of these death evading mechanisms may re-sensitize cells that have developed resistance to chemotherapies in this manner.  The importance of apoptosis as a maintenance process, and the promise that restoring this signaling could mean in treating cancer has placed many targets on the front line of oncol. research.  Approaches are being developed that will activate death receptor pathways, synthetically activate caspases, restore the activity of tumor suppressor genes such as p53, and counteract the effects of anti-apoptotic factors.  Among these approaches, small mols. are in clin. trials against several anti-apoptotic players, namely the Bcl-2 and IAP proteins.  This review will focus on the efforts being advanced against the Inhibitor of Apoptosis Proteins (IAP), the chem. matter of the inhibitors and the biol. emerging from this research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN1vzuchBUTLVg90H21EOLACvtfcHk0li5GkRwC3Ya8g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslahsLg%253D&md5=cd0024d0150802fed4051038c05d6a2b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F156802611794072623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611794072623%26sid%3Dliteratum%253Aachs%26aulast%3DStraub%26aufirst%3DC.%2BS.%26atitle%3DTargeting%2520IAPs%2520as%2520an%2520Approach%2520to%2520Anti-Cancer%2520Therapy%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D291%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Flygare, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span> </span><span class="NLM_article-title">Small-molecule pan-IAP antagonists: a patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">â</span> <span class="NLM_lpage">267</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1517%2F13543770903567077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=20100005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGktb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=251-267&author=J.+A.+Flygareauthor=W.+J.+Fairbrother&title=Small-molecule+pan-IAP+antagonists%3A+a+patent+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule pan-IAP antagonists: a patent review</span></div><div class="casAuthors">Flygare, John A.; Fairbrother, Wayne J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">251-267</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The inhibitor of apoptosis (IAP) proteins are crit. regulators of cancer cell survival that have become important targets for therapeutic intervention in human malignancies.  One strategy for targeting IAP proteins involves agents that mimic the amino terminus of the endogenous IAP protein antagonist second mitochondria-derived activator of caspases (Smac)/direct IAP-binding protein with low pI (DIABLO) and thus block crit. IAP protein interactions.  Areas covered in this review: This review of the IAP antagonist patent literature covers the period from 2000 to mid-2009.  Over 50 patents and patent applications pertaining to IAP antagonists have been published over the past 10 years.  In the case of several filings, only the original source is reviewed in this anal.  What the reader will gain: Readers will gain an overview of IAP protein antagonist scaffolds, with representative examples including monovalent and bivalent Smac mimetics, and an understanding of their structure-activity relationships.  Take home message: The feasibility of disrupting IAP protein interactions with pro-apoptotic proteins using monovalent and bivalent Smac-derived peptidomimetic compds. has been broadly established.  Four such compds. have entered or been approved to enter human clin. trials, which will hopefully allow the utility of this potential therapeutic approach to be evaluated in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN1K-xLSDlXrVg90H21EOLACvtfcHk0lh8P1oTYhq2KQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGktb0%253D&md5=9017c8266da17502a6c081d5ca2955ac</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1517%2F13543770903567077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903567077%26sid%3Dliteratum%253Aachs%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26atitle%3DSmall-molecule%2520pan-IAP%2520antagonists%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D251%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Design of Small-Molecule Peptidic and Nonpeptidic Smac Mimetics</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1264</span><span class="NLM_x">â</span> <span class="NLM_lpage">1276</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar8000553" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Kiur3L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=1264-1276&author=H.+Sunauthor=Z.+Nikolovska-Coleskaauthor=C.-Y.+Yangauthor=D.+Qianauthor=J.+Luauthor=S.+Qiuauthor=L.+Baiauthor=Y.+Pengauthor=Q.+Caiauthor=S.+Wang&title=Design+of+Small-Molecule+Peptidic+and+Nonpeptidic+Smac+Mimetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Small-Molecule Peptidic and Nonpeptidic Smac Mimetics</span></div><div class="casAuthors">Sun, Haiying; Nikolovska-Coleska, Zaneta; Yang, Chao-Yie; Qian, Dongguang; Lu, Jianfeng; Qiu, Su; Bai, Longchuan; Peng, Yuefeng; Cai, Qian; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1264-1277</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Smac/DIABLO is a protein released from mitochondria into the cytosol in response to apoptotic stimuli.  Smac promotes apoptosis at least in part through antagonizing inhibitor of apoptosis proteins (IAPs), including XIAP, cIAP-1, and cIAP-2.  Smac interacts with these IAPs via its N-terminal AVPI binding motif.  There has been an enormous interest in academic labs. and pharmaceutical companies in the design of small-mol. Smac mimetics as potential anticancer agents.  This task is particularly challenging because it involves targeting protein-protein interactions.  Nevertheless, intense research has now generated potent, specific, cell-permeable small-mol. peptidomimetics and nonpeptidic mimetics.  To date, two types of Smac mimetics have been reported, namely, monovalent and bivalent Smac mimetics.  The monovalent compds. are designed to mimic the binding of a single AVPI binding motif to IAP proteins, whereas the bivalent compds. contain two AVPI binding motif mimetics tethered together through a linker.  Studies from several groups have clearly demonstrated that both monovalent and bivalent Smac mimetics not only enhance the antitumor activity of other anticancer agents but also can induce apoptosis as single agents in a subset of human cancer cell lines in vitro and are capable of achieving tumor regression in animal models of human cancer.  In general, bivalent Smac mimetics are 100-1000 times more potent than their corresponding monovalent Smac mimetics in induction of apoptosis in tumor cells.  However, properly designed monovalent Smac mimetics can achieve oral bioavailability and may have major advantages over bivalent Smac mimetics as potential drug candidates.  In-depth insights on the mol. mechanism of action of Smac mimetics have been provided by several independent studies.  It was shown that Smac mimetics induce apoptosis in tumor cells by targeting cIAP-1/-2 for the rapid degrdn. of these proteins, which leads to activation of nuclear factor ÎºB (NF-ÎºB) and prodn. and secretion of tumor necrosis factor Î± (TNFÎ±).  TNFÎ± promotes formation of a receptor-interacting serine-threonine kinase 1 (RIPK1)-dependent caspase-8-activating complex, leading to activation of caspase-8 and -3/-7 and ultimately to apoptosis.  For the most efficient apoptosis induction, Smac mimetics also need to remove the inhibition of XIAP to caspase-3/-7.  Hence, Smac mimetics induce apoptosis in tumor cells by targeting not only cIAP-1/-2 but also XIAP.  The employment of potent, cell-permeable, small-mol. Smac mimetics has yielded important insights into the regulation of apoptosis by IAP proteins.  To date, at least one Smac mimetic has been advanced into clin. development.  Several other Smac mimetics are in an advanced preclin. development stage and are expected to enter human clin. testing for the treatment of cancer in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF2ORbmgx5q7Vg90H21EOLACvtfcHk0lh8P1oTYhq2KQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Kiur3L&md5=434530329024b75e59f7f88e29ea0de1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Far8000553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far8000553%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DQian%26aufirst%3DD.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%2520of%2520Small-Molecule%2520Peptidic%2520and%2520Nonpeptidic%2520Smac%2520Mimetics%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D1264%26epage%3D1276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Cai, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2714</span><span class="NLM_x">â</span> <span class="NLM_lpage">2726</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101505d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2714-2726&author=Q.+Caiauthor=H.+Sunauthor=Y.+Pengauthor=J.+Luauthor=Z.+Nikolovska-Coleskaauthor=D.+McEachernauthor=L.+Liuauthor=S.+Qiuauthor=C.-Y.+Yangauthor=R.+Millerauthor=H.+Yiauthor=T.+Zhangauthor=D.+Sunauthor=S.+Kangauthor=M.+Guoauthor=L.+Leopoldauthor=D.+Yangauthor=S.+Wang&title=A+Potent+and+Orally+Active+Antagonist+%28SM-406%2FAT-406%29+of+Multiple+Inhibitor+of+Apoptosis+Proteins+%28IAPs%29+in+Clinical+Development+for+Cancer+Treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment</span></div><div class="casAuthors">Cai, Qian; Sun, Haiying; Peng, Yuefeng; Lu, Jianfeng; Nikolovska-Coleska, Zaneta; McEachern, Donna; Liu, Liu; Qiu, Su; Yang, Chao-Yie; Miller, Rebecca; Yi, Han; Zhang, Tao; Sun, Duxin; Kang, Sanmao; Guo, Ming; Leopold, Lance; Yang, Dajun; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2714-2726</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the discovery and characterization of SM-406 (compd. 2), a potent and orally bioavailable Smac mimetic and an antagonist of the inhibitor of apoptosis proteins (IAPs).  This compd. binds to XIAP, cIAP1, and cIAP2 proteins with Ki of 66.4, 1.9, and 5.1 nM, resp.  Compd. 2 effectively antagonizes XIAP BIR3 protein in a cell-free functional assay, induces rapid degrdn. of cellular cIAP1 protein, and inhibits cancer cell growth in various human cancer cell lines.  It has good oral bioavailability in mice, rats, non-human primates, and dogs, is highly effective in induction of apoptosis in xenograft tumors, and is capable of complete inhibition of tumor growth.  Compd. 2 is currently in phase I clin. trials for the treatment of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgYOZBCwfnLrVg90H21EOLACvtfcHk0lh8P1oTYhq2KQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurg%253D&md5=5b73a2ea1a5a2a6b3e3f4c978b49706f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm101505d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101505d%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DLeopold%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DA%2520Potent%2520and%2520Orally%2520Active%2520Antagonist%2520%2528SM-406%252FAT-406%2529%2520of%2520Multiple%2520Inhibitor%2520of%2520Apoptosis%2520Proteins%2520%2528IAPs%2529%2520in%2520Clinical%2520Development%2520for%2520Cancer%2520Treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2714%26epage%3D2726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Flygare, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheeti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshayes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckhardt, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reisner, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazzard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halladay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hymowitz, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoRusso, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plise, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Um, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varfolomeev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span> </span><span class="NLM_article-title">Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4101</span><span class="NLM_x">â</span> <span class="NLM_lpage">4113</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300060k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Ois74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4101-4113&author=J.+A.+Flygareauthor=M.+Beresiniauthor=N.+Budhaauthor=H.+Chanauthor=I.+T.+Chanauthor=S.+Cheetiauthor=F.+Cohenauthor=K.+Deshayesauthor=K.+Doernerauthor=S.+G.+Eckhardtauthor=L.+O.+Elliottauthor=B.+Fengauthor=M.+C.+Franklinauthor=S.+F.+Reisnerauthor=L.+Gazzardauthor=J.+Halladayauthor=S.+G.+Hymowitzauthor=H.+Laauthor=P.+LoRussoauthor=B.+Maurerauthor=L.+Murrayauthor=E.+Pliseauthor=C.+Quanauthor=J.-P.+Stephanauthor=S.+G.+Youngauthor=J.+Tomauthor=V.+Tsuiauthor=J.+Umauthor=E.+Varfolomeevauthor=D.+Vucicauthor=A.+J.+Wagnerauthor=H.+J.+A.+Wallweberauthor=L.+Wangauthor=J.+Wareauthor=Z.+Wenauthor=H.+Wongauthor=J.+M.+Wongauthor=M.+Wongauthor=S.+Wongauthor=R.+Yuauthor=K.+Zobelauthor=W.+J.+Fairbrother&title=Discovery+of+a+Potent+Small-Molecule+Antagonist+of+Inhibitor+of+Apoptosis+%28IAP%29+Proteins+and+Clinical+Candidate+for+the+Treatment+of+Cancer+%28GDC-0152%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152)</span></div><div class="casAuthors">Flygare, John A.; Beresini, Maureen; Budha, Nageshwar; Chan, Helen; Chan, Iris T.; Cheeti, Sravanthi; Cohen, Frederick; Deshayes, Kurt; Doerner, Karl; Eckhardt, S. Gail; Elliott, Linda O.; Feng, Bainian; Franklin, Matthew C.; Reisner, Stacy Frankovitz; Gazzard, Lewis; Halladay, Jason; Hymowitz, Sarah G.; La, Hank; LoRusso, Patricia; Maurer, Brigitte; Murray, Lesley; Plise, Emile; Quan, Clifford; Stephan, Jean-Philippe; Young, Shin G.; Tom, Jeffrey; Tsui, Vickie; Um, Joanne; Varfolomeev, Eugene; Vucic, Domagoj; Wagner, Andrew J.; Wallweber, Heidi J. A.; Wang, Lan; Ware, Joseph; Wen, Zhaoyang; Wong, Harvey; Wong, Jonathan M.; Wong, Melisa; Wong, Susan; Yu, Ron; Zobel, Kerry; Fairbrother, Wayne J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4101-4113</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of compds. were designed and synthesized as antagonists of cIAP1/2, ML-IAP, and XIAP based on the N-terminus, AVPI, of mature Smac.  Compd. (I) (GDC-0152) has the best profile of these compds.; it binds to the XIAP BIR3 domain, the BIR domain of ML-IAP, and the BIR3 domains of cIAP1 and cIAP2 with Ki values of 28, 14, 17, and 43 nM, resp.  These compds. promote degrdn. of cIAP1, induce activation of caspase-3/7, and lead to decreased viability of breast cancer cells without affecting normal mammary epithelial cells.  Compd. I inhibits tumor growth when dosed orally in the MDA-MB-231 breast cancer xenograft model.  Compd. I was advanced to human clin. trials, and it exhibited linear pharmacokinetics over the dose range (0.049 to 1.48 mg/kg) tested.  Mean plasma clearance in humans was 9 Â± 3 mL/min/kg, and the vol. of distribution was 0.6 Â± 0.2 L/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZSPNVJ5gVWrVg90H21EOLACvtfcHk0lhiC7cvQgNauw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Ois74%253D&md5=19452878ea834d3c324d567b39a78fb2</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm300060k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300060k%26sid%3Dliteratum%253Aachs%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DBeresini%26aufirst%3DM.%26aulast%3DBudha%26aufirst%3DN.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DChan%26aufirst%3DI.%2BT.%26aulast%3DCheeti%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DDoerner%26aufirst%3DK.%26aulast%3DEckhardt%26aufirst%3DS.%2BG.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DFranklin%26aufirst%3DM.%2BC.%26aulast%3DReisner%26aufirst%3DS.%2BF.%26aulast%3DGazzard%26aufirst%3DL.%26aulast%3DHalladay%26aufirst%3DJ.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DLoRusso%26aufirst%3DP.%26aulast%3DMaurer%26aufirst%3DB.%26aulast%3DMurray%26aufirst%3DL.%26aulast%3DPlise%26aufirst%3DE.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DStephan%26aufirst%3DJ.-P.%26aulast%3DYoung%26aufirst%3DS.%2BG.%26aulast%3DTom%26aufirst%3DJ.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DUm%26aufirst%3DJ.%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DWagner%26aufirst%3DA.%2BJ.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWare%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DZ.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DJ.%2BM.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DR.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520Potent%2520Small-Molecule%2520Antagonist%2520of%2520Inhibitor%2520of%2520Apoptosis%2520%2528IAP%2529%2520Proteins%2520and%2520Clinical%2520Candidate%2520for%2520the%2520Treatment%2520of%2520Cancer%2520%2528GDC-0152%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4101%26epage%3D4113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Houghton, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorlick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keir, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carol, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lock, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maris, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billups, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span> </span><span class="NLM_article-title">Initial Testing (Stage 1) of LCL161, a SMAC Mimetic, by the Pediatric Preclinical Testing Program</span> <span class="citation_source-journal">Pediatr. Blood Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">636</span><span class="NLM_x">â</span> <span class="NLM_lpage">639</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1002%2Fpbc.23167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A280%3ADC%252BC383is1Grug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2012&pages=636-639&author=P.+J.+Houghtonauthor=M.+H.+Kangauthor=C.+P.+Reynoldsauthor=C.+L.+Mortonauthor=E.+A.+Kolbauthor=R.+Gorlickauthor=S.+T.+Keirauthor=H.+Carolauthor=R.+Lockauthor=J.+M.+Marisauthor=C.+A.+Billupsauthor=M.+A.+Smith&title=Initial+Testing+%28Stage+1%29+of+LCL161%2C+a+SMAC+Mimetic%2C+by+the+Pediatric+Preclinical+Testing+Program"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Initial testing (stage 1) of LCL161, a SMAC mimetic, by the Pediatric Preclinical Testing Program</span></div><div class="casAuthors">Houghton Peter J; Kang Min H; Reynolds C Patrick; Morton Christopher L; Kolb E Anders; Gorlick Richard; Keir Stephen T; Carol Hernan; Lock Richard; Maris John M; Billups Catherine A; Smith Malcolm A</div><div class="citationInfo"><span class="NLM_cas:title">Pediatric blood & cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">636-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">LCL161, a SMAC mimetic, was tested against the PPTP in vitro panel (1.0 nM to 10.0 Î¼M) and the PPTP in vivo panels (30 or 75 mg/kg [solid tumors] or 100 mg/kg [ALL]) administered orally twice in a week.  LCL161 showed a median relative IC(50) value of >10 Î¼M, being more potent against several leukemia and lymphoma lines.  In vivo LCL161 induced significant differences in EFS distribution in approximately one-third of solid tumor xenografts (osteosarcoma and glioblastoma), but not in ALL xenografts.  No objective tumor responses were observed.  In vivo LCL161 demonstrated limited single agent activity against the pediatric preclinical models studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRSUatUzOMj4MULxIEhxUjPfW6udTcc2eYjSjpn7NXPr7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383is1Grug%253D%253D&md5=39302864067c6f9d1bfc9fca041d6c3c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fpbc.23167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpbc.23167%26sid%3Dliteratum%253Aachs%26aulast%3DHoughton%26aufirst%3DP.%2BJ.%26aulast%3DKang%26aufirst%3DM.%2BH.%26aulast%3DReynolds%26aufirst%3DC.%2BP.%26aulast%3DMorton%26aufirst%3DC.%2BL.%26aulast%3DKolb%26aufirst%3DE.%2BA.%26aulast%3DGorlick%26aufirst%3DR.%26aulast%3DKeir%26aufirst%3DS.%2BT.%26aulast%3DCarol%26aufirst%3DH.%26aulast%3DLock%26aufirst%3DR.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26aulast%3DBillups%26aufirst%3DC.%2BA.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26atitle%3DInitial%2520Testing%2520%2528Stage%25201%2529%2520of%2520LCL161%252C%2520a%2520SMAC%2520Mimetic%252C%2520by%2520the%2520Pediatric%2520Preclinical%2520Testing%2520Program%26jtitle%3DPediatr.%2520Blood%2520Cancer%26date%3D2012%26volume%3D58%26spage%3D636%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Chen, K.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiau, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, W.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A.-L.</span><span> </span><span class="NLM_article-title">Inhibition of Bcl-2 improves effect of LCL 161, a SMAC, mimetic in hepatocellular carcinoma cells</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">â</span> <span class="NLM_lpage">277</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=268-277&author=K.-F.+Chenauthor=J.-P.+Linauthor=C.-W.+Shiauauthor=W.-T.+Taiauthor=C.-Y.+Liuauthor=H.-C.+Yuauthor=P.-J.+Chenauthor=A.-L.+Cheng&title=Inhibition+of+Bcl-2+improves+effect+of+LCL+161%2C+a+SMAC%2C+mimetic+in+hepatocellular+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.-F.%26aulast%3DLin%26aufirst%3DJ.-P.%26aulast%3DShiau%26aufirst%3DC.-W.%26aulast%3DTai%26aufirst%3DW.-T.%26aulast%3DLiu%26aufirst%3DC.-Y.%26aulast%3DYu%26aufirst%3DH.-C.%26aulast%3DChen%26aufirst%3DP.-J.%26aulast%3DCheng%26aufirst%3DA.-L.%26atitle%3DInhibition%2520of%2520Bcl-2%2520improves%2520effect%2520of%2520LCL%2520161%252C%2520a%2520SMAC%252C%2520mimetic%2520in%2520hepatocellular%2520carcinoma%2520cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D84%26spage%3D268%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="note"><p class="first last">See the discussion in ref  <a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">2</a> for more details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Petersen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yalcin-Chin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harran, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Autocrine TNFÎ± Signaling Renders Human Cancer Cells Susceptible to Smac-Mimetic-Induced Apoptosis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">â</span> <span class="NLM_lpage">456</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=445-456&author=S.+L.+Petersenauthor=L.+Wangauthor=A.+Yalcin-Chinauthor=L.+Liauthor=M.+Peytonauthor=J.+Minnaauthor=P.+Harranauthor=X.+Wang&title=Autocrine+TNF%CE%B1+Signaling+Renders+Human+Cancer+Cells+Susceptible+to+Smac-Mimetic-Induced+Apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetersen%26aufirst%3DS.%2BL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYalcin-Chin%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DPeyton%26aufirst%3DM.%26aulast%3DMinna%26aufirst%3DJ.%26aulast%3DHarran%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DAutocrine%2520TNF%25CE%25B1%2520Signaling%2520Renders%2520Human%2520Cancer%2520Cells%2520Susceptible%2520to%2520Smac-Mimetic-Induced%2520Apoptosis%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D445%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Varfolomeev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankenship, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorova, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayagaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dynek, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flygare, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshayes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixit, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucic, D.</span><span> </span><span class="NLM_article-title">IAP Antagonists Induce Autoubitquitination of c-IAPs, NJ-ÎºB Activation, and TNFÎ±-Dependent Apoptosis</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">â</span> <span class="NLM_lpage">681</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=669-681&author=E.+Varfolomeevauthor=J.+W.+Blankenshipauthor=S.+M.+Waysonauthor=A.+V.+Fedorovaauthor=N.+Kayagakiauthor=P.+Gargauthor=K.+Zobelauthor=J.+N.+Dynekauthor=L.+O.+Elliottauthor=H.+J.+A.+Wallweberauthor=J.+A.+Flygareauthor=W.+J.+Fairbrotherauthor=K.+Deshayesauthor=V.+M.+Dixitauthor=D.+Vucic&title=IAP+Antagonists+Induce+Autoubitquitination+of+c-IAPs%2C+NJ-%CE%BAB+Activation%2C+and+TNF%CE%B1-Dependent+Apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DBlankenship%26aufirst%3DJ.%2BW.%26aulast%3DWayson%26aufirst%3DS.%2BM.%26aulast%3DFedorova%26aufirst%3DA.%2BV.%26aulast%3DKayagaki%26aufirst%3DN.%26aulast%3DGarg%26aufirst%3DP.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DDynek%26aufirst%3DJ.%2BN.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DIAP%2520Antagonists%2520Induce%2520Autoubitquitination%2520of%2520c-IAPs%252C%2520NJ-%25CE%25BAB%2520Activation%252C%2520and%2520TNF%25CE%25B1-Dependent%2520Apoptosis%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D669%26epage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Vince, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, W. W.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, A. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benetatos, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chunduru, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinlay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverkus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tergaonkar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callus, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koentgen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaux, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silke, J.</span><span> </span><span class="NLM_article-title">IAP Antagonists Target cIAP1 to Induce TNFÎ±-Dependent Apoptosis</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">682</span><span class="NLM_x">â</span> <span class="NLM_lpage">693</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=682-693&author=J.+E.+Vinceauthor=W.+W.-L.+Wongauthor=N.+Khanauthor=R.+Felthamauthor=D.+Chauauthor=A.+U.+Ahmedauthor=C.+A.+Benetatosauthor=S.+K.+Chunduruauthor=S.+M.+Condonauthor=M.+McKinlayauthor=R.+Brinkauthor=M.+Leverkusauthor=V.+Tergaonkarauthor=P.+Schneiderauthor=B.+A.+Callusauthor=F.+Koentgenauthor=D.+L.+Vauxauthor=J.+Silke&title=IAP+Antagonists+Target+cIAP1+to+Induce+TNF%CE%B1-Dependent+Apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVince%26aufirst%3DJ.%2BE.%26aulast%3DWong%26aufirst%3DW.%2BW.-L.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DFeltham%26aufirst%3DR.%26aulast%3DChau%26aufirst%3DD.%26aulast%3DAhmed%26aufirst%3DA.%2BU.%26aulast%3DBenetatos%26aufirst%3DC.%2BA.%26aulast%3DChunduru%26aufirst%3DS.%2BK.%26aulast%3DCondon%26aufirst%3DS.%2BM.%26aulast%3DMcKinlay%26aufirst%3DM.%26aulast%3DBrink%26aufirst%3DR.%26aulast%3DLeverkus%26aufirst%3DM.%26aulast%3DTergaonkar%26aufirst%3DV.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DCallus%26aufirst%3DB.%2BA.%26aulast%3DKoentgen%26aufirst%3DF.%26aulast%3DVaux%26aufirst%3DD.%2BL.%26aulast%3DSilke%26aufirst%3DJ.%26atitle%3DIAP%2520Antagonists%2520Target%2520cIAP1%2520to%2520Induce%2520TNF%25CE%25B1-Dependent%2520Apoptosis%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D682%26epage%3D693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">GonzÃ¡lez-LÃ³pez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finlay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardecky, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganji, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teriete, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mace, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedl, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosford, N. D. P.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of monovalent Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAP</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4332</span><span class="NLM_x">â</span> <span class="NLM_lpage">4336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4332-4336&author=M.+Gonz%C3%A1lez-L%C3%B3pezauthor=K.+Welshauthor=D.+Finlayauthor=R.+J.+Ardeckyauthor=S.+R.+Ganjiauthor=Y.+Suauthor=H.+Yuanauthor=P.+Terieteauthor=P.+D.+Maceauthor=S.+J.+Riedlauthor=K.+Vuoriauthor=J.+C.+Reedauthor=N.+D.+P.+Cosford&title=Design%2C+synthesis+and+evaluation+of+monovalent+Smac+mimetics+that+bind+to+the+BIR2+domain+of+the+anti-apoptotic+protein+XIAP"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGonz%25C3%25A1lez-L%25C3%25B3pez%26aufirst%3DM.%26aulast%3DWelsh%26aufirst%3DK.%26aulast%3DFinlay%26aufirst%3DD.%26aulast%3DArdecky%26aufirst%3DR.%2BJ.%26aulast%3DGanji%26aufirst%3DS.%2BR.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DTeriete%26aufirst%3DP.%26aulast%3DMace%26aufirst%3DP.%2BD.%26aulast%3DRiedl%26aufirst%3DS.%2BJ.%26aulast%3DVuori%26aufirst%3DK.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520monovalent%2520Smac%2520mimetics%2520that%2520bind%2520to%2520the%2520BIR2%2520domain%2520of%2520the%2520anti-apoptotic%2520protein%2520XIAP%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4332%26epage%3D4336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="note"><p class="first last">For example, the clearance for <b>19</b> was 155 mL/min/kg in a cassette dosing study versus 116 mL/min/kg in a single-compound PK study.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><div class="note"><p class="first last">For additional discussion, see:</p></div><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belunis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowther, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danho, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goggin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remiszewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakur, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyagi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span> </span><span class="NLM_article-title">The structure of XIAP BIR2: understanding the selectivity of the BIR domains</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D.: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1717</span><span class="NLM_x">â</span> <span class="NLM_lpage">1725</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1107%2FS0907444913016284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=23999295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlKrsLnK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1717-1725&author=C.+Lukacsauthor=C.+Belunisauthor=R.+Crowtherauthor=W.+Danhoauthor=L.+Gaoauthor=B.+Gogginauthor=C.+A.+Jansonauthor=S.+Liauthor=S.+Remiszewskiauthor=A.+Schuttauthor=M.+K.+Thakurauthor=S.+K.+Singhauthor=S.+Swaminathanauthor=R.+Pandeyauthor=R.+Tyagiauthor=R.+Gosuauthor=A.+V.+Kamathauthor=A.+Kuglstatter&title=The+structure+of+XIAP+BIR2%3A+understanding+the+selectivity+of+the+BIR+domains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of XIAP BIR2: understanding the selectivity of the BIR domains</span></div><div class="casAuthors">Lukacs, Christine; Belunis, Charles; Crowther, Robert; Danho, Waleed; Gao, Lin; Goggin, Barry; Janson, Cheryl A.; Li, Shirley; Remiszewski, Stacy; Schutt, Andrew; Thakur, Manish K.; Singh, Saroj K.; Swaminathan, Srinivasan; Pandey, Rajat; Tyagi, Rajiv; Gosu, Ramachandraiah; Kamath, Ajith V.; Kuglstatter, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1717-1725</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">XIAP, a member of the inhibitor of apoptosis family of proteins, is a crit. regulator of apoptosis.  Inhibition of the BIR domain-caspase interaction is a promising approach towards treating cancer.  Previous work has been directed towards inhibiting the BIR3-caspase-9 interaction, which blocks the intrinsic apoptotic pathway; selectively inhibiting the BIR2-caspase-3 interaction would also block the extrinsic pathway.  The BIR2 domain of XIAP has successfully been crystd.; peptides and small-mol. inhibitors can be soaked into these crystals, which diffract to high resoln.  Here, the BIR2 apo crystal structure and the structures of five BIR2-tetrapeptide complexes are described.  The structural flexibility obsd. on comparing these structures, along with a comparison with XIAP BIR3, affords an understanding of the structural elements that drive selectivity between BIR2 and BIR3 and which can be used to design BIR2-selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6-upk5-drzbVg90H21EOLACvtfcHk0li_7KTd3jNT8w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlKrsLnK&md5=deebf6694f2e53929d7c6ec4e763cf14</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS0907444913016284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913016284%26sid%3Dliteratum%253Aachs%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DBelunis%26aufirst%3DC.%26aulast%3DCrowther%26aufirst%3DR.%26aulast%3DDanho%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DGoggin%26aufirst%3DB.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DRemiszewski%26aufirst%3DS.%26aulast%3DSchutt%26aufirst%3DA.%26aulast%3DThakur%26aufirst%3DM.%2BK.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DPandey%26aufirst%3DR.%26aulast%3DTyagi%26aufirst%3DR.%26aulast%3DGosu%26aufirst%3DR.%26aulast%3DKamath%26aufirst%3DA.%2BV.%26aulast%3DKuglstatter%26aufirst%3DA.%26atitle%3DThe%2520structure%2520of%2520XIAP%2520BIR2%253A%2520understanding%2520the%2520selectivity%2520of%2520the%2520BIR%2520domains%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D.%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1717%26epage%3D1725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="note"><p class="first last">The values for <b>3</b> were generated in-house.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Kaplan-Lefko, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoog, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branstetter, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huard, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peach, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kordich, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foltz, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gliniak, B. C.</span><span> </span><span class="NLM_article-title">Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor types</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">â</span> <span class="NLM_lpage">631</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.4161%2Fcbt.9.8.11264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=20150762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKgtrfP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=618-631&author=P.+J.+Kaplan-Lefkoauthor=J.+D.+Gravesauthor=S.+J.+Zoogauthor=Y.+Panauthor=J.+Wallauthor=D.+G.+Branstetterauthor=J.+Moriguchiauthor=A.+Coxonauthor=J.+N.+Huardauthor=R.+Xuauthor=M.+L.+Peachauthor=G.+Juanauthor=S.+Kaufmanauthor=Q.+Chenauthor=A.+Bianchiauthor=J.+J.+Kordichauthor=M.+Maauthor=I.+N.+Foltzauthor=B.+C.+Gliniak&title=Conatumumab%2C+a+fully+human+agonist+antibody+to+death+receptor+5%2C+induces+apoptosis+via+caspase+activation+in+multiple+tumor+types"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor types</span></div><div class="casAuthors">Kaplan-Lefko, Paula J.; Graves, Jonathan D.; Zoog, Stephen J.; Pan, Yang; Wall, Jason; Branstetter, Daniel G.; Moriguchi, Jodi; Coxon, Angela; Huard, Justin N.; Xu, Ren; Peach, Matthew L.; Juan, Gloria; Kaufman, Stephen; Chen, Qing; Bianchi, Allison; Kordich, Jennifer J.; Ma, Mark; Foltz, Ian N.; Gliniak, Brian C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">618-631</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) binds to death receptors 4 and 5 (DR4, DR5) to transduce apoptotic signals.  Conatumumab (AMG 655) is an investigational, fully human monoclonal agonist antibody (IgG1) to human DR5, which induces apoptosis via caspase activation.  In this study, we demonstrate that conatumumab binds to DR5, activating intracellular caspases in vitro in the presence of a cross-linker.  We also show that conatumumab has activity in vivo and inhibits tumor growth in colon (Colo205 and HCT-15), lung (H2122) and pancreatic (MiaPaCa2/T2) xenograft models.  Conatumumab also enhances the antitumor activity of chemotherapeutics in vivo.  Caspase activation in Colo205 tumors is dose-dependent and correlated with serum concns. of conatumumab.  We demonstrate for the first time that increases in serum caspase-3/7 activity and levels of M30 (neoepitope of caspase-cleaved cytokeratin-18) are linked to activation of the extrinsic apoptotic pathway using conatumumab in a preclin. model.  These data suggest that conatumumab has potential as a therapeutic agent for treating patients with multiple tumor types, and that serum caspase-3/7 and M30 levels may serve as biomarkers of conatumumab activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosXSy5jCCO67Vg90H21EOLACvtfcHk0li_7KTd3jNT8w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKgtrfP&md5=49c72f2ab0f2d2006c708ccea0940f4b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.4161%2Fcbt.9.8.11264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.9.8.11264%26sid%3Dliteratum%253Aachs%26aulast%3DKaplan-Lefko%26aufirst%3DP.%2BJ.%26aulast%3DGraves%26aufirst%3DJ.%2BD.%26aulast%3DZoog%26aufirst%3DS.%2BJ.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DWall%26aufirst%3DJ.%26aulast%3DBranstetter%26aufirst%3DD.%2BG.%26aulast%3DMoriguchi%26aufirst%3DJ.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DHuard%26aufirst%3DJ.%2BN.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DPeach%26aufirst%3DM.%2BL.%26aulast%3DJuan%26aufirst%3DG.%26aulast%3DKaufman%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DBianchi%26aufirst%3DA.%26aulast%3DKordich%26aufirst%3DJ.%2BJ.%26aulast%3DMa%26aufirst%3DM.%26aulast%3DFoltz%26aufirst%3DI.%2BN.%26aulast%3DGliniak%26aufirst%3DB.%2BC.%26atitle%3DConatumumab%252C%2520a%2520fully%2520human%2520agonist%2520antibody%2520to%2520death%2520receptor%25205%252C%2520induces%2520apoptosis%2520via%2520caspase%2520activation%2520in%2520multiple%2520tumor%2520types%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D618%26epage%3D631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Gaither, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borawski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donovan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sage, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slisz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straub, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iourgenko, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlegel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawel, L.</span><span> </span><span class="NLM_article-title">A Smac Mimetic Rescue Screen Reveals Roles for Inhibitor of Apoptosis Proteins in Tumor Necrosis Factor-Î± Signaling</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">11493</span><span class="NLM_x">â</span> <span class="NLM_lpage">11498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=11493-11498&author=A.+Gaitherauthor=D.+Porterauthor=Y.+Yaoauthor=J.+Borawskiauthor=G.+Yangauthor=J.+Donovanauthor=D.+Sageauthor=J.+Sliszauthor=M.+Tranauthor=C.+Straubauthor=T.+Ramseyauthor=V.+Iourgenkoauthor=A.+Huangauthor=Y.+Chenauthor=R.+Schlegelauthor=M.+Labowauthor=S.+Fawellauthor=W.+R.+Sellersauthor=L.+Zawel&title=A+Smac+Mimetic+Rescue+Screen+Reveals+Roles+for+Inhibitor+of+Apoptosis+Proteins+in+Tumor+Necrosis+Factor-%CE%B1+Signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGaither%26aufirst%3DA.%26aulast%3DPorter%26aufirst%3DD.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DBorawski%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DDonovan%26aufirst%3DJ.%26aulast%3DSage%26aufirst%3DD.%26aulast%3DSlisz%26aufirst%3DJ.%26aulast%3DTran%26aufirst%3DM.%26aulast%3DStraub%26aufirst%3DC.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DIourgenko%26aufirst%3DV.%26aulast%3DHuang%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSchlegel%26aufirst%3DR.%26aulast%3DLabow%26aufirst%3DM.%26aulast%3DFawell%26aufirst%3DS.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DZawel%26aufirst%3DL.%26atitle%3DA%2520Smac%2520Mimetic%2520Rescue%2520Screen%2520Reveals%2520Roles%2520for%2520Inhibitor%2520of%2520Apoptosis%2520Proteins%2520in%2520Tumor%2520Necrosis%2520Factor-%25CE%25B1%2520Signaling%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D11493%26epage%3D11498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Kester, R. F.; Donnell, A. F.; Lou, Y.; Remiszewski, S. W.; Lombardo, L. J.; Chen, S.; Le, N. T.; Lo, J.; Moliterni, J. A.; Han, X.; Hogg, J. H.; Liang, W.; Michoud, C.; Rupert, K. C.; Mischke, S.; Le, K.; Weisel, M.; Janson, C. A.; Lukacs, C. M.; Fretland, A. J.; Hong, K.; Polonskaia, A.; Gao, L.; Li, S.; Solis, D. S.; Aguilar, D.; Tardell, C.; Dvorozniak, M.; Tannu, S.; Lee, E. C.; Schutt, A. D.; Goggin, B.</span><span> </span><span class="NLM_article-title">Optimization of Benzodiazepinones as Selective Inhibitors of the X-Linked Inhibitor of Apoptosis Protein (XIAP) Second Baculovirus IAP Repeat (BIR2) Domain</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span>DOI: <span class="refDoi">Â DOI: 10.1021/jm400732v</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm400732v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=R.+F.+Kester&author=A.+F.+Donnell&author=Y.+Lou&author=S.+W.+Remiszewski&author=L.+J.+Lombardo&author=S.+Chen&author=N.+T.+Le&author=J.+Lo&author=J.+A.+Moliterni&author=X.+Han&author=J.+H.+Hogg&author=W.+Liang&author=C.+Michoud&author=K.+C.+Rupert&author=S.+Mischke&author=K.+Le&author=M.+Weisel&author=C.+A.+Janson&author=C.+M.+Lukacs&author=A.+J.+Fretland&author=K.+Hong&author=A.+Polonskaia&author=L.+Gao&author=S.+Li&author=D.+S.+Solis&author=D.+Aguilar&author=C.+Tardell&author=M.+Dvorozniak&author=S.+Tannu&author=E.+C.+Lee&author=A.+D.+Schutt&author=B.+Goggin&title=Optimization+of+Benzodiazepinones+as+Selective+Inhibitors+of+the+X-Linked+Inhibitor+of+Apoptosis+Protein+%28XIAP%29+Second+Baculovirus+IAP+Repeat+%28BIR2%29+Domain&doi=10.1021%2Fjm400732v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm400732v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400732v%26sid%3Dliteratum%253Aachs%26aulast%3DKester%26aufirst%3DR.%2BF.%26atitle%3DOptimization%2520of%2520Benzodiazepinones%2520as%2520Selective%2520Inhibitors%2520of%2520the%2520X-Linked%2520Inhibitor%2520of%2520Apoptosis%2520Protein%2520%2528XIAP%2529%2520Second%2520Baculovirus%2520IAP%2520Repeat%2520%2528BIR2%2529%2520Domain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26doi%3D10.1021%2Fjm400732v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Schutt, A.; Goggin, B. S.; Hong, K.; Polonskaia, A.; To, T.; Tardell, C.; Dvorozniak, M.; Tannu, S.; Aguilar, D.; Solis, D.; Gao, L.; Lukacs, C.; Janson, C.; Hilton, H.; Fretland, A.; Liang, Z.; Lee, K.; Kester, R.; Donnell, A.; Mischke, S.; Han, X.; Chen, S.; Le, N.; Lou, Y.; Remiszewski, S.; Packman, K.; Lee, E. C.</span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schutt%2C+A.%3B+Goggin%2C+B.+S.%3B+Hong%2C+K.%3B+Polonskaia%2C+A.%3B+To%2C+T.%3B+Tardell%2C+C.%3B+Dvorozniak%2C+M.%3B+Tannu%2C+S.%3B+Aguilar%2C+D.%3B+Solis%2C+D.%3B+Gao%2C+L.%3B+Lukacs%2C+C.%3B+Janson%2C+C.%3B+Hilton%2C+H.%3B+Fretland%2C+A.%3B+Liang%2C+Z.%3B+Lee%2C+K.%3B+Kester%2C+R.%3B+Donnell%2C+A.%3B+Mischke%2C+S.%3B+Han%2C+X.%3B+Chen%2C+S.%3B+Le%2C+N.%3B+Lou%2C+Y.%3B+Remiszewski%2C+S.%3B+Packman%2C+K.%3B+Lee%2C+E.+C.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSchutt%26aufirst%3DA." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Zhang, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, T. D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldenburg, K. R.</span><span> </span><span class="NLM_article-title">A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">â</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1177%2F108705719900400206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=10838414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1999&pages=67-73&author=J.-H.+Zhangauthor=T.+D.+Y.+Chungauthor=K.+R.+Oldenburg&title=A+Simple+Statistical+Parameter+for+Use+in+Evaluation+and+Validation+of+High+Throughput+Screening+Assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays</span></div><div class="casAuthors">Zhang; Chung; Oldenburg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">67-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The ability to identify active compounds (3hits2) from large chemical libraries accurately and rapidly has been the ultimate goal in developing high-throughput screening (HTS) assays.  The ability to identify hits from a particular HTS assay depends largely on the suitability or quality of the assay used in the screening.  The criteria or parameters for evaluating the 3suitability2 of an HTS assay for hit identification are not well defined and hence it still remains difficult to compare the quality of assays directly.  In this report, a screening window coefficient, called 3Z-factor,2 is defined.  This coefficient is reflective of both the assay signal dynamic range and the data variation associated with the signal measurements, and therefore is suitable for assay quality assessment.  The Z-factor is a dimensionless, simple statistical characteristic for each HTS assay.  The Z-factor provides a useful tool for comparison and evaluation of the quality of assays, and can be utilized in assay optimization and validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkwW5JDdXnbsNIRw0GKUoEfW6udTcc2ebZfbxJ6V3fWrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D&md5=0ec4ed2ccdd3b4a16521567a0975d31f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1177%2F108705719900400206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F108705719900400206%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.-H.%26aulast%3DChung%26aufirst%3DT.%2BD.%2BY.%26aulast%3DOldenburg%26aufirst%3DK.%2BR.%26atitle%3DA%2520Simple%2520Statistical%2520Parameter%2520for%2520Use%2520in%2520Evaluation%2520and%2520Validation%2520of%2520High%2520Throughput%2520Screening%2520Assays%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D1999%26volume%3D4%26spage%3D67%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':[],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':[],'ref30':['cit30'],'ref31':[],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 22 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Nicole Blaquiere, Elisia Villemure, <span class="NLM_string-name hlFld-ContribAuthor">Steven T. Staben</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry of Inhibiting RING-Type E3 Ubiquitin Ligases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 7957-7985. <a href="https://doi.org/10.1021/acs.jmedchem.9b01451" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01451</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01451%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMedicinal%252BChemistry%252Bof%252BInhibiting%252BRING-Type%252BE3%252BUbiquitin%252BLigases%26aulast%3DBlaquiere%26aufirst%3DNicole%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D31082019%26date%3D02042020%26date%3D06032020%26volume%3D63%26issue%3D15%26spage%3D7957%26epage%3D7985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hui Cong, Lijuan Xu, Yougen Wu, Zhuo Qu, Tengfei Bian, Wannian Zhang, Chengguo Xing, <span class="NLM_string-name hlFld-ContribAuthor">Chunlin Zhuang</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (12)
                                     , 5750-5772. <a href="https://doi.org/10.1021/acs.jmedchem.8b01668" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01668</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01668%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibitor%252Bof%252BApoptosis%252BProtein%252B%252528IAP%252529%252BAntagonists%252Bin%252BAnticancer%252BAgent%252BDiscovery%25253A%252BCurrent%252BStatus%252Band%252BPerspectives%26aulast%3DCong%26aufirst%3DHui%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D27102018%26date%3D01022019%26date%3D24012019%26volume%3D62%26issue%3D12%26spage%3D5750%26epage%3D5772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Carlo Baggio, Luca Gambini, Parima Udompholkul, Ahmed F. Salem, Alexander Aronson, Ada Dona, Estelle Troadec, Flavia Pichiorri, <span class="NLM_string-name hlFld-ContribAuthor">Maurizio Pellecchia</span>. </span><span class="cited-content_cbyCitation_article-title">Design of Potent pan-IAP and Lys-Covalent XIAP Selective Inhibitors Using a Thermodynamics Driven Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (14)
                                     , 6350-6363. <a href="https://doi.org/10.1021/acs.jmedchem.8b00810" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00810</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00810%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252BPotent%252Bpan-IAP%252Band%252BLys-Covalent%252BXIAP%252BSelective%252BInhibitors%252BUsing%252Ba%252BThermodynamics%252BDriven%252BApproach%26aulast%3DBaggio%26aufirst%3DCarlo%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D21052018%26date%3D09072018%26date%3D25062018%26volume%3D61%26issue%3D14%26spage%3D6350%26epage%3D6363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mirna  El Khatib</span> and <span class="hlFld-ContribAuthor ">Gary A.  Molander</span>  . </span><span class="cited-content_cbyCitation_article-title">Copper(II)-Mediated O-Arylation of Protected Serines and Threonines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2014,</strong> <em>16 </em>
                                    (18)
                                     , 4944-4947. <a href="https://doi.org/10.1021/ol5024689" title="DOI URL">https://doi.org/10.1021/ol5024689</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol5024689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol5024689%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCopper%252528II%252529-Mediated%252BO-Arylation%252Bof%252BProtected%252BSerines%252Band%252BThreonines%26aulast%3DEl%2BKhatib%26aufirst%3DMirna%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D20082014%26date%3D10092014%26date%3D19092014%26volume%3D16%26issue%3D18%26spage%3D4944%26epage%3D4947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert F.  Kester</span>, <span class="hlFld-ContribAuthor ">Andrew F.  Donnell</span>, <span class="hlFld-ContribAuthor ">Yan  Lou</span>, <span class="hlFld-ContribAuthor ">Stacy W.  Remiszewski</span>, <span class="hlFld-ContribAuthor ">Louis J.  Lombardo</span>, <span class="hlFld-ContribAuthor ">Shaoqing  Chen</span>, <span class="hlFld-ContribAuthor ">Nam T.  Le</span>, <span class="hlFld-ContribAuthor ">Jennifer  Lo</span>, <span class="hlFld-ContribAuthor ">John A.  Moliterni</span>, <span class="hlFld-ContribAuthor ">Xiaochun  Han</span>, <span class="hlFld-ContribAuthor ">J. Heather  Hogg</span>, <span class="hlFld-ContribAuthor ">Weiling  Liang</span>, <span class="hlFld-ContribAuthor ">Christophe  Michoud</span>, <span class="hlFld-ContribAuthor ">Kenneth C.  Rupert</span>, <span class="hlFld-ContribAuthor ">Steven  Mischke</span>, <span class="hlFld-ContribAuthor ">Kang  Le</span>, <span class="hlFld-ContribAuthor ">Martin  Weisel</span>, <span class="hlFld-ContribAuthor ">Cheryl A.  Janson</span>, <span class="hlFld-ContribAuthor ">Christine M.  Lukacs</span>, <span class="hlFld-ContribAuthor ">Adrian J.  Fretland</span>, <span class="hlFld-ContribAuthor ">Kyoungja  Hong</span>, <span class="hlFld-ContribAuthor ">Ann  Polonskaia</span>, <span class="hlFld-ContribAuthor ">Lin  Gao</span>, <span class="hlFld-ContribAuthor ">Shirley  Li</span>, <span class="hlFld-ContribAuthor ">Dave S.  Solis</span>, <span class="hlFld-ContribAuthor ">Doug  Aguilar</span>, <span class="hlFld-ContribAuthor ">Christine  Tardell</span>, <span class="hlFld-ContribAuthor ">Mark  Dvorozniak</span>, <span class="hlFld-ContribAuthor ">Shahid  Tannu</span>, <span class="hlFld-ContribAuthor ">Edmund C.  Lee</span>, <span class="hlFld-ContribAuthor ">Andy D.  Schutt</span>, and <span class="hlFld-ContribAuthor ">Barry  Goggin</span>  . </span><span class="cited-content_cbyCitation_article-title">Optimization of Benzodiazepinones as Selective Inhibitors of the X-Linked Inhibitor of Apoptosis Protein (XIAP) Second Baculovirus IAP Repeat (BIR2) Domain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (20)
                                     , 7788-7803. <a href="https://doi.org/10.1021/jm400732v" title="DOI URL">https://doi.org/10.1021/jm400732v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400732v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400732v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BBenzodiazepinones%252Bas%252BSelective%252BInhibitors%252Bof%252Bthe%252BX-Linked%252BInhibitor%252Bof%252BApoptosis%252BProtein%252B%252528XIAP%252529%252BSecond%252BBaculovirus%252BIAP%252BRepeat%252B%252528BIR2%252529%252BDomain%26aulast%3DKester%26aufirst%3DRobert%2BF.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D15052013%26date%3D07102013%26date%3D24102013%26volume%3D56%26issue%3D20%26spage%3D7788%26epage%3D7803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongyan  Yang</span>, <span class="hlFld-ContribAuthor ">Haixia  Wang</span>, <span class="hlFld-ContribAuthor ">Zhijin  Fan</span>, <span class="hlFld-ContribAuthor ">Zhengming  Li</span>, <span class="hlFld-ContribAuthor ">Shuang  Zhou</span>, <span class="hlFld-ContribAuthor ">Zesheng  Hao</span>, <span class="hlFld-ContribAuthor ">You  Lv</span>, <span class="hlFld-ContribAuthor ">Tatiana A.  Kalinina</span>, <span class="hlFld-ContribAuthor ">Tatiana V.  Glukhareva</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and antifungal activity of (E)-3-acyl-5-(methoxyimino)-1,5-dihydrobenzo[e][1,2]oxazepin-4(3H)-one analogues. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2021,</strong> <em>25 </em>
                                    (1)
                                     , 159-169. <a href="https://doi.org/10.1007/s11030-020-10035-z" title="DOI URL">https://doi.org/10.1007/s11030-020-10035-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-020-10035-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-020-10035-z%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bantifungal%252Bactivity%252Bof%252B%252528E%252529-3-acyl-5-%252528methoxyimino%252529-1%25252C5-dihydrobenzo%25255Be%25255D%25255B1%25252C2%25255Doxazepin-4%2525283H%252529-one%252Banalogues%26aulast%3DYang%26aufirst%3DDongyan%26date%3D2021%26date%3D2020%26volume%3D25%26issue%3D1%26spage%3D159%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heng  Xu</span>, <span class="hlFld-ContribAuthor ">Zhengkuan  Tang</span>, <span class="hlFld-ContribAuthor ">Yu  Zuo</span>, <span class="hlFld-ContribAuthor ">Fengmin  Xiong</span>, <span class="hlFld-ContribAuthor ">Kaixian  Chen</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Hao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular dynamics simulation revealed the intrinsic conformational change of cellular inhibitor of apoptosis protein-1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>38 </em>
                                    (4)
                                     , 975-984. <a href="https://doi.org/10.1080/07391102.2019.1591303" title="DOI URL">https://doi.org/10.1080/07391102.2019.1591303</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1591303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1591303%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DMolecular%252Bdynamics%252Bsimulation%252Brevealed%252Bthe%252Bintrinsic%252Bconformational%252Bchange%252Bof%252Bcellular%252Binhibitor%252Bof%252Bapoptosis%252Bprotein-1%26aulast%3DXu%26aufirst%3DHeng%26date%3D2020%26date%3D2019%26volume%3D38%26issue%3D4%26spage%3D975%26epage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pandurangan  Thiyagamurthy</span>, <span class="hlFld-ContribAuthor ">Fazlur Rahman Nawaz  Khan</span>. </span><span class="cited-content_cbyCitation_article-title">A BaseâFree PdâPrecatalyst Mediated SuzukiâMiyaura and Sonogashira CrossâCoupling in Deep Eutectic Solvents. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (8)
                                     , 2610-2617. <a href="https://doi.org/10.1002/slct.202000276" title="DOI URL">https://doi.org/10.1002/slct.202000276</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202000276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202000276%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DA%252BBase%2525E2%252580%252590Free%252BPd%2525E2%252580%252590Precatalyst%252BMediated%252BSuzuki%2525E2%252580%252590Miyaura%252Band%252BSonogashira%252BCross%2525E2%252580%252590Coupling%252Bin%252BDeep%252BEutectic%252BSolvents%26aulast%3DThiyagamurthy%26aufirst%3DPandurangan%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D8%26spage%3D2610%26epage%3D2617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tatiana  Goncharov</span>, <span class="hlFld-ContribAuthor ">Stefanie  Hedayati</span>, <span class="hlFld-ContribAuthor ">Melinda M.  Mulvihill</span>, <span class="hlFld-ContribAuthor ">Anita  Izrael-Tomasevic</span>, <span class="hlFld-ContribAuthor ">Kerry  Zobel</span>, <span class="hlFld-ContribAuthor ">Surinder  Jeet</span>, <span class="hlFld-ContribAuthor ">Anna V.  Fedorova</span>, <span class="hlFld-ContribAuthor ">Celine  Eidenschenk</span>, <span class="hlFld-ContribAuthor ">Jason  deVoss</span>, <span class="hlFld-ContribAuthor ">Kebing  Yu</span>, <span class="hlFld-ContribAuthor ">Andrey S.  Shaw</span>, <span class="hlFld-ContribAuthor ">Donald S.  Kirkpatrick</span>, <span class="hlFld-ContribAuthor ">Wayne J.  Fairbrother</span>, <span class="hlFld-ContribAuthor ">Kurt  Deshayes</span>, <span class="hlFld-ContribAuthor ">Domagoj  Vucic</span>. </span><span class="cited-content_cbyCitation_article-title">Disruption of XIAP-RIP2 Association Blocks NOD2-Mediated Inflammatory Signaling. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cell</span><span> <strong>2018,</strong> <em>69 </em>
                                    (4)
                                     , 551-565.e7. <a href="https://doi.org/10.1016/j.molcel.2018.01.016" title="DOI URL">https://doi.org/10.1016/j.molcel.2018.01.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molcel.2018.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molcel.2018.01.016%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cell%26atitle%3DDisruption%252Bof%252BXIAP-RIP2%252BAssociation%252BBlocks%252BNOD2-Mediated%252BInflammatory%252BSignaling%26aulast%3DGoncharov%26aufirst%3DTatiana%26date%3D2018%26volume%3D69%26issue%3D4%26spage%3D551%26epage%3D565.e7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jae Uk  Jeong</span>, <span class="hlFld-ContribAuthor ">Philip A.  Harris</span>, <span class="hlFld-ContribAuthor ">James  Kang</span>, <span class="hlFld-ContribAuthor ">Lara  Leister</span>, <span class="hlFld-ContribAuthor ">Yunfeng  Lan</span>, <span class="hlFld-ContribAuthor ">Joseph  Romano</span>, <span class="hlFld-ContribAuthor ">Xiaoyang  Dong</span>, <span class="hlFld-ContribAuthor ">Robert W.  Marquis</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of ( S )-3-amino-benzo[ b ][1,4]oxazepin-4-one via Mitsunobu and S N Ar reaction for a first-in-class RIP1 kinase inhibitor GSK2982772 in clinical trials. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (23)
                                     , 2306-2308. <a href="https://doi.org/10.1016/j.tetlet.2017.05.001" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.05.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.05.001%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Bof%252B%252528%252BS%252B%252529-3-amino-benzo%25255B%252Bb%252B%25255D%25255B1%25252C4%25255Doxazepin-4-one%252Bvia%252BMitsunobu%252Band%252BS%252BN%252BAr%252Breaction%252Bfor%252Ba%252Bfirst-in-class%252BRIP1%252Bkinase%252Binhibitor%252BGSK2982772%252Bin%252Bclinical%252Btrials%26aulast%3DJeong%26aufirst%3DJae%2BUk%26date%3D2017%26volume%3D58%26issue%3D23%26spage%3D2306%26epage%3D2308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.M.  Tice</span>, <span class="hlFld-ContribAuthor ">Y.  Zheng</span>, <span class="hlFld-ContribAuthor ">S.B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Spirocyclic Scaffolds in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 211-263. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12291-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12291-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12291-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12291-7%26sid%3Dliteratum%253Aachs%26atitle%3DSpirocyclic%252BScaffolds%252Bin%252BDrug%252BDiscovery%26aulast%3DTice%26aufirst%3DC.M.%26date%3D2017%26spage%3D211%26epage%3D263%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongyan  Yang</span>, <span class="hlFld-ContribAuthor ">Chuan  Wan</span>, <span class="hlFld-ContribAuthor ">MengMeng  He</span>, <span class="hlFld-ContribAuthor ">Chuanliang  Che</span>, <span class="hlFld-ContribAuthor ">Yumei  Xiao</span>, <span class="hlFld-ContribAuthor ">Bin  Fu</span>, <span class="hlFld-ContribAuthor ">Zhaohai  Qin</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, crystal structure and fungicidal activity of (E)-5-(methoxyimino)-3,5-dihydrobenzo[e][1,2]oxazepin-4(1H)-one analogues. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (5)
                                     , 1007-1014. <a href="https://doi.org/10.1039/C7MD00025A" title="DOI URL">https://doi.org/10.1039/C7MD00025A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00025A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00025A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bcrystal%252Bstructure%252Band%252Bfungicidal%252Bactivity%252Bof%252B%252528E%252529-5-%252528methoxyimino%252529-3%25252C5-dihydrobenzo%25255Be%25255D%25255B1%25252C2%25255Doxazepin-4%2525281H%252529-one%252Banalogues%26aulast%3DYang%26aufirst%3DDongyan%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D5%26spage%3D1007%26epage%3D1014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiao-Di  Nie</span>, <span class="hlFld-ContribAuthor ">Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Chang-Mei  Si</span>, <span class="hlFld-ContribAuthor ">Zhu  Zhou</span>, <span class="hlFld-ContribAuthor ">Xun  Sun</span>, <span class="hlFld-ContribAuthor ">Bang-Guo  Wei</span>. </span><span class="cited-content_cbyCitation_article-title">A practical approach to asymmetric synthesis of dolastatin 10. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2017,</strong> <em>15 </em>
                                    (29)
                                     , 6119-6131. <a href="https://doi.org/10.1039/C7OB01395G" title="DOI URL">https://doi.org/10.1039/C7OB01395G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB01395G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB01395G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DA%252Bpractical%252Bapproach%252Bto%252Basymmetric%252Bsynthesis%252Bof%252Bdolastatin%252B10%26aulast%3DZhou%26aufirst%3DWen%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D29%26spage%3D6119%26epage%3D6131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Duncan E.  Scott</span>, <span class="hlFld-ContribAuthor ">Andrew R.  Bayly</span>, <span class="hlFld-ContribAuthor ">Chris  Abell</span>, <span class="hlFld-ContribAuthor ">John  Skidmore</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecules, big targets: drug discovery faces the proteinâprotein interaction challenge. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2016,</strong> <em>15 </em>
                                    (8)
                                     , 533-550. <a href="https://doi.org/10.1038/nrd.2016.29" title="DOI URL">https://doi.org/10.1038/nrd.2016.29</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd.2016.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd.2016.29%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DSmall%252Bmolecules%25252C%252Bbig%252Btargets%25253A%252Bdrug%252Bdiscovery%252Bfaces%252Bthe%252Bprotein%2525E2%252580%252593protein%252Binteraction%252Bchallenge%26aulast%3DScott%26aufirst%3DDuncan%2BE.%26date%3D2016%26date%3D2016%26volume%3D15%26issue%3D8%26spage%3D533%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Ulmer</span>, <span class="hlFld-ContribAuthor ">Christoph  Brunner</span>, <span class="hlFld-ContribAuthor ">Andreas M.  Arnold</span>, <span class="hlFld-ContribAuthor ">Alexander  PÃ¶thig</span>, <span class="hlFld-ContribAuthor ">Tanja  Gulder</span>. </span><span class="cited-content_cbyCitation_article-title">A Fluorination/Aryl Migration/Cyclization Cascade for the Metal-Free Synthesis of Fluoro-Benzoxazepines. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2016,</strong> <em>22 </em>
                                    (11)
                                     , 3660-3664. <a href="https://doi.org/10.1002/chem.201504749" title="DOI URL">https://doi.org/10.1002/chem.201504749</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201504749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201504749%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DA%252BFluorination%25252FAryl%252BMigration%25252FCyclization%252BCascade%252Bfor%252Bthe%252BMetal-Free%252BSynthesis%252Bof%252BFluoro-Benzoxazepines%26aulast%3DUlmer%26aufirst%3DAnna%26date%3D2016%26date%3D2015%26volume%3D22%26issue%3D11%26spage%3D3660%26epage%3D3664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ajay K.  Chaudhary</span>, <span class="hlFld-ContribAuthor ">Neelu  Yadav</span>, <span class="hlFld-ContribAuthor ">Tariq A.  Bhat</span>, <span class="hlFld-ContribAuthor ">Jordan  OâMalley</span>, <span class="hlFld-ContribAuthor ">Sandeep  Kumar</span>, <span class="hlFld-ContribAuthor ">Dhyan  Chandra</span>. </span><span class="cited-content_cbyCitation_article-title">A potential role of X-linked inhibitor of apoptosis protein in mitochondrial membrane permeabilization and its implication in cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2016,</strong> <em>21 </em>
                                    (1)
                                     , 38-47. <a href="https://doi.org/10.1016/j.drudis.2015.07.014" title="DOI URL">https://doi.org/10.1016/j.drudis.2015.07.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2015.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2015.07.014%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DA%252Bpotential%252Brole%252Bof%252BX-linked%252Binhibitor%252Bof%252Bapoptosis%252Bprotein%252Bin%252Bmitochondrial%252Bmembrane%252Bpermeabilization%252Band%252Bits%252Bimplication%252Bin%252Bcancer%252Btherapy%26aulast%3DChaudhary%26aufirst%3DAjay%2BK.%26date%3D2016%26volume%3D21%26issue%3D1%26spage%3D38%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander W  Hird</span>, <span class="hlFld-ContribAuthor ">Brian M  Aquila</span>, <span class="hlFld-ContribAuthor ">Edward J  Hennessy</span>, <span class="hlFld-ContribAuthor ">Melissa M  Vasbinder</span>, <span class="hlFld-ContribAuthor ">Bin  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule inhibitor of apoptosis proteins antagonists: a patent review. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2015,</strong> <em>25 </em>
                                    (7)
                                     , 755-774. <a href="https://doi.org/10.1517/13543776.2015.1041922" title="DOI URL">https://doi.org/10.1517/13543776.2015.1041922</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2015.1041922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2015.1041922%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSmall%252Bmolecule%252Binhibitor%252Bof%252Bapoptosis%252Bproteins%252Bantagonists%25253A%252Ba%252Bpatent%252Breview%26aulast%3DHird%26aufirst%3DAlexander%2BW%26date%3D2015%26date%3D2015%26volume%3D25%26issue%3D7%26spage%3D755%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pauline  Petiot</span>, <span class="hlFld-ContribAuthor ">Julien  Dansereau</span>, <span class="hlFld-ContribAuthor ">Martin  HÃ©bert</span>, <span class="hlFld-ContribAuthor ">Imene  Khene</span>, <span class="hlFld-ContribAuthor ">Tabinda  Ahmad</span>, <span class="hlFld-ContribAuthor ">Samira  Samaali</span>, <span class="hlFld-ContribAuthor ">Maxime  Leroy</span>, <span class="hlFld-ContribAuthor ">Francis  Pinsonneault</span>, <span class="hlFld-ContribAuthor ">Claude Y.  Legault</span>, <span class="hlFld-ContribAuthor ">Alexandre  Gagnon</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-catalyzed O-arylation of N-protected 1,2-aminoalcohols using functionalized trivalent organobismuth reagents. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2015,</strong> <em>13 </em>
                                    (5)
                                     , 1322-1327. <a href="https://doi.org/10.1039/C4OB02497D" title="DOI URL">https://doi.org/10.1039/C4OB02497D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4OB02497D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4OB02497D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DCopper-catalyzed%252BO-arylation%252Bof%252BN-protected%252B1%25252C2-aminoalcohols%252Busing%252Bfunctionalized%252Btrivalent%252Borganobismuth%252Breagents%26aulast%3DPetiot%26aufirst%3DPauline%26date%3D2015%26date%3D2015%26volume%3D13%26issue%3D5%26spage%3D1322%26epage%3D1327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barreddi  Chiranjeevi</span>, <span class="hlFld-ContribAuthor ">Botla  Vinayak</span>, <span class="hlFld-ContribAuthor ">Thupakula  Parsharamulu</span>, <span class="hlFld-ContribAuthor ">Vemulapalli S.  PhaniBabu</span>, <span class="hlFld-ContribAuthor ">Bharatam  Jagadeesh</span>, <span class="hlFld-ContribAuthor ">Balasubramanian  Sridhar</span>, <span class="hlFld-ContribAuthor ">Malapaka  Chandrasekharam</span>. </span><span class="cited-content_cbyCitation_article-title">Iron(III)-Catalyzed C-H Functionalization:
              ortho
              -Benzoyloxylation of
              N
              ,
              N
              -Dialkylanilines and Its Application to 1,4-Benzoxazepines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>2014 </em>
                                    (35)
                                     , 7839-7849. <a href="https://doi.org/10.1002/ejoc.201402751" title="DOI URL">https://doi.org/10.1002/ejoc.201402751</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201402751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201402751%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DIron%252528III%252529-Catalyzed%252BC-H%252BFunctionalization%25253A%252Bortho%252B-Benzoyloxylation%252Bof%252BN%252B%25252C%252BN%252B-Dialkylanilines%252Band%252BIts%252BApplication%252Bto%252B1%25252C4-Benzoxazepines%26aulast%3DChiranjeevi%26aufirst%3DBarreddi%26date%3D2014%26date%3D2014%26volume%3D2014%26issue%3D35%26spage%3D7839%26epage%3D7849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yajun  Zheng</span>, <span class="hlFld-ContribAuthor ">Colin M.  Tice</span>, <span class="hlFld-ContribAuthor ">Suresh B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">The use of spirocyclic scaffolds in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (16)
                                     , 3673-3682. <a href="https://doi.org/10.1016/j.bmcl.2014.06.081" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.06.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.06.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.06.081%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Buse%252Bof%252Bspirocyclic%252Bscaffolds%252Bin%252Bdrug%252Bdiscovery%26aulast%3DZheng%26aufirst%3DYajun%26date%3D2014%26volume%3D24%26issue%3D16%26spage%3D3673%26epage%3D3682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James B  Jaquith</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the Inhibitor of Apoptosis Protein BIR3 Binding Domains. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Patent Analyst</span><span> <strong>2014,</strong> <em>3 </em>
                                    (3)
                                     , 297-312. <a href="https://doi.org/10.4155/ppa.14.16" title="DOI URL">https://doi.org/10.4155/ppa.14.16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ppa.14.16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fppa.14.16%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Patent%2520Analyst%26atitle%3DTargeting%252Bthe%252BInhibitor%252Bof%252BApoptosis%252BProtein%252BBIR3%252BBinding%252BDomains%26aulast%3DJaquith%26aufirst%3DJames%2BB%26date%3D2014%26volume%3D3%26issue%3D3%26spage%3D297%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John H.  Ryan</span>, <span class="hlFld-ContribAuthor ">Jason A.  Smith</span>, <span class="hlFld-ContribAuthor ">Christopher  Hyland</span>, <span class="hlFld-ContribAuthor ">Adam G.  Meyer</span>, <span class="hlFld-ContribAuthor ">Charlotte C.  Williams</span>, <span class="hlFld-ContribAuthor ">Alex C.  Bissember</span>, <span class="hlFld-ContribAuthor ">Jeremy  Just</span>. </span><span class="cited-content_cbyCitation_article-title">Seven-Membered Rings. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 521-571. <a href="https://doi.org/10.1016/B978-0-08-100017-5.00016-9" title="DOI URL">https://doi.org/10.1016/B978-0-08-100017-5.00016-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-100017-5.00016-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-100017-5.00016-9%26sid%3Dliteratum%253Aachs%26atitle%3DSeven-Membered%252BRings%26aulast%3DRyan%26aufirst%3DJohn%2BH.%26date%3D2014%26spage%3D521%26epage%3D571%26pub%3DElsevier%26date%3D2014%26volume%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. IAP inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. HTS hit and initial lead evolution.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Benzazepinones <b>12</b>â<b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sup>1</sup>CO<sub>2</sub>H, HBTU, HOBt, Et<sub>3</sub>N, DMF, rt, 47%âquant; (b) R<sup>2</sup>CH<sub>2</sub>X, Cs<sub>2</sub>CO<sub>3</sub>, NaI, DMF, 60 Â°C; (c) HCl, MeOH, Et<sub>2</sub>O, rt or TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 24â60% (2 steps).</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0013.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Benzoxazepinone <b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, 1-fluoro-2-nitrobenzene, DMF, 0 Â°C, 97%; (b) H<sub>2</sub>, 10% Pd/C, EtOH, rt, 95%; (c) EDCI, DMF, rt, 62%; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C, quant; (e) BOC-<i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine, HBTU, HOBt, Et<sub>3</sub>N, DMF, rt, 95%; (f) 6-bromo-1-(chloromethyl)-2-methoxynaphthalene, Cs<sub>2</sub>CO<sub>3</sub>, NaI, DMF, 60 Â°C, 54%; (g) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C, 56%.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0014.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Spirocyclic Benzoxazepinone Analogues <b>33</b>â<b>40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LDA, THF; dihydro-2<i>H</i>-pyran-4(3<i>H</i>)-one, â78 Â°C to rt, 50%; (b) KOH, H<sub>2</sub>O, MeOH, 60 Â°C, 92%; (c) 1-fluoro-2-nitrobenzene, KHMDS, THF, rt, 92%; (d) Zn, NH<sub>4</sub>Cl, MeOH, 65 Â°C, quant; (e) EDCI, HOBt, DMF, rt, 74%; (f) H<sub>2</sub>, Pd(OH)<sub>2</sub>/C, MeOH, rt, quant; (g) BOC-<i>N</i>-methyl-<span class="smallcaps smallerCapital">l</span>-alanine, HBTU, HOBt, Et<sub>3</sub>N, DMF, rt, separated diastereomers, 37%; (h) RCH<sub>2</sub>X, Cs<sub>2</sub>CO<sub>3</sub>, NaI, DMF, rtâ70 Â°C; (i) for <b>33</b>â<b>35</b>, <b>37</b>, <b>38</b>, HCl, MeOH, Et<sub>2</sub>O, rt; for <b>39</b>, <b>40</b>, TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C, 44â93% (2 steps); (j) 6-bromo-1-(chloromethyl)-2-methoxynaphthalene, Cs<sub>2</sub>CO<sub>3</sub>, NaI, DMF, 60 Â°C, 54%; (k) CO, MeOH, Pd(OAc)<sub>2</sub>, Xantphos, Et<sub>3</sub>N, 70 Â°C, 67%; (l) LiOHÂ·H<sub>2</sub>O, THFâH<sub>2</sub>O, rt, 88%; (m) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 83%.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray cocrystal structure of <b>36</b> bound to the peptide-binding groove of the BIR2 domain of XIAP, represented with an electrostatic surface. Hydrogen-bonding interactions between the ligand and the protein are indicated by dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. The energy-minimized structure of <b>39</b> (green) overlaid with the crystal structure of <b>36</b> (yellow) bound to XIAP BIR2. The energy minimization of <b>39</b> was performed with MOE (Chemical Computing Group Inc., version 2011.10) using the MMFF94x forcefield.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A,B) Comparison of the activity of <b>3</b> and <b>40</b> in combination with the DR5 antibody conatumumab in SW620 cells in a 5 day MTS cell proliferation assay. Each graph shows doseâresponse curves for conatumumab in the presence of the indicated concentration of test compound. Values are the mean of four determinations Â± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cell line sensitivity to <b>40</b> and <b>3</b> in combination with DR5 agonistic antibody conatumumab. Each bar represents the EC<sub>50</sub> of conatumumab, either alone (blue bars) or in the presence of <b>3</b> (3.3 Î¼M) (red bars) or <b>40</b> (3.3 Î¼M) (green bars) in a 5 day MTS assay measuring viability of the indicated cell line (for LOX cells, the assay was performed in a 3 day format).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Caspase 3/7 activity in SW620 cells 4 h after treatment with the test compounds. Cells were incubated with conatumumab, <b>3</b>, and/or <b>40</b> at the indicated concentrations (combinations used 0.5 Î¼g/mL conatumumab with the indicated concentrations of <b>3</b> or <b>40</b>) for 4 h, and then they were lysed and the caspase 3/7 activity was measured by the cleavage of DEVD-AMC. Values are the mean of two determinations Â± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0009.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Presence of TNFÎ± in the supernate from MDA-MB-231 cells 19 h after treatment with the indicated concentration of BIR3-selective compound <b>3</b> or BIR2-selective compound <b>40</b> in comparison with TNFÎ± standards. Values are the mean of two determinations Â± SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0010.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Caspase 3/7 activity in LOX melanoma xenografts. Tumor-bearing nude mice were treated with a single dose of conatumumab (1 mg/kg ip), <b>40</b> (100 mg/kg po), <b>3</b> (200 mg/kg po), or a combination. After 8 h, xenografts were removed and caspase 3/7 activity was determined with a fluorescence assay measuring cleavage of DEVD-AMC. Mean Â± SD is indicated for each group (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/medium/jm-2013-00731m_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0011.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Western blot analysis of LOX melanoma xenograft homogenates after 8 h treatment with a single dose of the DR5 antibody conatumumab (1 mg/kg ip) or a combination of conatumumab (1 mg/kg ip) with <b>3</b> (100 mg/kg po) or <b>40</b> (200 mg/kg po). Each lane is the result of a single xenograft.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400731m/production/images/large/jm-2013-00731m_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400731m&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74706" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74706" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 36 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hanahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span> </span><span class="NLM_article-title">Hallmarks of Cancer: The Next Generation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">646</span><span class="NLM_x">â</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+Cancer%3A+The+Next+Generation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0lgRZN_cex-zZw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520Cancer%253A%2520The%2520Next%2520Generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26spage%3D646%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Fulda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucic, D.</span><span> </span><span class="NLM_article-title">Targeting IAP proteins for therapeutic intervention in cancer</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">â</span> <span class="NLM_lpage">123</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=109-123&author=S.+Fuldaauthor=D.+Vucic&title=Targeting+IAP+proteins+for+therapeutic+intervention+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DTargeting%2520IAP%2520proteins%2520for%2520therapeutic%2520intervention%2520in%2520cancer%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D109%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Gyrd-Hansen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, P.</span><span> </span><span class="NLM_article-title">IAPs: from caspase inhibitors to modulators of NF-ÎºB, inflammation and cancer</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">â</span> <span class="NLM_lpage">573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1038%2Fnrc2889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=20651737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1Gjtbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=561-573&author=M.+Gyrd-Hansenauthor=P.+Meier&title=IAPs%3A+from+caspase+inhibitors+to+modulators+of+NF-%CE%BAB%2C+inflammation+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">IAPs: from caspase inhibitors to modulators of NF-ÎºB, inflammation and cancer</span></div><div class="casAuthors">Gyrd-Hansen, Mads; Meier, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">561-574</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The realization that alterations in inhibitor of apoptosis (IAP) proteins are found in many types of human cancer and are assocd. with chemoresistance, disease progression, and poor prognosis, has sparked a worldwide frenzy in the development of small pharmacol. inhibitors of IAPs.  The development of such inhibitors has radically changed our knowledge of the signaling processes that are regulated by IAPs.  Recent studies indicate that IAPs not only regulate caspases and apoptosis, but also modulate inflammatory signaling and immunity, mitogenic kinase signaling, proliferation and mitosis, as well as cell invasion and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNNte9JiwXrbVg90H21EOLACvtfcHk0lh4_yIfgf9_iw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1Gjtbw%253D&md5=7cf8b18a0d79f00b36aa0b9caf9d66ed</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc2889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2889%26sid%3Dliteratum%253Aachs%26aulast%3DGyrd-Hansen%26aufirst%3DM.%26aulast%3DMeier%26aufirst%3DP.%26atitle%3DIAPs%253A%2520from%2520caspase%2520inhibitors%2520to%2520modulators%2520of%2520NF-%25CE%25BAB%252C%2520inflammation%2520and%2520cancer%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D561%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Dean, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackhall, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dive, C.</span><span> </span><span class="NLM_article-title">X-linked inhibitor of apoptosis protein as a therapeutic target</span> <span class="citation_source-journal">Expert. Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1459</span><span class="NLM_x">â</span> <span class="NLM_lpage">1471</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1517%2F14728222.11.11.1459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1amsbbM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=1459-1471&author=E.+J.+Deanauthor=M.+Ransonauthor=F.+Blackhallauthor=C.+Dive&title=X-linked+inhibitor+of+apoptosis+protein+as+a+therapeutic+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">X-linked inhibitor of apoptosis protein as a therapeutic target</span></div><div class="casAuthors">Dean, Emma J.; Ranson, Malcolm; Blackhall, Fiona; Dive, Caroline</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1459-1471</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Dysregulation of apoptosis has been shown to contribute to many diseases, including cancer formation, development and resistance, as well as neurodegenerative and autoimmune disorders.  One mechanism through which tumor cells are believed to acquire resistance to apoptosis is by overexpression of X-linked inhibitor of apoptosis protein (XIAP), which belongs to a family of inhibitor of apoptosis proteins.  When XIAP is overexpressed, cancer cells are rendered resistant to apoptosis, both intrinsically and in response to chemotherapy and radiotherapy.  Significant progress has been made in targeting XIAP therapeutically, both directly and indirectly through the modulation of other mols. involved in the apoptotic pathway.  This review introduces XIAP from its mol. origins, discusses its modulation and potential as a novel drug target, and considers future therapeutic perspectives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU2krTm9JIOLVg90H21EOLACvtfcHk0lh4_yIfgf9_iw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1amsbbM&md5=378d6c00969aa089bc28f07fa644cb6f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1517%2F14728222.11.11.1459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.11.11.1459%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DE.%2BJ.%26aulast%3DRanson%26aufirst%3DM.%26aulast%3DBlackhall%26aufirst%3DF.%26aulast%3DDive%26aufirst%3DC.%26atitle%3DX-linked%2520inhibitor%2520of%2520apoptosis%2520protein%2520as%2520a%2520therapeutic%2520target%26jtitle%3DExpert.%2520Opin.%2520Ther.%2520Targets%26date%3D2007%26volume%3D11%26spage%3D1459%26epage%3D1471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Hunter, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaCasse, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korneluk, R. G.</span><span> </span><span class="NLM_article-title">The inhibitors of apoptosis (IAPs) as cancer targets</span> <span class="citation_source-journal">Apoptosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1543</span><span class="NLM_x">â</span> <span class="NLM_lpage">1568</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=1543-1568&author=A.+M.+Hunterauthor=E.+C.+LaCasseauthor=R.+G.+Korneluk&title=The+inhibitors+of+apoptosis+%28IAPs%29+as+cancer+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHunter%26aufirst%3DA.%2BM.%26aulast%3DLaCasse%26aufirst%3DE.%2BC.%26aulast%3DKorneluk%26aufirst%3DR.%2BG.%26atitle%3DThe%2520inhibitors%2520of%2520apoptosis%2520%2528IAPs%2529%2520as%2520cancer%2520targets%26jtitle%3DApoptosis%26date%3D2007%26volume%3D12%26spage%3D1543%26epage%3D1568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Eckelman, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvesen, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, F. L.</span><span> </span><span class="NLM_article-title">Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">988</span><span class="NLM_x">â</span> <span class="NLM_lpage">994</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1038%2Fsj.embor.7400795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=17016456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVajtr7K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=988-994&author=B.+P.+Eckelmanauthor=G.+S.+Salvesenauthor=F.+L.+Scott&title=Human+inhibitor+of+apoptosis+proteins%3A+why+XIAP+is+the+black+sheep+of+the+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family</span></div><div class="casAuthors">Eckelman, Brendan P.; Salvesen, Guy S.; Scott, Fiona L.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">988-994</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Several of the inhibitor of apoptosis protein (IAP) family members regulate apoptosis in response to various cellular assaults.  Some members are also involved in cell signaling, mitosis and targeting proteins to the ubiquitin-proteasome degrdn. machinery.  The most intensively studied family member, X-linked IAP (XIAP), is a potent inhibitor of caspase activity; hence, it is generally assumed that direct caspase inhibition is an important conserved function of most members of the family.  Biochem. and structural studies have precisely mapped the elements of XIAP required for caspase inhibition.  Intriguingly, these elements are not conserved among IAPs.  Here, we review current knowledge of the caspase-inhibitory potential of the human IAPs and show that XIAP is probably the only bona fide caspase inhibitor, suggesting that the other family members never gained the ability to directly inhibit caspase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi2WCkDI8Vs7Vg90H21EOLACvtfcHk0lh4_yIfgf9_iw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVajtr7K&md5=7db7a68e171e0303dd25ba6e2a97be34</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.embor.7400795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.embor.7400795%26sid%3Dliteratum%253Aachs%26aulast%3DEckelman%26aufirst%3DB.%2BP.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DScott%26aufirst%3DF.%2BL.%26atitle%3DHuman%2520inhibitor%2520of%2520apoptosis%2520proteins%253A%2520why%2520XIAP%2520is%2520the%2520black%2520sheep%2520of%2520the%2520family%26jtitle%3DEMBO%2520Rep.%26date%3D2006%26volume%3D7%26spage%3D988%26epage%3D994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Srinivasa, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegde, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saleh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Datta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiozaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes-Alnemri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alnemri, E. S.</span><span> </span><span class="NLM_article-title">A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">410</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">â</span> <span class="NLM_lpage">116</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=2001&pages=112-116&author=S.+M.+Srinivasaauthor=R.+Hegdeauthor=A.+Salehauthor=P.+Dattaauthor=E.+Shiozakiauthor=J.+Chaiauthor=R.-A.+Leeauthor=P.+D.+Robbinsauthor=T.+Fernandes-Alnemriauthor=Y.+Shiauthor=E.+S.+Alnemri&title=A+conserved+XIAP-interaction+motif+in+caspase-9+and+Smac%2FDIABLO+regulates+caspase+activity+and+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSrinivasa%26aufirst%3DS.%2BM.%26aulast%3DHegde%26aufirst%3DR.%26aulast%3DSaleh%26aufirst%3DA.%26aulast%3DDatta%26aufirst%3DP.%26aulast%3DShiozaki%26aufirst%3DE.%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DR.-A.%26aulast%3DRobbins%26aufirst%3DP.%2BD.%26aulast%3DFernandes-Alnemri%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DAlnemri%26aufirst%3DE.%2BS.%26atitle%3DA%2520conserved%2520XIAP-interaction%2520motif%2520in%2520caspase-9%2520and%2520Smac%252FDIABLO%2520regulates%2520caspase%2520activity%2520and%2520apoptosis%26jtitle%3DNature%26date%3D2001%26volume%3D410%26spage%3D112%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Shiozaki, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigotti, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedl, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasula, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alnemri, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Mechanism of XIAP-Mediated Inhibition of Caspase-9</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">â</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1016%2FS1097-2765%2803%2900054-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=12620238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1WgsLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=519-527&author=E.+N.+Shiozakiauthor=J.+Chaiauthor=D.+J.+Rigottiauthor=S.+J.+Riedlauthor=P.+Liauthor=S.+M.+Srinivasulaauthor=E.+S.+Alnemriauthor=R.+Fairmanauthor=Y.+Shi&title=Mechanism+of+XIAP-Mediated+Inhibition+of+Caspase-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of XIAP-mediated inhibition of caspase-9</span></div><div class="casAuthors">Shiozaki, Eric N.; Chai, Jijie; Rigotti, Daniel J.; Riedl, Stefan J.; Li, Pingwei; Srinivasula, Srinivasa M.; Alnemri, Emad S.; Fairman, Robert; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">519-527</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis (IAP) proteins potently inhibit the catalytic activity of caspases.  While profound insight into the inhibition of the effector caspases has been gained in recent years, the mechanism of how the initiator caspase-9 is regulated by IAPs remains enigmatic.  This paper reports the crystal structure of caspase-9 in an inhibitory complex with the third baculoviral IAP repeat (BIR3) of XIAP at 2.4 Ã resoln.  The structure reveals that the BIR3 domain forms a heterodimer with a caspase-9 monomer.  Strikingly, the surface of caspase-9 that interacts with BIR3 also mediates its homodimerization.  We demonstrate that monomeric caspase-9 is catalytically inactive due to the absence of a supporting sequence element that could be provided by homodimerization.  Thus, XIAP sequesters caspase-9 in a monomeric state, which serves to prevent catalytic activity.  These studies, in conjunction with other observations, define a unified mechanism for the activation of all caspases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2rbChsxBIPbVg90H21EOLACvtfcHk0ljpS09oKko66w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1WgsLg%253D&md5=9e01d0078d4f8d676cb96d37c4027827</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900054-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900054-6%26sid%3Dliteratum%253Aachs%26aulast%3DShiozaki%26aufirst%3DE.%2BN.%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DRigotti%26aufirst%3DD.%2BJ.%26aulast%3DRiedl%26aufirst%3DS.%2BJ.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DSrinivasula%26aufirst%3DS.%2BM.%26aulast%3DAlnemri%26aufirst%3DE.%2BS.%26aulast%3DFairman%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DMechanism%2520of%2520XIAP-Mediated%2520Inhibition%2520of%2520Caspase-9%26jtitle%3DMol.%2520Cell%26date%3D2003%26volume%3D11%26spage%3D519%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Chai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiozaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasula, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dataa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alnemri, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Structural Basis of Caspase-7 Inhibition by XIAP</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">â</span> <span class="NLM_lpage">780</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1016%2FS0092-8674%2801%2900272-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=11257230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitFakurg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2001&pages=769-780&author=J.+Chaiauthor=E.+Shiozakiauthor=S.+M.+Srinivasulaauthor=Q.+Wuauthor=P.+Dataaauthor=E.+S.+Alnemriauthor=Y.+Shi&title=Structural+Basis+of+Caspase-7+Inhibition+by+XIAP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of caspase-7 inhibition by XIAP</span></div><div class="casAuthors">Chai, Jijie; Shiozaki, Eric; Srinivasula, Srinivasa M.; Wu, Qi; Dataa, Pinaki; Alnemri, Emad S.; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">769-780</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis (IAP) proteins suppress cell death by inhibiting the catalytic activity of caspases.  Here we present the crystal structure of caspase-7 in complex with a potent inhibitory fragment from XIAP at 2.45 Ã resoln.  An 18-residue XIAP peptide binds the catalytic groove of caspase-7, making extensive contacts to the residues that are essential for its catalytic activity.  Strikingly, despite a reversal of relative orientation, a subset of interactions between caspase-7 and XIAP closely resemble those between caspase-7 and its tetrapeptide inhibitor DEVD-CHO.  Our biochem. and structural analyses reveal that the BIR domains are dispensable for the inhibition of caspase-3 and -7.  This study provides a structural basis for the design of the next-generation caspase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolipWoAs9habVg90H21EOLACvtfcHk0ljpS09oKko66w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitFakurg%253D&md5=fe072a2bacd6c76e3763fff9bc678897</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2801%2900272-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252801%252900272-0%26sid%3Dliteratum%253Aachs%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DShiozaki%26aufirst%3DE.%26aulast%3DSrinivasula%26aufirst%3DS.%2BM.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DDataa%26aufirst%3DP.%26aulast%3DAlnemri%26aufirst%3DE.%2BS.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520Basis%2520of%2520Caspase-7%2520Inhibition%2520by%2520XIAP%26jtitle%3DCell%26date%3D2001%26volume%3D104%26spage%3D769%26epage%3D780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myszka, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span> </span><span class="NLM_article-title">Structural Basis of Caspase Inhibition by XIAP: Differential Roles of the Linker versus the BIR Domain</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">â</span> <span class="NLM_lpage">790</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=11257231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitFakurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2001&pages=781-790&author=Y.+Huangauthor=Y.+C.+Parkauthor=R.+L.+Richauthor=D.+Segalauthor=D.+G.+Myszkaauthor=H.+Wu&title=Structural+Basis+of+Caspase+Inhibition+by+XIAP%3A+Differential+Roles+of+the+Linker+versus+the+BIR+Domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain</span></div><div class="casAuthors">Huang, Yihua; Park, Young Chul; Rich, Rebecca L.; Segal, Deena; Myszka, David G.; Wu, Hao</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">781-790</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis proteins (IAPs) represent the only endogenous caspase inhibitors and are characterized by the presence of baculoviral IAP repeats (BIRs).  Here, we report the crystal structure of the complex between human caspase-7 and XIAP (BIR2 and the proceeding linker).  The structure surprisingly reveals that the linker is the only contacting element for the caspase, while the BIR2 domain is invisible in the crystal.  The linker interacts with and blocks the substrate groove of the caspase in a backward fashion, distinct from substrate recognition.  Structural analyses suggest that the linker is the energetic and specificity determinant of the interaction.  Further biochem. characterizations clearly establish that the linker harbors the major energetic determinant, while the BIR2 domain serves as a regulatory element for caspase binding and Smac neutralization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZjYs6k2CfhrVg90H21EOLACvtfcHk0ljpS09oKko66w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitFakurk%253D&md5=c12e25afe67e2979324ba5bf6151c6bf</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DY.%2BC.%26aulast%3DRich%26aufirst%3DR.%2BL.%26aulast%3DSegal%26aufirst%3DD.%26aulast%3DMyszka%26aufirst%3DD.%2BG.%26aulast%3DWu%26aufirst%3DH.%26atitle%3DStructural%2520Basis%2520of%2520Caspase%2520Inhibition%2520by%2520XIAP%253A%2520Differential%2520Roles%2520of%2520the%2520Linker%2520versus%2520the%2520BIR%2520Domain%26jtitle%3DCell%26date%3D2001%26volume%3D104%26spage%3D781%26epage%3D790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Riedl, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renatus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzenbacher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liddington, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvesen, G. S.</span><span> </span><span class="NLM_article-title">Structural Basis for the Inhibition of Caspase-3 by XIAP</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">â</span> <span class="NLM_lpage">800</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1016%2FS0092-8674%2801%2900274-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=11257232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitFakurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2001&pages=791-800&author=S.+J.+Riedlauthor=M.+Renatusauthor=R.+Schwarzenbacherauthor=Q.+Zhouauthor=C.+Sunauthor=S.+W.+Fesikauthor=R.+C.+Liddingtonauthor=G.+S.+Salvesen&title=Structural+Basis+for+the+Inhibition+of+Caspase-3+by+XIAP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the inhibition of caspase-3 by XIAP</span></div><div class="casAuthors">Riedl, Stefan J.; Renatus, Martin; Schwarzenbacher, Robert; Zhou, Qiao; Sun, Chaohong; Fesik, Stephen W.; Liddington, Robert C.; Salvesen, Guy S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">791-800</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The mol. mechanism(s) that regulate apoptosis by caspase inhibition remain poorly understood.  The main endogenous inhibitors are members of the IAP family and are exemplified by XIAP, which regulates the initiator caspase-9, and the executioner caspases-3 and -7.  We report the crystal structure of the second BIR domain of XIAP (BIR2) in complex with caspase-3, at a resoln. of 2.7 Ã, revealing the structural basis for inhibition.  The inhibitor makes limited contacts through its BIR domain to the surface of the enzyme, and most contacts to caspase-3 originate from the N-terminal extension.  This lies across the substrate binding cleft, but in reverse orientation compared to substrate binding.  The mechanism of inhibition is due to a steric blockade prohibitive of substrate binding, and is distinct from the mechanism utilized by synthetic substrate analog inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaCJZgSAEzrLVg90H21EOLACvtfcHk0lgbbJy-Sc2SFQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitFakurY%253D&md5=7a06c657d5b3700b4dd8e77ab8569613</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2801%2900274-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252801%252900274-4%26sid%3Dliteratum%253Aachs%26aulast%3DRiedl%26aufirst%3DS.%2BJ.%26aulast%3DRenatus%26aufirst%3DM.%26aulast%3DSchwarzenbacher%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DLiddington%26aufirst%3DR.%2BC.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26atitle%3DStructural%2520Basis%2520for%2520the%2520Inhibition%2520of%2520Caspase-3%2520by%2520XIAP%26jtitle%3DCell%26date%3D2001%26volume%3D104%26spage%3D791%26epage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Du, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Smac, a Mitochondrial Protein that Promotes Cytochrome c-Dependent Caspase Activation by Eliminating IAP Inhibition</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">â</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1016%2FS0092-8674%2800%2900008-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=10929711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFCrsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=33-42&author=C.+Duauthor=M.+Fangauthor=Y.+Liauthor=L.+Liauthor=X.+Wang&title=Smac%2C+a+Mitochondrial+Protein+that+Promotes+Cytochrome+c-Dependent+Caspase+Activation+by+Eliminating+IAP+Inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition</span></div><div class="casAuthors">Du, Chunying; Fang, Min; Li, Yucheng; Li, Lily; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-42</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We report here the identification of a novel protein, Smac, which promotes caspase activation in the cytochrome c/Apaf-1/caspase-9 pathway.  Smac promotes caspase-9 activation by binding to inhibitor of apoptosis proteins, IAPs, and removing their inhibitory activity.  Smac is normally a mitochondrial protein but is released into the cytosol when cells undergo apoptosis.  Mitochondrial import and cleavage of its signal peptide are required for Smac to gain its apoptotic activity.  Overexpression of Smac increases cells' sensitivity to apoptotic stimuli.  Smac is the second mitochondrial protein, along with cytochrome c, that promotes apoptosis by activating caspases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEUyaGmAsnprVg90H21EOLACvtfcHk0lgbbJy-Sc2SFQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFCrsbc%253D&md5=8321d44bed77ff7c2da398e1b02f9e20</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900008-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900008-8%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DC.%26aulast%3DFang%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DSmac%252C%2520a%2520Mitochondrial%2520Protein%2520that%2520Promotes%2520Cytochrome%2520c-Dependent%2520Caspase%2520Activation%2520by%2520Eliminating%2520IAP%2520Inhibition%26jtitle%3DCell%26date%3D2000%26volume%3D102%26spage%3D33%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Verhagen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekert, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pakusch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritz, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaux, D. L.</span><span> </span><span class="NLM_article-title">Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP Proteins</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">â</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1016%2FS0092-8674%2800%2900009-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=10929712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFCrtr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=43-53&author=A.+M.+Verhagenauthor=P.+G.+Ekertauthor=M.+Pakuschauthor=J.+Silkeauthor=L.+M.+Connollyauthor=G.+E.+Reidauthor=R.+L.+Moritzauthor=R.+J.+Simpsonauthor=D.+L.+Vaux&title=Identification+of+DIABLO%2C+a+Mammalian+Protein+that+Promotes+Apoptosis+by+Binding+to+and+Antagonizing+IAP+Proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins</span></div><div class="casAuthors">Verhagen, Anne M.; Ekert, Paul G.; Pakusch, Miha; Silke, John; Connolly, Lisa M.; Reid, Gavin E.; Moritz, Robert L.; Simpson, Richard J.; Vaux, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-53</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">To identify proteins that bind mammalian IAP homolog A (MIHA, also known as XIAP), we used coimmunopptn. and 2D immobilized pH gradient/SDS-PAGE, followed by electrospray ionization tandem mass spectrometry.  DIABLO (direct IAP binding protein with low pI) is a novel protein that can bind MIHA and can also interact with MIHB and MIHC and the baculoviral IAP, OpIAP.  The N-terminally processed, IAP-interacting form of DIABLO is concd. in membrane fractions in healthy cells but released into the MIHA-contg. cytosolic fractions upon UV irradn.  As transfection of cells with DIABLO was able to counter the protection afforded by MIHA against UV irradn., DIABLO may promote apoptosis by binding to IAPs and preventing them from inhibiting caspases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6-TYWHjxeE7Vg90H21EOLACvtfcHk0lgbbJy-Sc2SFQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFCrtr4%253D&md5=475519bd43e9d625b06b0293895d9693</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2900009-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252900009-X%26sid%3Dliteratum%253Aachs%26aulast%3DVerhagen%26aufirst%3DA.%2BM.%26aulast%3DEkert%26aufirst%3DP.%2BG.%26aulast%3DPakusch%26aufirst%3DM.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DConnolly%26aufirst%3DL.%2BM.%26aulast%3DReid%26aufirst%3DG.%2BE.%26aulast%3DMoritz%26aufirst%3DR.%2BL.%26aulast%3DSimpson%26aufirst%3DR.%2BJ.%26aulast%3DVaux%26aufirst%3DD.%2BL.%26atitle%3DIdentification%2520of%2520DIABLO%252C%2520a%2520Mammalian%2520Protein%2520that%2520Promotes%2520Apoptosis%2520by%2520Binding%2520to%2520and%2520Antagonizing%2520IAP%2520Proteins%26jtitle%3DCell%26date%3D2000%26volume%3D102%26spage%3D43%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suber, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Structural basis of IAP recognition by Smac/DIABLO</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">1008</span><span class="NLM_x">â</span> <span class="NLM_lpage">1012</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1038%2F35050012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=11140638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslahsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=1008-1012&author=G.+Wuauthor=J.+Chaiauthor=T.+L.+Suberauthor=J.-W.+Wuauthor=C.+Duauthor=X.+Wangauthor=Y.+Shi&title=Structural+basis+of+IAP+recognition+by+Smac%2FDIABLO"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of IAP recognition by Smac/DIABLO</span></div><div class="casAuthors">Wu, Geng; Chai, Jijie; Suber, Tomeka L.; Wu, Jia-Wel; Du, Chunying; Wang, Xiaodong; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6815</span>),
    <span class="NLM_cas:pages">1008-1012</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Apoptosis is an essential process in the development and homeostasis of all metazoans.  The inhibitor-of-apoptosis (IAP) proteins suppress cell death by inhibiting the activity of caspases; this inhibition is performed by the zinc-binding BIR domains of the IAP proteins.  The mitochondrial protein Smac/DIABLO promotes apoptosis by eliminating the inhibitory effect of IAPs through phys. interactions.  Amino-terminal sequences in Smac/DIABLO are required for this function, as mutation of the very first amino acid leads to loss of interaction with LAPs and concomitant loss of Smac/DIABLO function.  Here we report the high-resoln. crystal structure of Smac/DIABLO complexed with the third BIR domain (BIR3) of XIAP.  Our results show that the N-terminal four residues (Ala-Val-Pro-Ile) in Smac/DIABLO recognize a surface groove on BIR3, with the first residue Ala binding a hydrophobic pocket and making five hydrogen bonds to neighboring residues on BIR3.  These observations provide a structural explanation for the roles of the Smac N terminus as well as the conserved N-terminal sequences in the Drosophila proteins Hid/Grim/Reaper.  In conjunction with other observations, our results reveal how Smac may relieve IAP inhibition of caspase-9 activity.  In addn. to explaining a no. of biol. observations, our structural anal. identifies potential targets for drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV3qy8uKazsrVg90H21EOLACvtfcHk0li82Kv7iC_Lsw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslahsQ%253D%253D&md5=fab609edfb1833053eeb78dd2d4ed536</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2F35050012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35050012%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DG.%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DSuber%26aufirst%3DT.%2BL.%26aulast%3DWu%26aufirst%3DJ.-W.%26aulast%3DDu%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520of%2520IAP%2520recognition%2520by%2520Smac%252FDIABLO%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D1008%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olejniczak, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meadows, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betz, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oost, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">1004</span><span class="NLM_x">â</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1038%2F35050006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=11140637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslaiug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=1004-1008&author=Z.+Liuauthor=C.+Sunauthor=E.+T.+Olejniczakauthor=R.+P.+Meadowsauthor=S.+F.+Betzauthor=T.+Oostauthor=J.+Herrmannauthor=J.+C.+Wuauthor=S.+W.+Fesik&title=Structural+basis+for+binding+of+Smac%2FDIABLO+to+the+XIAP+BIR3+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain</span></div><div class="casAuthors">Liu, Zhlhong; Sun, Chaohong; Olejniczak, Edward T.; Meadows, Robert P.; Betz, Stephen F.; Oost, Thorsten; Hemnann, Julia; Wu, Joe C.; Feslk, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6815</span>),
    <span class="NLM_cas:pages">1004-1008</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The inhibitor-of-apoptosis proteins (IAPs) regulate programmed cell death by inhibiting members of the caspase family of enzymes.  Recently, a mammalian protein called Smac (also named DIABLO) was identified that binds to the LAPs and promotes caspase activation.  Although undefined in the x-ray structure, the amino-terminal residues of Smac are crit. for its function.  To understand the structural basis for mol. recognition between Smac and the IAPs, we detd. the soln. structure of the BIR3 domain of X-linked IAP (XIAP) complexed with a functionally active nine-residue peptide derived from the N terminus of Smac.  The peptide binds across the third Î²-strand of the BIR3 domain in an extended conformation with only the first four residues contacting the protein.  The complex is stabilized by four intermol. hydrogen bonds, an electrostatic interaction involving the N terminus of the peptide, and several hydrophobic interactions.  This structural information, along with the binding data from BIR3 and Smac peptide mutants reported here, should aid in the design of small mols. that may be used for the treatment of cancers that overexpress IAPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM4pZbM96xmrVg90H21EOLACvtfcHk0li82Kv7iC_Lsw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslaiug%253D%253D&md5=d81bd94ecd9cf9c11d96ee228ff371aa</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2F35050006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35050006%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DBetz%26aufirst%3DS.%2BF.%26aulast%3DOost%26aufirst%3DT.%26aulast%3DHerrmann%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DStructural%2520basis%2520for%2520binding%2520of%2520Smac%252FDIABLO%2520to%2520the%2520XIAP%2520BIR3%2520domain%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D1004%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Condon, S. M.</span><span> </span><span class="NLM_article-title">The Discovery and Development of Smac MimeticsâSmall-Molecule Antagonists of the Inhibitor of Apoptosis Proteins</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">â</span> <span class="NLM_lpage">226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=211-226&author=S.+M.+Condon&title=The+Discovery+and+Development+of+Smac+Mimetics%E2%80%94Small-Molecule+Antagonists+of+the+Inhibitor+of+Apoptosis+Proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCondon%26aufirst%3DS.%2BM.%26atitle%3DThe%2520Discovery%2520and%2520Development%2520of%2520Smac%2520Mimetics%25E2%2580%2594Small-Molecule%2520Antagonists%2520of%2520the%2520Inhibitor%2520of%2520Apoptosis%2520Proteins%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D211%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Straub, C. S.</span><span> </span><span class="NLM_article-title">Targeting IAPs as an Approach to Anti-Cancer Therapy</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">â</span> <span class="NLM_lpage">316</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.2174%2F156802611794072623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=21320059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslahsLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=291-316&author=C.+S.+Straub&title=Targeting+IAPs+as+an+Approach+to+Anti-Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting IAPs as an approach to anti-cancer therapy</span></div><div class="casAuthors">Straub, Christopher S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-316</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Apoptosis is an essential process for embryonic and lymphocyte development, immune system modulation and tissue homeostasis.  Defects in apoptotic signaling often lead to diseases of immune deficiency, neurodegeneration and cancer.  In the cancer arena, these defects may contribute to the establishment and growth of tumors.  Moreover, many cytotoxic chemotherapies act in part by activating these apoptotic networks.  Occasionally apoptotic pathways are activated, however key players downstream of initiation are inhibited by neg. regulators that have been dysregulated by the diseased state of the cell.  Removal of these barriers to apoptosis signaling, it has been rationalized, could restore cell death in diseased cells while sparing those that are not primed for programmed cell death.  Addnl., the subversion of these death evading mechanisms may re-sensitize cells that have developed resistance to chemotherapies in this manner.  The importance of apoptosis as a maintenance process, and the promise that restoring this signaling could mean in treating cancer has placed many targets on the front line of oncol. research.  Approaches are being developed that will activate death receptor pathways, synthetically activate caspases, restore the activity of tumor suppressor genes such as p53, and counteract the effects of anti-apoptotic factors.  Among these approaches, small mols. are in clin. trials against several anti-apoptotic players, namely the Bcl-2 and IAP proteins.  This review will focus on the efforts being advanced against the Inhibitor of Apoptosis Proteins (IAP), the chem. matter of the inhibitors and the biol. emerging from this research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN1vzuchBUTLVg90H21EOLACvtfcHk0li82Kv7iC_Lsw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslahsLg%253D&md5=cd0024d0150802fed4051038c05d6a2b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F156802611794072623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611794072623%26sid%3Dliteratum%253Aachs%26aulast%3DStraub%26aufirst%3DC.%2BS.%26atitle%3DTargeting%2520IAPs%2520as%2520an%2520Approach%2520to%2520Anti-Cancer%2520Therapy%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D291%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Flygare, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span> </span><span class="NLM_article-title">Small-molecule pan-IAP antagonists: a patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">â</span> <span class="NLM_lpage">267</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1517%2F13543770903567077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=20100005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGktb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=251-267&author=J.+A.+Flygareauthor=W.+J.+Fairbrother&title=Small-molecule+pan-IAP+antagonists%3A+a+patent+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule pan-IAP antagonists: a patent review</span></div><div class="casAuthors">Flygare, John A.; Fairbrother, Wayne J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">251-267</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The inhibitor of apoptosis (IAP) proteins are crit. regulators of cancer cell survival that have become important targets for therapeutic intervention in human malignancies.  One strategy for targeting IAP proteins involves agents that mimic the amino terminus of the endogenous IAP protein antagonist second mitochondria-derived activator of caspases (Smac)/direct IAP-binding protein with low pI (DIABLO) and thus block crit. IAP protein interactions.  Areas covered in this review: This review of the IAP antagonist patent literature covers the period from 2000 to mid-2009.  Over 50 patents and patent applications pertaining to IAP antagonists have been published over the past 10 years.  In the case of several filings, only the original source is reviewed in this anal.  What the reader will gain: Readers will gain an overview of IAP protein antagonist scaffolds, with representative examples including monovalent and bivalent Smac mimetics, and an understanding of their structure-activity relationships.  Take home message: The feasibility of disrupting IAP protein interactions with pro-apoptotic proteins using monovalent and bivalent Smac-derived peptidomimetic compds. has been broadly established.  Four such compds. have entered or been approved to enter human clin. trials, which will hopefully allow the utility of this potential therapeutic approach to be evaluated in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN1K-xLSDlXrVg90H21EOLACvtfcHk0liy0ANTsqvMgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGktb0%253D&md5=9017c8266da17502a6c081d5ca2955ac</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1517%2F13543770903567077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903567077%26sid%3Dliteratum%253Aachs%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26atitle%3DSmall-molecule%2520pan-IAP%2520antagonists%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D251%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Design of Small-Molecule Peptidic and Nonpeptidic Smac Mimetics</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1264</span><span class="NLM_x">â</span> <span class="NLM_lpage">1276</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar8000553" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Kiur3L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=1264-1276&author=H.+Sunauthor=Z.+Nikolovska-Coleskaauthor=C.-Y.+Yangauthor=D.+Qianauthor=J.+Luauthor=S.+Qiuauthor=L.+Baiauthor=Y.+Pengauthor=Q.+Caiauthor=S.+Wang&title=Design+of+Small-Molecule+Peptidic+and+Nonpeptidic+Smac+Mimetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Small-Molecule Peptidic and Nonpeptidic Smac Mimetics</span></div><div class="casAuthors">Sun, Haiying; Nikolovska-Coleska, Zaneta; Yang, Chao-Yie; Qian, Dongguang; Lu, Jianfeng; Qiu, Su; Bai, Longchuan; Peng, Yuefeng; Cai, Qian; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1264-1277</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Smac/DIABLO is a protein released from mitochondria into the cytosol in response to apoptotic stimuli.  Smac promotes apoptosis at least in part through antagonizing inhibitor of apoptosis proteins (IAPs), including XIAP, cIAP-1, and cIAP-2.  Smac interacts with these IAPs via its N-terminal AVPI binding motif.  There has been an enormous interest in academic labs. and pharmaceutical companies in the design of small-mol. Smac mimetics as potential anticancer agents.  This task is particularly challenging because it involves targeting protein-protein interactions.  Nevertheless, intense research has now generated potent, specific, cell-permeable small-mol. peptidomimetics and nonpeptidic mimetics.  To date, two types of Smac mimetics have been reported, namely, monovalent and bivalent Smac mimetics.  The monovalent compds. are designed to mimic the binding of a single AVPI binding motif to IAP proteins, whereas the bivalent compds. contain two AVPI binding motif mimetics tethered together through a linker.  Studies from several groups have clearly demonstrated that both monovalent and bivalent Smac mimetics not only enhance the antitumor activity of other anticancer agents but also can induce apoptosis as single agents in a subset of human cancer cell lines in vitro and are capable of achieving tumor regression in animal models of human cancer.  In general, bivalent Smac mimetics are 100-1000 times more potent than their corresponding monovalent Smac mimetics in induction of apoptosis in tumor cells.  However, properly designed monovalent Smac mimetics can achieve oral bioavailability and may have major advantages over bivalent Smac mimetics as potential drug candidates.  In-depth insights on the mol. mechanism of action of Smac mimetics have been provided by several independent studies.  It was shown that Smac mimetics induce apoptosis in tumor cells by targeting cIAP-1/-2 for the rapid degrdn. of these proteins, which leads to activation of nuclear factor ÎºB (NF-ÎºB) and prodn. and secretion of tumor necrosis factor Î± (TNFÎ±).  TNFÎ± promotes formation of a receptor-interacting serine-threonine kinase 1 (RIPK1)-dependent caspase-8-activating complex, leading to activation of caspase-8 and -3/-7 and ultimately to apoptosis.  For the most efficient apoptosis induction, Smac mimetics also need to remove the inhibition of XIAP to caspase-3/-7.  Hence, Smac mimetics induce apoptosis in tumor cells by targeting not only cIAP-1/-2 but also XIAP.  The employment of potent, cell-permeable, small-mol. Smac mimetics has yielded important insights into the regulation of apoptosis by IAP proteins.  To date, at least one Smac mimetic has been advanced into clin. development.  Several other Smac mimetics are in an advanced preclin. development stage and are expected to enter human clin. testing for the treatment of cancer in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF2ORbmgx5q7Vg90H21EOLACvtfcHk0liy0ANTsqvMgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Kiur3L&md5=434530329024b75e59f7f88e29ea0de1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Far8000553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far8000553%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DQian%26aufirst%3DD.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%2520of%2520Small-Molecule%2520Peptidic%2520and%2520Nonpeptidic%2520Smac%2520Mimetics%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D1264%26epage%3D1276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Cai, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2714</span><span class="NLM_x">â</span> <span class="NLM_lpage">2726</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101505d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2714-2726&author=Q.+Caiauthor=H.+Sunauthor=Y.+Pengauthor=J.+Luauthor=Z.+Nikolovska-Coleskaauthor=D.+McEachernauthor=L.+Liuauthor=S.+Qiuauthor=C.-Y.+Yangauthor=R.+Millerauthor=H.+Yiauthor=T.+Zhangauthor=D.+Sunauthor=S.+Kangauthor=M.+Guoauthor=L.+Leopoldauthor=D.+Yangauthor=S.+Wang&title=A+Potent+and+Orally+Active+Antagonist+%28SM-406%2FAT-406%29+of+Multiple+Inhibitor+of+Apoptosis+Proteins+%28IAPs%29+in+Clinical+Development+for+Cancer+Treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment</span></div><div class="casAuthors">Cai, Qian; Sun, Haiying; Peng, Yuefeng; Lu, Jianfeng; Nikolovska-Coleska, Zaneta; McEachern, Donna; Liu, Liu; Qiu, Su; Yang, Chao-Yie; Miller, Rebecca; Yi, Han; Zhang, Tao; Sun, Duxin; Kang, Sanmao; Guo, Ming; Leopold, Lance; Yang, Dajun; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2714-2726</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the discovery and characterization of SM-406 (compd. 2), a potent and orally bioavailable Smac mimetic and an antagonist of the inhibitor of apoptosis proteins (IAPs).  This compd. binds to XIAP, cIAP1, and cIAP2 proteins with Ki of 66.4, 1.9, and 5.1 nM, resp.  Compd. 2 effectively antagonizes XIAP BIR3 protein in a cell-free functional assay, induces rapid degrdn. of cellular cIAP1 protein, and inhibits cancer cell growth in various human cancer cell lines.  It has good oral bioavailability in mice, rats, non-human primates, and dogs, is highly effective in induction of apoptosis in xenograft tumors, and is capable of complete inhibition of tumor growth.  Compd. 2 is currently in phase I clin. trials for the treatment of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgYOZBCwfnLrVg90H21EOLACvtfcHk0liy0ANTsqvMgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurg%253D&md5=5b73a2ea1a5a2a6b3e3f4c978b49706f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm101505d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101505d%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DLeopold%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DA%2520Potent%2520and%2520Orally%2520Active%2520Antagonist%2520%2528SM-406%252FAT-406%2529%2520of%2520Multiple%2520Inhibitor%2520of%2520Apoptosis%2520Proteins%2520%2528IAPs%2529%2520in%2520Clinical%2520Development%2520for%2520Cancer%2520Treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2714%26epage%3D2726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Flygare, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheeti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshayes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckhardt, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reisner, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazzard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halladay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hymowitz, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoRusso, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plise, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Um, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varfolomeev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span> </span><span class="NLM_article-title">Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4101</span><span class="NLM_x">â</span> <span class="NLM_lpage">4113</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300060k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Ois74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4101-4113&author=J.+A.+Flygareauthor=M.+Beresiniauthor=N.+Budhaauthor=H.+Chanauthor=I.+T.+Chanauthor=S.+Cheetiauthor=F.+Cohenauthor=K.+Deshayesauthor=K.+Doernerauthor=S.+G.+Eckhardtauthor=L.+O.+Elliottauthor=B.+Fengauthor=M.+C.+Franklinauthor=S.+F.+Reisnerauthor=L.+Gazzardauthor=J.+Halladayauthor=S.+G.+Hymowitzauthor=H.+Laauthor=P.+LoRussoauthor=B.+Maurerauthor=L.+Murrayauthor=E.+Pliseauthor=C.+Quanauthor=J.-P.+Stephanauthor=S.+G.+Youngauthor=J.+Tomauthor=V.+Tsuiauthor=J.+Umauthor=E.+Varfolomeevauthor=D.+Vucicauthor=A.+J.+Wagnerauthor=H.+J.+A.+Wallweberauthor=L.+Wangauthor=J.+Wareauthor=Z.+Wenauthor=H.+Wongauthor=J.+M.+Wongauthor=M.+Wongauthor=S.+Wongauthor=R.+Yuauthor=K.+Zobelauthor=W.+J.+Fairbrother&title=Discovery+of+a+Potent+Small-Molecule+Antagonist+of+Inhibitor+of+Apoptosis+%28IAP%29+Proteins+and+Clinical+Candidate+for+the+Treatment+of+Cancer+%28GDC-0152%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152)</span></div><div class="casAuthors">Flygare, John A.; Beresini, Maureen; Budha, Nageshwar; Chan, Helen; Chan, Iris T.; Cheeti, Sravanthi; Cohen, Frederick; Deshayes, Kurt; Doerner, Karl; Eckhardt, S. Gail; Elliott, Linda O.; Feng, Bainian; Franklin, Matthew C.; Reisner, Stacy Frankovitz; Gazzard, Lewis; Halladay, Jason; Hymowitz, Sarah G.; La, Hank; LoRusso, Patricia; Maurer, Brigitte; Murray, Lesley; Plise, Emile; Quan, Clifford; Stephan, Jean-Philippe; Young, Shin G.; Tom, Jeffrey; Tsui, Vickie; Um, Joanne; Varfolomeev, Eugene; Vucic, Domagoj; Wagner, Andrew J.; Wallweber, Heidi J. A.; Wang, Lan; Ware, Joseph; Wen, Zhaoyang; Wong, Harvey; Wong, Jonathan M.; Wong, Melisa; Wong, Susan; Yu, Ron; Zobel, Kerry; Fairbrother, Wayne J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4101-4113</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of compds. were designed and synthesized as antagonists of cIAP1/2, ML-IAP, and XIAP based on the N-terminus, AVPI, of mature Smac.  Compd. (I) (GDC-0152) has the best profile of these compds.; it binds to the XIAP BIR3 domain, the BIR domain of ML-IAP, and the BIR3 domains of cIAP1 and cIAP2 with Ki values of 28, 14, 17, and 43 nM, resp.  These compds. promote degrdn. of cIAP1, induce activation of caspase-3/7, and lead to decreased viability of breast cancer cells without affecting normal mammary epithelial cells.  Compd. I inhibits tumor growth when dosed orally in the MDA-MB-231 breast cancer xenograft model.  Compd. I was advanced to human clin. trials, and it exhibited linear pharmacokinetics over the dose range (0.049 to 1.48 mg/kg) tested.  Mean plasma clearance in humans was 9 Â± 3 mL/min/kg, and the vol. of distribution was 0.6 Â± 0.2 L/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZSPNVJ5gVWrVg90H21EOLACvtfcHk0lj_-5pwTFHpBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Ois74%253D&md5=19452878ea834d3c324d567b39a78fb2</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm300060k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300060k%26sid%3Dliteratum%253Aachs%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DBeresini%26aufirst%3DM.%26aulast%3DBudha%26aufirst%3DN.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DChan%26aufirst%3DI.%2BT.%26aulast%3DCheeti%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DDoerner%26aufirst%3DK.%26aulast%3DEckhardt%26aufirst%3DS.%2BG.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DFranklin%26aufirst%3DM.%2BC.%26aulast%3DReisner%26aufirst%3DS.%2BF.%26aulast%3DGazzard%26aufirst%3DL.%26aulast%3DHalladay%26aufirst%3DJ.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DLoRusso%26aufirst%3DP.%26aulast%3DMaurer%26aufirst%3DB.%26aulast%3DMurray%26aufirst%3DL.%26aulast%3DPlise%26aufirst%3DE.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DStephan%26aufirst%3DJ.-P.%26aulast%3DYoung%26aufirst%3DS.%2BG.%26aulast%3DTom%26aufirst%3DJ.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DUm%26aufirst%3DJ.%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DWagner%26aufirst%3DA.%2BJ.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWare%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DZ.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DJ.%2BM.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DR.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520Potent%2520Small-Molecule%2520Antagonist%2520of%2520Inhibitor%2520of%2520Apoptosis%2520%2528IAP%2529%2520Proteins%2520and%2520Clinical%2520Candidate%2520for%2520the%2520Treatment%2520of%2520Cancer%2520%2528GDC-0152%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4101%26epage%3D4113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Houghton, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorlick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keir, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carol, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lock, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maris, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billups, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span> </span><span class="NLM_article-title">Initial Testing (Stage 1) of LCL161, a SMAC Mimetic, by the Pediatric Preclinical Testing Program</span> <span class="citation_source-journal">Pediatr. Blood Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">636</span><span class="NLM_x">â</span> <span class="NLM_lpage">639</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1002%2Fpbc.23167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A280%3ADC%252BC383is1Grug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2012&pages=636-639&author=P.+J.+Houghtonauthor=M.+H.+Kangauthor=C.+P.+Reynoldsauthor=C.+L.+Mortonauthor=E.+A.+Kolbauthor=R.+Gorlickauthor=S.+T.+Keirauthor=H.+Carolauthor=R.+Lockauthor=J.+M.+Marisauthor=C.+A.+Billupsauthor=M.+A.+Smith&title=Initial+Testing+%28Stage+1%29+of+LCL161%2C+a+SMAC+Mimetic%2C+by+the+Pediatric+Preclinical+Testing+Program"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Initial testing (stage 1) of LCL161, a SMAC mimetic, by the Pediatric Preclinical Testing Program</span></div><div class="casAuthors">Houghton Peter J; Kang Min H; Reynolds C Patrick; Morton Christopher L; Kolb E Anders; Gorlick Richard; Keir Stephen T; Carol Hernan; Lock Richard; Maris John M; Billups Catherine A; Smith Malcolm A</div><div class="citationInfo"><span class="NLM_cas:title">Pediatric blood & cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">636-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">LCL161, a SMAC mimetic, was tested against the PPTP in vitro panel (1.0 nM to 10.0 Î¼M) and the PPTP in vivo panels (30 or 75 mg/kg [solid tumors] or 100 mg/kg [ALL]) administered orally twice in a week.  LCL161 showed a median relative IC(50) value of >10 Î¼M, being more potent against several leukemia and lymphoma lines.  In vivo LCL161 induced significant differences in EFS distribution in approximately one-third of solid tumor xenografts (osteosarcoma and glioblastoma), but not in ALL xenografts.  No objective tumor responses were observed.  In vivo LCL161 demonstrated limited single agent activity against the pediatric preclinical models studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRSUatUzOMj4MULxIEhxUjPfW6udTcc2eZGCYPXDwivBrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383is1Grug%253D%253D&md5=39302864067c6f9d1bfc9fca041d6c3c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fpbc.23167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpbc.23167%26sid%3Dliteratum%253Aachs%26aulast%3DHoughton%26aufirst%3DP.%2BJ.%26aulast%3DKang%26aufirst%3DM.%2BH.%26aulast%3DReynolds%26aufirst%3DC.%2BP.%26aulast%3DMorton%26aufirst%3DC.%2BL.%26aulast%3DKolb%26aufirst%3DE.%2BA.%26aulast%3DGorlick%26aufirst%3DR.%26aulast%3DKeir%26aufirst%3DS.%2BT.%26aulast%3DCarol%26aufirst%3DH.%26aulast%3DLock%26aufirst%3DR.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26aulast%3DBillups%26aufirst%3DC.%2BA.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26atitle%3DInitial%2520Testing%2520%2528Stage%25201%2529%2520of%2520LCL161%252C%2520a%2520SMAC%2520Mimetic%252C%2520by%2520the%2520Pediatric%2520Preclinical%2520Testing%2520Program%26jtitle%3DPediatr.%2520Blood%2520Cancer%26date%3D2012%26volume%3D58%26spage%3D636%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Chen, K.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiau, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, W.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A.-L.</span><span> </span><span class="NLM_article-title">Inhibition of Bcl-2 improves effect of LCL 161, a SMAC, mimetic in hepatocellular carcinoma cells</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">â</span> <span class="NLM_lpage">277</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=268-277&author=K.-F.+Chenauthor=J.-P.+Linauthor=C.-W.+Shiauauthor=W.-T.+Taiauthor=C.-Y.+Liuauthor=H.-C.+Yuauthor=P.-J.+Chenauthor=A.-L.+Cheng&title=Inhibition+of+Bcl-2+improves+effect+of+LCL+161%2C+a+SMAC%2C+mimetic+in+hepatocellular+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.-F.%26aulast%3DLin%26aufirst%3DJ.-P.%26aulast%3DShiau%26aufirst%3DC.-W.%26aulast%3DTai%26aufirst%3DW.-T.%26aulast%3DLiu%26aufirst%3DC.-Y.%26aulast%3DYu%26aufirst%3DH.-C.%26aulast%3DChen%26aufirst%3DP.-J.%26aulast%3DCheng%26aufirst%3DA.-L.%26atitle%3DInhibition%2520of%2520Bcl-2%2520improves%2520effect%2520of%2520LCL%2520161%252C%2520a%2520SMAC%252C%2520mimetic%2520in%2520hepatocellular%2520carcinoma%2520cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D84%26spage%3D268%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="note"><p class="first last">See the discussion in ref  <a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">2</a> for more details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Petersen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yalcin-Chin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harran, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Autocrine TNFÎ± Signaling Renders Human Cancer Cells Susceptible to Smac-Mimetic-Induced Apoptosis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">â</span> <span class="NLM_lpage">456</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=445-456&author=S.+L.+Petersenauthor=L.+Wangauthor=A.+Yalcin-Chinauthor=L.+Liauthor=M.+Peytonauthor=J.+Minnaauthor=P.+Harranauthor=X.+Wang&title=Autocrine+TNF%CE%B1+Signaling+Renders+Human+Cancer+Cells+Susceptible+to+Smac-Mimetic-Induced+Apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetersen%26aufirst%3DS.%2BL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYalcin-Chin%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DPeyton%26aufirst%3DM.%26aulast%3DMinna%26aufirst%3DJ.%26aulast%3DHarran%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DAutocrine%2520TNF%25CE%25B1%2520Signaling%2520Renders%2520Human%2520Cancer%2520Cells%2520Susceptible%2520to%2520Smac-Mimetic-Induced%2520Apoptosis%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D445%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Varfolomeev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankenship, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorova, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayagaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dynek, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flygare, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshayes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixit, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucic, D.</span><span> </span><span class="NLM_article-title">IAP Antagonists Induce Autoubitquitination of c-IAPs, NJ-ÎºB Activation, and TNFÎ±-Dependent Apoptosis</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">â</span> <span class="NLM_lpage">681</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=669-681&author=E.+Varfolomeevauthor=J.+W.+Blankenshipauthor=S.+M.+Waysonauthor=A.+V.+Fedorovaauthor=N.+Kayagakiauthor=P.+Gargauthor=K.+Zobelauthor=J.+N.+Dynekauthor=L.+O.+Elliottauthor=H.+J.+A.+Wallweberauthor=J.+A.+Flygareauthor=W.+J.+Fairbrotherauthor=K.+Deshayesauthor=V.+M.+Dixitauthor=D.+Vucic&title=IAP+Antagonists+Induce+Autoubitquitination+of+c-IAPs%2C+NJ-%CE%BAB+Activation%2C+and+TNF%CE%B1-Dependent+Apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DBlankenship%26aufirst%3DJ.%2BW.%26aulast%3DWayson%26aufirst%3DS.%2BM.%26aulast%3DFedorova%26aufirst%3DA.%2BV.%26aulast%3DKayagaki%26aufirst%3DN.%26aulast%3DGarg%26aufirst%3DP.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DDynek%26aufirst%3DJ.%2BN.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DIAP%2520Antagonists%2520Induce%2520Autoubitquitination%2520of%2520c-IAPs%252C%2520NJ-%25CE%25BAB%2520Activation%252C%2520and%2520TNF%25CE%25B1-Dependent%2520Apoptosis%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D669%26epage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Vince, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, W. W.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, A. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benetatos, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chunduru, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinlay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverkus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tergaonkar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callus, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koentgen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaux, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silke, J.</span><span> </span><span class="NLM_article-title">IAP Antagonists Target cIAP1 to Induce TNFÎ±-Dependent Apoptosis</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">682</span><span class="NLM_x">â</span> <span class="NLM_lpage">693</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=682-693&author=J.+E.+Vinceauthor=W.+W.-L.+Wongauthor=N.+Khanauthor=R.+Felthamauthor=D.+Chauauthor=A.+U.+Ahmedauthor=C.+A.+Benetatosauthor=S.+K.+Chunduruauthor=S.+M.+Condonauthor=M.+McKinlayauthor=R.+Brinkauthor=M.+Leverkusauthor=V.+Tergaonkarauthor=P.+Schneiderauthor=B.+A.+Callusauthor=F.+Koentgenauthor=D.+L.+Vauxauthor=J.+Silke&title=IAP+Antagonists+Target+cIAP1+to+Induce+TNF%CE%B1-Dependent+Apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVince%26aufirst%3DJ.%2BE.%26aulast%3DWong%26aufirst%3DW.%2BW.-L.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DFeltham%26aufirst%3DR.%26aulast%3DChau%26aufirst%3DD.%26aulast%3DAhmed%26aufirst%3DA.%2BU.%26aulast%3DBenetatos%26aufirst%3DC.%2BA.%26aulast%3DChunduru%26aufirst%3DS.%2BK.%26aulast%3DCondon%26aufirst%3DS.%2BM.%26aulast%3DMcKinlay%26aufirst%3DM.%26aulast%3DBrink%26aufirst%3DR.%26aulast%3DLeverkus%26aufirst%3DM.%26aulast%3DTergaonkar%26aufirst%3DV.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DCallus%26aufirst%3DB.%2BA.%26aulast%3DKoentgen%26aufirst%3DF.%26aulast%3DVaux%26aufirst%3DD.%2BL.%26aulast%3DSilke%26aufirst%3DJ.%26atitle%3DIAP%2520Antagonists%2520Target%2520cIAP1%2520to%2520Induce%2520TNF%25CE%25B1-Dependent%2520Apoptosis%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D682%26epage%3D693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">GonzÃ¡lez-LÃ³pez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finlay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardecky, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganji, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teriete, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mace, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedl, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosford, N. D. P.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of monovalent Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAP</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4332</span><span class="NLM_x">â</span> <span class="NLM_lpage">4336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4332-4336&author=M.+Gonz%C3%A1lez-L%C3%B3pezauthor=K.+Welshauthor=D.+Finlayauthor=R.+J.+Ardeckyauthor=S.+R.+Ganjiauthor=Y.+Suauthor=H.+Yuanauthor=P.+Terieteauthor=P.+D.+Maceauthor=S.+J.+Riedlauthor=K.+Vuoriauthor=J.+C.+Reedauthor=N.+D.+P.+Cosford&title=Design%2C+synthesis+and+evaluation+of+monovalent+Smac+mimetics+that+bind+to+the+BIR2+domain+of+the+anti-apoptotic+protein+XIAP"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGonz%25C3%25A1lez-L%25C3%25B3pez%26aufirst%3DM.%26aulast%3DWelsh%26aufirst%3DK.%26aulast%3DFinlay%26aufirst%3DD.%26aulast%3DArdecky%26aufirst%3DR.%2BJ.%26aulast%3DGanji%26aufirst%3DS.%2BR.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DTeriete%26aufirst%3DP.%26aulast%3DMace%26aufirst%3DP.%2BD.%26aulast%3DRiedl%26aufirst%3DS.%2BJ.%26aulast%3DVuori%26aufirst%3DK.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520monovalent%2520Smac%2520mimetics%2520that%2520bind%2520to%2520the%2520BIR2%2520domain%2520of%2520the%2520anti-apoptotic%2520protein%2520XIAP%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4332%26epage%3D4336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="note"><p class="first last">For example, the clearance for <b>19</b> was 155 mL/min/kg in a cassette dosing study versus 116 mL/min/kg in a single-compound PK study.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><div class="note"><p class="first last">For additional discussion, see:</p></div><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belunis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowther, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danho, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goggin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remiszewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakur, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyagi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span> </span><span class="NLM_article-title">The structure of XIAP BIR2: understanding the selectivity of the BIR domains</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D.: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1717</span><span class="NLM_x">â</span> <span class="NLM_lpage">1725</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1107%2FS0907444913016284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=23999295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlKrsLnK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1717-1725&author=C.+Lukacsauthor=C.+Belunisauthor=R.+Crowtherauthor=W.+Danhoauthor=L.+Gaoauthor=B.+Gogginauthor=C.+A.+Jansonauthor=S.+Liauthor=S.+Remiszewskiauthor=A.+Schuttauthor=M.+K.+Thakurauthor=S.+K.+Singhauthor=S.+Swaminathanauthor=R.+Pandeyauthor=R.+Tyagiauthor=R.+Gosuauthor=A.+V.+Kamathauthor=A.+Kuglstatter&title=The+structure+of+XIAP+BIR2%3A+understanding+the+selectivity+of+the+BIR+domains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of XIAP BIR2: understanding the selectivity of the BIR domains</span></div><div class="casAuthors">Lukacs, Christine; Belunis, Charles; Crowther, Robert; Danho, Waleed; Gao, Lin; Goggin, Barry; Janson, Cheryl A.; Li, Shirley; Remiszewski, Stacy; Schutt, Andrew; Thakur, Manish K.; Singh, Saroj K.; Swaminathan, Srinivasan; Pandey, Rajat; Tyagi, Rajiv; Gosu, Ramachandraiah; Kamath, Ajith V.; Kuglstatter, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1717-1725</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">XIAP, a member of the inhibitor of apoptosis family of proteins, is a crit. regulator of apoptosis.  Inhibition of the BIR domain-caspase interaction is a promising approach towards treating cancer.  Previous work has been directed towards inhibiting the BIR3-caspase-9 interaction, which blocks the intrinsic apoptotic pathway; selectively inhibiting the BIR2-caspase-3 interaction would also block the extrinsic pathway.  The BIR2 domain of XIAP has successfully been crystd.; peptides and small-mol. inhibitors can be soaked into these crystals, which diffract to high resoln.  Here, the BIR2 apo crystal structure and the structures of five BIR2-tetrapeptide complexes are described.  The structural flexibility obsd. on comparing these structures, along with a comparison with XIAP BIR3, affords an understanding of the structural elements that drive selectivity between BIR2 and BIR3 and which can be used to design BIR2-selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6-upk5-drzbVg90H21EOLACvtfcHk0lgF2OYfImdEgg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlKrsLnK&md5=deebf6694f2e53929d7c6ec4e763cf14</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS0907444913016284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913016284%26sid%3Dliteratum%253Aachs%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DBelunis%26aufirst%3DC.%26aulast%3DCrowther%26aufirst%3DR.%26aulast%3DDanho%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DGoggin%26aufirst%3DB.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DRemiszewski%26aufirst%3DS.%26aulast%3DSchutt%26aufirst%3DA.%26aulast%3DThakur%26aufirst%3DM.%2BK.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DPandey%26aufirst%3DR.%26aulast%3DTyagi%26aufirst%3DR.%26aulast%3DGosu%26aufirst%3DR.%26aulast%3DKamath%26aufirst%3DA.%2BV.%26aulast%3DKuglstatter%26aufirst%3DA.%26atitle%3DThe%2520structure%2520of%2520XIAP%2520BIR2%253A%2520understanding%2520the%2520selectivity%2520of%2520the%2520BIR%2520domains%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D.%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1717%26epage%3D1725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="note"><p class="first last">The values for <b>3</b> were generated in-house.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Kaplan-Lefko, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoog, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branstetter, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huard, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peach, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kordich, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foltz, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gliniak, B. C.</span><span> </span><span class="NLM_article-title">Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor types</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">â</span> <span class="NLM_lpage">631</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.4161%2Fcbt.9.8.11264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=20150762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKgtrfP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=618-631&author=P.+J.+Kaplan-Lefkoauthor=J.+D.+Gravesauthor=S.+J.+Zoogauthor=Y.+Panauthor=J.+Wallauthor=D.+G.+Branstetterauthor=J.+Moriguchiauthor=A.+Coxonauthor=J.+N.+Huardauthor=R.+Xuauthor=M.+L.+Peachauthor=G.+Juanauthor=S.+Kaufmanauthor=Q.+Chenauthor=A.+Bianchiauthor=J.+J.+Kordichauthor=M.+Maauthor=I.+N.+Foltzauthor=B.+C.+Gliniak&title=Conatumumab%2C+a+fully+human+agonist+antibody+to+death+receptor+5%2C+induces+apoptosis+via+caspase+activation+in+multiple+tumor+types"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor types</span></div><div class="casAuthors">Kaplan-Lefko, Paula J.; Graves, Jonathan D.; Zoog, Stephen J.; Pan, Yang; Wall, Jason; Branstetter, Daniel G.; Moriguchi, Jodi; Coxon, Angela; Huard, Justin N.; Xu, Ren; Peach, Matthew L.; Juan, Gloria; Kaufman, Stephen; Chen, Qing; Bianchi, Allison; Kordich, Jennifer J.; Ma, Mark; Foltz, Ian N.; Gliniak, Brian C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">618-631</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) binds to death receptors 4 and 5 (DR4, DR5) to transduce apoptotic signals.  Conatumumab (AMG 655) is an investigational, fully human monoclonal agonist antibody (IgG1) to human DR5, which induces apoptosis via caspase activation.  In this study, we demonstrate that conatumumab binds to DR5, activating intracellular caspases in vitro in the presence of a cross-linker.  We also show that conatumumab has activity in vivo and inhibits tumor growth in colon (Colo205 and HCT-15), lung (H2122) and pancreatic (MiaPaCa2/T2) xenograft models.  Conatumumab also enhances the antitumor activity of chemotherapeutics in vivo.  Caspase activation in Colo205 tumors is dose-dependent and correlated with serum concns. of conatumumab.  We demonstrate for the first time that increases in serum caspase-3/7 activity and levels of M30 (neoepitope of caspase-cleaved cytokeratin-18) are linked to activation of the extrinsic apoptotic pathway using conatumumab in a preclin. model.  These data suggest that conatumumab has potential as a therapeutic agent for treating patients with multiple tumor types, and that serum caspase-3/7 and M30 levels may serve as biomarkers of conatumumab activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosXSy5jCCO67Vg90H21EOLACvtfcHk0lg5TC3XgfUljA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKgtrfP&md5=49c72f2ab0f2d2006c708ccea0940f4b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.4161%2Fcbt.9.8.11264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.9.8.11264%26sid%3Dliteratum%253Aachs%26aulast%3DKaplan-Lefko%26aufirst%3DP.%2BJ.%26aulast%3DGraves%26aufirst%3DJ.%2BD.%26aulast%3DZoog%26aufirst%3DS.%2BJ.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DWall%26aufirst%3DJ.%26aulast%3DBranstetter%26aufirst%3DD.%2BG.%26aulast%3DMoriguchi%26aufirst%3DJ.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DHuard%26aufirst%3DJ.%2BN.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DPeach%26aufirst%3DM.%2BL.%26aulast%3DJuan%26aufirst%3DG.%26aulast%3DKaufman%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DBianchi%26aufirst%3DA.%26aulast%3DKordich%26aufirst%3DJ.%2BJ.%26aulast%3DMa%26aufirst%3DM.%26aulast%3DFoltz%26aufirst%3DI.%2BN.%26aulast%3DGliniak%26aufirst%3DB.%2BC.%26atitle%3DConatumumab%252C%2520a%2520fully%2520human%2520agonist%2520antibody%2520to%2520death%2520receptor%25205%252C%2520induces%2520apoptosis%2520via%2520caspase%2520activation%2520in%2520multiple%2520tumor%2520types%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D618%26epage%3D631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Gaither, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borawski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donovan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sage, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slisz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straub, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iourgenko, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlegel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawel, L.</span><span> </span><span class="NLM_article-title">A Smac Mimetic Rescue Screen Reveals Roles for Inhibitor of Apoptosis Proteins in Tumor Necrosis Factor-Î± Signaling</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">11493</span><span class="NLM_x">â</span> <span class="NLM_lpage">11498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=11493-11498&author=A.+Gaitherauthor=D.+Porterauthor=Y.+Yaoauthor=J.+Borawskiauthor=G.+Yangauthor=J.+Donovanauthor=D.+Sageauthor=J.+Sliszauthor=M.+Tranauthor=C.+Straubauthor=T.+Ramseyauthor=V.+Iourgenkoauthor=A.+Huangauthor=Y.+Chenauthor=R.+Schlegelauthor=M.+Labowauthor=S.+Fawellauthor=W.+R.+Sellersauthor=L.+Zawel&title=A+Smac+Mimetic+Rescue+Screen+Reveals+Roles+for+Inhibitor+of+Apoptosis+Proteins+in+Tumor+Necrosis+Factor-%CE%B1+Signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGaither%26aufirst%3DA.%26aulast%3DPorter%26aufirst%3DD.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DBorawski%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DDonovan%26aufirst%3DJ.%26aulast%3DSage%26aufirst%3DD.%26aulast%3DSlisz%26aufirst%3DJ.%26aulast%3DTran%26aufirst%3DM.%26aulast%3DStraub%26aufirst%3DC.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DIourgenko%26aufirst%3DV.%26aulast%3DHuang%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSchlegel%26aufirst%3DR.%26aulast%3DLabow%26aufirst%3DM.%26aulast%3DFawell%26aufirst%3DS.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DZawel%26aufirst%3DL.%26atitle%3DA%2520Smac%2520Mimetic%2520Rescue%2520Screen%2520Reveals%2520Roles%2520for%2520Inhibitor%2520of%2520Apoptosis%2520Proteins%2520in%2520Tumor%2520Necrosis%2520Factor-%25CE%25B1%2520Signaling%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D11493%26epage%3D11498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Kester, R. F.; Donnell, A. F.; Lou, Y.; Remiszewski, S. W.; Lombardo, L. J.; Chen, S.; Le, N. T.; Lo, J.; Moliterni, J. A.; Han, X.; Hogg, J. H.; Liang, W.; Michoud, C.; Rupert, K. C.; Mischke, S.; Le, K.; Weisel, M.; Janson, C. A.; Lukacs, C. M.; Fretland, A. J.; Hong, K.; Polonskaia, A.; Gao, L.; Li, S.; Solis, D. S.; Aguilar, D.; Tardell, C.; Dvorozniak, M.; Tannu, S.; Lee, E. C.; Schutt, A. D.; Goggin, B.</span><span> </span><span class="NLM_article-title">Optimization of Benzodiazepinones as Selective Inhibitors of the X-Linked Inhibitor of Apoptosis Protein (XIAP) Second Baculovirus IAP Repeat (BIR2) Domain</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span>DOI: <span class="refDoi">Â DOI: 10.1021/jm400732v</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm400732v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=R.+F.+Kester&author=A.+F.+Donnell&author=Y.+Lou&author=S.+W.+Remiszewski&author=L.+J.+Lombardo&author=S.+Chen&author=N.+T.+Le&author=J.+Lo&author=J.+A.+Moliterni&author=X.+Han&author=J.+H.+Hogg&author=W.+Liang&author=C.+Michoud&author=K.+C.+Rupert&author=S.+Mischke&author=K.+Le&author=M.+Weisel&author=C.+A.+Janson&author=C.+M.+Lukacs&author=A.+J.+Fretland&author=K.+Hong&author=A.+Polonskaia&author=L.+Gao&author=S.+Li&author=D.+S.+Solis&author=D.+Aguilar&author=C.+Tardell&author=M.+Dvorozniak&author=S.+Tannu&author=E.+C.+Lee&author=A.+D.+Schutt&author=B.+Goggin&title=Optimization+of+Benzodiazepinones+as+Selective+Inhibitors+of+the+X-Linked+Inhibitor+of+Apoptosis+Protein+%28XIAP%29+Second+Baculovirus+IAP+Repeat+%28BIR2%29+Domain&doi=10.1021%2Fjm400732v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm400732v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400732v%26sid%3Dliteratum%253Aachs%26aulast%3DKester%26aufirst%3DR.%2BF.%26atitle%3DOptimization%2520of%2520Benzodiazepinones%2520as%2520Selective%2520Inhibitors%2520of%2520the%2520X-Linked%2520Inhibitor%2520of%2520Apoptosis%2520Protein%2520%2528XIAP%2529%2520Second%2520Baculovirus%2520IAP%2520Repeat%2520%2528BIR2%2529%2520Domain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26doi%3D10.1021%2Fjm400732v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Schutt, A.; Goggin, B. S.; Hong, K.; Polonskaia, A.; To, T.; Tardell, C.; Dvorozniak, M.; Tannu, S.; Aguilar, D.; Solis, D.; Gao, L.; Lukacs, C.; Janson, C.; Hilton, H.; Fretland, A.; Liang, Z.; Lee, K.; Kester, R.; Donnell, A.; Mischke, S.; Han, X.; Chen, S.; Le, N.; Lou, Y.; Remiszewski, S.; Packman, K.; Lee, E. C.</span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schutt%2C+A.%3B+Goggin%2C+B.+S.%3B+Hong%2C+K.%3B+Polonskaia%2C+A.%3B+To%2C+T.%3B+Tardell%2C+C.%3B+Dvorozniak%2C+M.%3B+Tannu%2C+S.%3B+Aguilar%2C+D.%3B+Solis%2C+D.%3B+Gao%2C+L.%3B+Lukacs%2C+C.%3B+Janson%2C+C.%3B+Hilton%2C+H.%3B+Fretland%2C+A.%3B+Liang%2C+Z.%3B+Lee%2C+K.%3B+Kester%2C+R.%3B+Donnell%2C+A.%3B+Mischke%2C+S.%3B+Han%2C+X.%3B+Chen%2C+S.%3B+Le%2C+N.%3B+Lou%2C+Y.%3B+Remiszewski%2C+S.%3B+Packman%2C+K.%3B+Lee%2C+E.+C.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSchutt%26aufirst%3DA." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Zhang, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, T. D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldenburg, K. R.</span><span> </span><span class="NLM_article-title">A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">â</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm400731m&amp;key=10.1177%2F108705719900400206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm400731m&amp;key=10838414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm400731m&amp;key=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1999&pages=67-73&author=J.-H.+Zhangauthor=T.+D.+Y.+Chungauthor=K.+R.+Oldenburg&title=A+Simple+Statistical+Parameter+for+Use+in+Evaluation+and+Validation+of+High+Throughput+Screening+Assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays</span></div><div class="casAuthors">Zhang; Chung; Oldenburg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">67-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The ability to identify active compounds (3hits2) from large chemical libraries accurately and rapidly has been the ultimate goal in developing high-throughput screening (HTS) assays.  The ability to identify hits from a particular HTS assay depends largely on the suitability or quality of the assay used in the screening.  The criteria or parameters for evaluating the 3suitability2 of an HTS assay for hit identification are not well defined and hence it still remains difficult to compare the quality of assays directly.  In this report, a screening window coefficient, called 3Z-factor,2 is defined.  This coefficient is reflective of both the assay signal dynamic range and the data variation associated with the signal measurements, and therefore is suitable for assay quality assessment.  The Z-factor is a dimensionless, simple statistical characteristic for each HTS assay.  The Z-factor provides a useful tool for comparison and evaluation of the quality of assays, and can be utilized in assay optimization and validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkwW5JDdXnbsNIRw0GKUoEfW6udTcc2ebuUfdxywXsprntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D&md5=0ec4ed2ccdd3b4a16521567a0975d31f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1177%2F108705719900400206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F108705719900400206%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.-H.%26aulast%3DChung%26aufirst%3DT.%2BD.%2BY.%26aulast%3DOldenburg%26aufirst%3DK.%2BR.%26atitle%3DA%2520Simple%2520Statistical%2520Parameter%2520for%2520Use%2520in%2520Evaluation%2520and%2520Validation%2520of%2520High%2520Throughput%2520Screening%2520Assays%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D1999%26volume%3D4%26spage%3D67%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KJV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KJV','PDB','4KJV'); return false;">PDB: 4KJV</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i78"><a href="/doi/suppl/10.1021/jm400731m">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_70784"></div></div></div></div></div><hr /></hr><p class="last">EC<sub>50</sub> values for activity in multiple cell lines, synthetic procedures for intermediates, crystallographic method, crystallographic data refinement and statistics.  This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400731m/suppl_file/jm400731m_si_001.pdf">jm400731m_si_001.pdf (163.38 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB ID code for <b>36</b> bound to XIAP BIR2 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KJV">4KJV</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400731m&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Fjm400731m%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-20" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400731m" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a81fdadb2428","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
